---
title: 'Medicine üçä‚≠ê'
date: 2023-01-03
permalink: /note/medicine
tags:
  - note
toc: true
---

Essences of clinical medicine.

{% include toc %}

# Cardiology / Âæ™Áí∞Âô®Áßë

## Introduction / Á∑èË´ñ

## Ischemic Heart Disease and Heart Failure / ËôöË°ÄÊÄßÂøÉÁñæÊÇ£„ÉªÂøÉ‰∏çÂÖ®

### Effort Angina / Âä¥‰ΩúÊÄßÁã≠ÂøÉÁóá

* **Overview**
  * Transient myocardial ischemia due to coronary artery stenosis (from atherosclerosis) and increased oxygen demand (during exertion)
  * Risk factors: Hypertension, DM, dyslipidemia, smoking, aging
* **Presentation**
  * **Chest tightness/pressure during exertion (lasting 3-5 minutes)**: Temporary myocardial ischemia, rapid relief with nitroglycerin
* **Examination**
  * **[ECG] ST depression (during attack or exercise stress)**: Ischemia
  * **[Echocardiography] Wall motion abnormality**: Ischemia
  * **[Blood] No elevation in cardiac biomarkers**: Excludes myocardial necrosis
  * **[Myocardial perfusion SPECT] Reduced uptake during stress, improved at rest**: Reversible ischemia
* **Management**
  * **Nitroglycerin (sublingual)**: Rapid relief of acute attacks (relax coronary artery)
  * **Œ≤-blockers, calcium channel blockers**: Prevent attacks (decrease oxygen demand)
  * **Antiplatelet drugs, statins**: Prevent thrombosis, improve atherosclerosis
  * **Percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG)**: For severe cases
  * **Lifestyle modifications**
{: .notice--info}

### Vasospastic Angina / ÂÜ†Êî£Á∏ÆÊÄßÁã≠ÂøÉÁóá

* **Overview**
  * Transient myocardial ischemia caused by coronary artery spasm
  * Risk factors: Smoking, hypertension, DM, dyslipidemia
* **Presentation**
  * **Chest tightness/pressure at night to early morning or at rest (lasting several to 15 minutes)**: Coronary artery spasm, triggered by hyperventilation, alcohol, or early morning exercise
* **Examination**
  * **[ECG] ST elevation or depression (during attack)**: Ischemia due to spasm
  * **[Blood] No elevation in cardiac biomarkers**: Excludes myocardial infarction
  * **[Coronary angiography] Hyperventilation or drug-induced spasm**: Confirms diagnosis
* **Management**
  * **Nitroglycerin (sublingual)**: Rapid relief of acute attacks (relax coronary artery)
  * **Calcium channel blockers, nitrates**: Prevent attacks (relax coronary artery)
  * **Lifestyle modifications**
{: .notice--info}

### Acute Coronary Syndrome / ÊÄ•ÊÄßÂÜ†ÁóáÂÄôÁæ§

* **Overview**
  * Myocardial ischemia and necrosis due to rapid narrowing or obstruction of coronary artery by thrombosis formation, encompasses unstable angina, acute myocardial infarction, and sudden cardiac death due to ischemia
  * Classified as non-ST elevation ACS (NSTE-ACS) and ST elevation myocardial infarction (STEMI)
  * Risk factors: Hypertension, DM, dyslipidemia, smoking, aging
* **Presentation**
  * **Chest pain at rest or during exertion (lasting several to >15 minutes)**: Acute myocardial ischemia
* **Examination**
  * **[ECG] ST elevation (or depression for NSTE-ACS), hyperacute T, abnoraml Q**:  Infarction or ischemia
  * **[Blood] Elevated cardiac troponin**: Confirms myocardial injury
  * **[Echocardiography]**: Abnormal wall motions
* **Management**
  * **[Initial treatment] Morphine, oxygen, nitroglycerin, aspirin**: Stabilize general condition
  * **[Reperfusion therapy] Percutaneous coronary intervention (PCI), thrombolysis (t-PA), coronary artery bypass grafting (CABG)**: Reopen obstructed coronary artery (first choice: PCI)
  * **[Antiplatelet drugs] Aspirin, clopidogrel, prasugrel**: Prevent thrombosis
  * **[Anti-anginal drugs] Œ≤-blockers, nitrates, calcium channel blockers**: Reduce oxygen demant and relax coronary artery
  * **[Anti-hypertensive drugs] ACE inhibitors, ARBs, MRAs**: Reduce afterload
  * **[Anti-hyperlipidemic drugs] Statins**: Prevent recurrence
  * **[Complications management] Arrhythmias, heart failure, stroke, cardiac rehabilitation**
{: .notice--info}

### Heart Failure / ÂøÉ‰∏çÂÖ®

* **Overview**
  * Cardiac pump dysfunction leading to pulmonary and systemic congestion
  * Causes: Ischemic heart disease, valvular heart disease, cardiomyopathy, hypertension
* **Presentation**
  * **Dyspnea, tachypnea, orthopnea, paroxysmal nocturnal dyspnea**: Left-sided heart failure (pulmonary congestion)
  * **Leg edema, jugular vein distension**: Right-sided heart failure (systemic congestion)
* **Examination**
  * **[Auscultation] Coarse crackles, S3 or S4 gallop**: Pulmonary congestion, ventricular dysfunction
  * **[Chest X-ray] Cardiomegaly, pulmonary vascular markings, butterfly shadow, Kerley's lines, pleural effusion**: Cardiac enlargement and congestion
  * **[Blood] BNP‚Üë, NT-proBNP‚Üë**: Sensitive markers of heart failure
  * **[Echocardiography] Systolic dysfunction, diastolic dysfunction**: Cardiac function assessment
* **Management**
  * **Diuretics, vasodilators**: Improve hemodynamics and symptoms
  * **ACE inhibitors, ARBs, ARNI, MRAs, Œ≤-blockers, ivabradine**: Cardioprotective effects
  * **ICD, CRT, MitraClip, IABP, ECMO, IMPELLA, VAD**: Cardiac and circulatory support for severe cases
  * **Heart transplantation**: For end-stage heart failure
  * **Disease management**: Address underlying causes
{: .notice--info}

## Arrhythmia / ‰∏çÊï¥ËÑà

### Atrial Premature Contraction / ÂøÉÊàøÊúüÂ§ñÂèéÁ∏Æ

* **Overview**
  * Premature excitation from atria earlier than sinus node firing
* **Presentation**
  * **Asymptomatic, palpitations, chest discomfort**: Mostly asymptomatic
* **Examination**
  * **[ECG] Early P wave**: Premature atrial depolarization
* **Management**
  * **Observation**: For asymptomatic cases
  * **Œ≤-blockers , Na channel blockers**: For symptomatic cases
{: .notice--info}

### Paroxysmal Supraventricular Tachycardia / Áô∫‰ΩúÊÄß‰∏äÂÆ§È†ªÊãç

* **Overview**
  * Supraventricular tachycardia due to reentry involving AV node (AVNRT) or accessory pathway (AVRT)
* **Presentation**
  * **Palpitations (sudden onset and termination)**: Reentry mechanism
  * **Dizziness, syncope (in severe cases)**: Due to reduced cardiac output
* **Examination**
  * **[ECG] Regular narrow QRS complexes at 120-220 bpm**: Supraventricular origin of tachycardia
* **Management**
  * **Vagal maneuvers, ATP, calcium channel blockers**: For stable hemodynamics
  * **Cardioversion, overdrive pacing**: For unstable hemodynamics
  * **Catheter ablation**: Curative treatment
{: .notice--info}

### Wolff-Parkinson-White Syndrome / WPWÁóáÂÄôÁæ§

* **Overview**
  * Presence of accessory pathway directly connecting atria and ventricles, can cause AVRT or AF resembling VT
* **Presentation**
  * **Asymptomatic**: Mostly
  * **Palpitations, syncope**: During tachycardia episodes
* **Examination**
  * **[ECG] Delta wave, short PQ interval, wide QRS complex**: Ventricular pre-excitation through accessory pathway
  * **[ECG] AVRT or AF resembling VT (during episodes)**: Reentry or direct connection
* **Management**
  * **Observation**: For asymptomatic cases
  * **Vagal maneuvers, ATP, Ca channel blockers**: For AVRT
  * **Na channel blockers**: For AF resembling VT (digitalis and Ca channel blockers contraindicated)
  * **Cardioversion**: For hemodynamically unstable AVRT or AF
  * **Catheter ablation**: Curative treatment
{: .notice--info}

### Atrial Flutter / ÂøÉÊàøÁ≤óÂãï

* **Overview**
  * Regular reentrant circuit in atria with consistent conduction to ventricles
* **Presentation**
  * **Palpitations, dyspnea**: Due to rapid heart rate
* **Examination**
  * **[ECG] Regular RR intervals, narrow QRS complexes, regular flutter waves (~300/min)**: Regular tachycardia with consistent AV conduction ratio
* **Management**
  * **Na channel blockers, K channel blockers, Ca channel blockers, cardioversion**: Termination of episodes
  * **Catheter ablation**: Prevention of recurrence
  * **Anticoagulation**: For thromboembolic prevention
  * **Upstream therapy**: Treatment of underlying diseases
{: .notice--info}

### Atrial Fibrillation / ÂøÉÊàøÁ¥∞Âãï

* **Overview**
  * Rapid and disorganized electrical activity in atria leading to irregular ventricular conduction
  * Common in elderly, hypertension, valvular disease, heart failure, ischemic heart disease, hyperthyroidism
  * High risk of thromboembolism due to left atrial thrombus formation
* **Presentation**
  * **Palpitations, irregular pulse**: Due to irregular ventricular conduction
* **Examination**
  * **[ECG] Irregular RR intervals, narrow QRS complexes, absence of P waves with fine baseline oscillations**: Rapid atrial activation with irregular conduction to ventricles
* **Management**
  * **Anticoagulation (warfarin, DOAC)**: Thromboembolism prevention
  * **Œ≤-blockers, Ca channel blockers, digitalis**: Rate control
  * **Na channel blockers, K channel blockers, cardioversion**: Rhythm control
  * **Catheter ablation**: Prevention of recurrence
  * **Upstream therapy**: Treatment of underlying diseases
{: .notice--info}

### Ventricular Premature Contraction / ÂøÉÂÆ§ÊúüÂ§ñÂèéÁ∏Æ

* **Overview**
  * Premature ectopic excitation from ventricles, seen in patients with underlying heart diseases
* **Presentation**
  * **Asymptomatic, palpitations, chest discomfort**
* **Examination**
  * **[ECG] Wide QRS complex without preceding P wave**: Premature ventricular depolarization
* **Management**
  * **Observation**: For asymptomatic cases without risk factors
  * **Na channel blockers, K channel blockers, Œ≤-blockers**: For symptomatic cases or risk of VT/VF (myocardial infarction)
{: .notice--info}

### Ventricular Tachycardia / ÂøÉÂÆ§È†ªÊãç

* **Overview**
  * Consecutive VPCs causing tachycardia, dangerous arrhythmia with risk of pulselessness and VF
* **Presentation**
  * **Palpitations, shortness of breath**: Due to rapid heart rate
  * **Dizziness, syncope, loss of consciousness**: Due to reduced cardiac output
* **Examination**
  * **[ECG] Wide QRS complexes occurring regularly**: Regular ventricular tachycardia
* **Management**
  * **Amiodarone, nifekalant, procainamide**: Acute termination (hemodynamically stable)
  * **Cardioversion, electrical defibrillation**: Acute termination (hemodynamically unstable)
  * **Amiodarone, sotalol, bepridil, catheter ablation**: Prevention of recurrence (normal cardiac function)
  * **Implantable cardioverter-defibrillator (ICD)**: Prevention of recurrence (reduced cardiac function)
{: .notice--info}

### Ventricular Fibrillation / ÂøÉÂÆ§Á¥∞Âãï

* **Overview**
  * Completely disorganized ventricular excitation resulting in zero cardiac output, rapidly fatal without immediate treatment
  * Common in: STEMI, cardiomyopathy, Brugada syndrome, long QT syndrome, hypoxemia, hypothermia
* **Presentation**
  * **Dizziness followed by immediate syncope, absence of pulse**: Sudden loss of cardiac output
* **Examination**
  * **[ECG] Completely irregular waves with variable amplitude and frequency**: Chaotic ventricular activity
* **Management**
  * **Immediate electrical defibrillation**: First-line treatment
  * **CPR 2 minutes, IV adrenaline, defibrillation**: If above unsuccessful
  * **CPR 2 minutes, IV nifekalant or amiodarone, defibrillation**: If above unsuccessful
  * **CPR 2 minutes, IV Œ≤-blockers, left stellate ganglion block**: If above unsuccessful
  * **Treatment of underlying disease**: If defibrillation successful
{: .notice--info}

### Sick Sinus Syndrome / Ê¥û‰∏çÂÖ®ÁóáÂÄôÁæ§

* **Overview**
  * Dysfunction of sinoatrial node or surrounding tissue, leading to sinus bradycardia, sinoatrial block, or sinus arrest
* **Presentation**
  * **Dizziness, lightheadedness, syncope**: Cerebral hypoperfusion due to bradycardia
  * **Fatigue, shortness of breath**: Heart failure symptoms
* **Examination**
  * **[ECG] Sinus bradycardia (HR < 50 bpm), sinus arrest (absence of P waves)**: Dysfunction of sinoatrial node
* **Management**
  * **Observation**: For asymptomatic cases
  * **Pacemaker implantation**: For persistent symptomatic bradycardia
  * **Atropine, isoproterenol, theophylline, cilostazol**: For cases where pacemaker is not suitable
{: .notice--info}

### Atrioventricular Block / ÊàøÂÆ§„Éñ„É≠„ÉÉ„ÇØ

* **Overview**
  * Delayed or interrupted conduction from atria to ventricles at AV node or His bundle
* **Presentation**
  * **Syncope, heart failure**: Due to decreased cardiac output
* **Examination**
  * **[ECG] Prolonged PQ intervals**: 1st degree AV block
  * **[ECG] Progressive lengthing of PQ intervals with subsequent QRS drop**: Mobitz I 2nd degree AV block
  * **[ECG] Regular PQ intervals with random QRS drop**: Mobitz II 2nd degree AV block
  * **[ECG] P and QRS independently at regular intervals**: 3rd degree AV block
  * **[Auscultation] Cannon sound**: Loud S1 every few beats (3rd degree AV block)
* **Management**
  * **Observation**: For 1st degree and Mobitz I 2nd degree AV block
  * **Pacemaker implantation**: For Mobitz II 2nd degree and 3rd degree AV block
  * **Atropine, isoproterenol**: Bridge therapy before pacemaker implantation
{: .notice--info}

### Bundle Branch Block / ËÑö„Éñ„É≠„ÉÉ„ÇØ

* **Overview**
  * Impaired conduction in right or left bundle branch due to myocardial ischemia or degeneration
* **Presentation**
  * Asymptomatic
* **Examination**
  * **[ECG] Wide QRS, rSR' in V1, wide S in V6**: Right bundle branch block
  * **[ECG] Wide QRS, QS or rS in V1, absent septal Q and notched QRS in V6**: Left bundle branch block
* **Management**
  * **Observation**: Mostly
  * **Cardiac resynchronization therapy (CRT)**: For some left bundle branch block 
{: .notice--info}

### Brugada Syndrome / BrugadaÁóáÂÄôÁæ§

* **Overview**
  * Genetic disorder causing ventricular fibrillation during parasympathetic dominance
  * More common in young to middle-aged men, often associated with family history of sudden death
* **Presentation**
  * **Recurrent syncope, loss of consciousness**: Due to VF episodes
  * **Sudden cardiac death**: Especially during sleep or rest after meals
* **Examination**
  * **[ECG] Right bundle branch block pattern, characteristic ST elevation**: Diagnostic feature
* **Management**
  * **Implantable cardioverter defibrillator (ICD)**: Only effective prevention for sudden death
  * **Pharmacological therapy, catheter ablation**: Considered in some cases
{: .notice--info}

### Long QT Syndrome / QTÂª∂Èï∑ÁóáÂÄôÁæ§

* **Overview**
  * Prolongation of myocardial action potential leading to extended QT interval, can cause torsades de pointes (a type of polymorphic VT)
* **Presentation**
  * **Recurrent syncope**: Due to TdP episodes
  * **Sudden cardiac death**: In severe cases
* **Examination**
  * **[ECG] Corrected QT interval > 0.48 seconds**: Diagnostic feature
* **Management**
  * **Beta-blockers, temporary pacing**: For congenital LQTS
  * **Remove underlying cause**: For acquired LQTS
  * **Magnesium sulfate**: During TdP episodes
{: .notice--info}

## Endocardium and Valvular Disease / ÂøÉÂÜÖËÜú„ÉªÂºÅËÜúÁñæÊÇ£

### Mitral Stenosis / ÂÉßÂ∏ΩÂºÅÁã≠Á™ÑÁóá

* **Overview**
  * Narrowing of mitral valve, impeding blood flow from left atrium to left ventricle
  * Common in women over 40-50 years, often with history of rheumatic fever
* **Presentation**
  * **Dyspnea on exertion, palpitations, irregular pulse**: Due to pulmonary congestion and atrial fibrillation
  * **Embolism**: Thrombus formation in left atrium
* **Examination**
  * **[Auscultation] Accentuated S1, opening snap, diastolic rumble, presystolic murmur**: Mitral valve stenosis
  * **[ECG] Left atrial enlargement, atrial fibrillation**: Increase left atrium pressure
  * **[Chest X-ray] Prominent left 3rd arc**: Enlarged left atrium
  * **[Echocardiography] Reduced valve area, dome-shaped anterior mitral leaflet**: Confirms diagnosis
* **Management**
  * **Symptomatic treatment**: For heart failure
  * **Anticoagulation**: For patients with AF
  * **Percutaneous mitral commissurotomy (PTMC)**: Catheter-based valve opening
  * **Open mitral commissurotomy (OMC) or mitral valve replacement (MVR)**: Surgical options
{: .notice--info}

### Mitral Regurgitation / ÂÉßÂ∏ΩÂºÅÈñâÈéñ‰∏çÂÖ®Áóá

* **Overview**
  * Backflow of blood from left ventricle to left atrium during systole
  * Common causes: mitral valve prolapse, ischemic heart disease
* **Presentation**
  * **Dyspnea on exertion, palpitations, fatigue, paroxysmal nocturnal dyspnea, orthopnea**: Left heart failure symptoms
* **Examination**
  * **[Auscultation] Holosystolic murmur at apex, diminished S1, S3**: Mitral valve regurgitation
  * **[ECG] Left atrial enlargement, left ventricular hypertrophy, atrial fibrillation**: Increased volume load
  * **[Chest X-ray] Prominent left 3rd and 4th arcs**: Left atrial and ventricular enlargement
  * **[Echocardiography] Valve abnormalities, left heart enlargement, regurgitation**: Confirms diagnosis
* **Management**
  * **Symptomatic treatment**: For heart failure
  * **Mitral valve repair or replacement (MVR)**: Surgical options
{: .notice--info}

### Mitral Valve Prolapse / ÂÉßÂ∏ΩÂºÅÈÄ∏ËÑ±Áóá

* **Overview**
  * Syndrome characterized by prolapse of mitral valve leaflets into left atrium during systole
  * Often idiopathic, can be associated with Marfan syndrome
* **Presentation**
  * **Asymptomatic, chest pain, dizziness**: Mild cases
  * **Heart failure symptoms**: Severe mitral regurgitation
* **Examination**
  * **[Auscultation] Mid-systolic click or Holosystolic murmur**: Mitral valve prolapse or regurgitation
  * **[Echocardiography] Prolapse of mitral valve leaflets during systole**: Confirms diagnosis
* **Management**
  * **Œ≤ blockers**: For chest pain and dizziness
{: .notice--info}

### Aortic Stenosis / Â§ßÂãïËÑàÂºÅÁã≠Á™ÑÁóá

* **Overview**
  * Narrowing of aortic valve, impeding blood flow from left ventricle to aorta
  * Causes: Degeneration due to aging, abnormal number of valves
* **Presentation**
  * **Dyspnea, angina**: Left heart failure, myocardial ischemia due to ventricular hypertrophy
  * **Syncope, dizziness, slow and weak pulse, hypotension**: Reduced cardiac output
* **Examination**
  * **[Auscultation] Ejection click, systolic ejection murmur, diminished and paradoxical splitting of S2**: Aortic valve stenosis
  * **[ECG] Left ventricular hypertrophy**
  * **[Echocardiography] Restricted valve opening, reduced valve area, increased transvalvular gradient**: Confirms diagnosis
* **Management**
  * **Aortic valve replacement (AVR)**: Surgical option
  * **Transcatheter aortic valve implantation (TAVI)**: Less invasive option
{: .notice--info}

### Aortic Regurgitation / Â§ßÂãïËÑàÂºÅÈñâÈéñ‰∏çÂÖ®Áóá

* **Overview**
  * Backflow of blood from aorta to left ventricle during diastole
  * Causes left ventricular volume and pressure overload, leading to LV enlargement and hypertrophy
  * Can be compensated for long periods, but poor prognosis once heart failure develops
* **Presentation**
  * **Palpitations**: Increased stroke volume
  * **Dyspnea, angina**: Pulmonary congestion, decreased diastolic aortic pressure
  * **Strong and fast pulse, capillary pulsations of fingernail bed (Quincke's sign)**: Increased pulse pressure
* **Examination**
  * **[Auscultation] Diastolic decrescendo murmur, systolic ejection murmur, Austin-Flint murmur**: Aortic valve regurgitation, relative AS, functional MS
  * **[Chest X-ray] Prominent left 4th arc**: Left ventricular enlargement
  * **[ECG] Left ventricular hypertrophy**
  * **[Echocardiography] Valve abnormalities, left ventricular enlargement, regurgitation, fluttering of mitral valve**: Confirms diagnosis
* **Management**
  * **Aortic valve replacement (AVR) or aortic valvuloplasty (AVP)**: Surgical option
{: .notice--info}


### Tricuspid Stenosis / ‰∏âÂ∞ñÂºÅÁã≠Á™ÑÁóá

* **Overview**
  * Narrowing of tricuspid valve, impeding blood flow from right atrium to right ventricle
  * Mostly due to rheumatic fever
* **Presentation**
  * **Asymptomatic**
  * **Right heart failure symptoms**: In advanced cases
* **Examination**
  * **[Auscultation] Diastolic rumble**: Tricuspid valve stenosis
  * **[Echocardiography] Restricted tricuspid valve, increased transvalvular gradient**: Confirms diagnosis
* **Management**
  * **Symptomatic treatment**: For heart failure
  * **Tricuspid valve replacement**: Surgical options
{: .notice--info}

### Tricuspid Regurgitation / ‰∏âÂ∞ñÂºÅÈñâÈéñ‰∏çÂÖ®Áóá

* **Overview**
  * Backflow of blood from right ventricle to right atrium during systole
  * Common causes: Pulmonary hypertension due to left valvular heart disease
* **Presentation**
  * **Asymptomatic**
  * **Right heart failure symptoms**: In advanced cases
* **Examination**
  * **[Auscultation] Holosystolic murmur**: Tricuspid valve regurgitation
  * **[Echocardiography] Valve abnormalities, regurgitation**: Confirms diagnosis
* **Management**
  * **Symptomatic treatment**: For heart failure
  * **Tricuspid valve repair or replacement**: Surgical options
{: .notice--info}

### Infective Endocarditis / ÊÑüÊüìÊÄßÂøÉÂÜÖËÜúÁÇé

* **Overview**
  * Systemic septic disease with vegetation formation on heart valves or endocardium due to bacterial infection
  * Common cause: Dental intervention, with underlying congenital heart disease or valvular heart disease
* **Presentation**
  * **Fever, joint pain, muscle pain**: Systemic infection
  * **Petechiae, splinter hemorrhages, Osler nodes, Janeway lesions, Roth spots**: Peripheral embolism
  * **Stroke, renal infarction, splenic infarction**: Systemic embolism
  * **Congestive heart failure**: Valve destruction, regurgitation, or chordae tendineae rupture
* **Examination**
  * **[Auscultation] Heart murmur**: Valvular damage
  * **[Blood] WBC‚Üë, ESR‚Üë, CRP‚Üë, Œ≥-globulin‚Üë, fibrinogen‚Üë**: Inflammatory response
  * **[Blood culture] Pathogen detection**: Confirms causative microorganism
  * **[Echocardiography] Vegetation**: Confirms cardiac involvement
* **Management**
  * **High-dose, long-term intravenous antibiotics**: Based on causative microorganism
  * **Surgical intervention**: If antibiotics ineffective
{: .notice--info}

### Cardiac Myxoma / ÂøÉËáìÁ≤òÊ∂≤ËÖ´

* **Overview**
  * Most common primary cardiac tumor, mostly occur in the left atrium
* **Presentation**
  * **Fatigue, weight loss, fever, joint pain**: Systemic effects due to IL-6 secreted by tumor
* **Examination**
  * **[Auscultation] Variable diastolic murmur with position changes, tumor plop**: Tumor movement mimicking mitral stenosis
  * **[Blood] ESR‚Üë, WBC‚Üë, CRP‚Üë, Œ≥-globulin‚Üë**: Inflammation due to IL-6 secreted by tumor
  * **[Echocardiography] Mass in atrium**: Confirms diagnosis
* **Management**
  * **Surgical resection**: Prevents potentially fatal embolization
{: .notice--info}

## Myocardium Disease / ÂøÉÁ≠ãÁñæÊÇ£

### Dilated Cardiomyopathy / Êã°ÂºµÂûãÂøÉÁ≠ãÁóá

* **Overview**
  * Degenerative myocardial disease with left ventricular dilation and reduced contractility
  * More common in males aged 40-70, about 20-30% are familial
* **Presentation**
  * **Palpitations, dyspnea, pulsus alternans, edema**: Chronic progressive heart failure
* **Examination**
  * **[Auscultation] S3 or S4 (gallop rhythm), systolic murmur**: Heart failure, ventricular dilation leading to mitral regurgitation
  * **[ECG] Left ventricular high voltage, wide QRS**: Left ventricular hypertrophy
  * **[Chest X-ray] Cardiomegaly**: Heart failure
  * **[Echocardiography, MRI] Dilated left ventricle, diffuse hypokinesis**: Left ventricular dilation
  * **[Cardiac catheterization] LVEDP‚Üë, PAWP‚Üë**: Left heart failure
* **Management**
  * **Lifestyle modifications (restrict water and salt), medication (Œ≤-blockers, ACE inhibitors, ARBs, MRAs)**: For heart failure
  * **Cardiac resynchronization therapy (CRT), ventricular assist devices (VAD), heart transplantation**: For severe heart failure
  * **Anticoagulation**: For thromboembolism prevention
  * **Antiarrhythmic drugs, implantable cardioverter-defibrillator (ICD), pacemaker**: For arrhythmia management
{: .notice--info}

### Hypertrophic Cardiomyopathy / ËÇ•Â§ßÂûãÂøÉÁ≠ãÁóá

* **Overview**
  * Degenerative myocardial disease with asymmetric ventricular hypertrophy, with high risk of sudden death
  * 50% familial (autosomal dominant, mutation of sarcomere protein gene)
* **Presentation**
  * **Chest pain, dyspnea, palpitations**: Due to increased oxygen demand, pulmonary congestion, and arrhythmia
  * **Dizziness, syncope**: Due to left ventricular outflow tract obstruction or arrhythmia
* **Examination**
  * **[Auscultation] S4, S3, increased apical impulse**: Ventricular diastolic dysfunction
  * **[ECG] Left ventricular high voltage, ST depression, negative T waves**: Left ventricular hypertrophy, relative ischemia
  * **[Chest X-ray] Normal or mild cardiomegaly, upper lung field congestion**: Pulmonary congestion
  * **[Echocardiography, MRI] Asymmetric left ventricular wall hypertrophy (thickness ‚â•15 mm), diastolic dysfunction**: Left ventricular hypertrophy
  * **[Cardiac catheterization] LVEDP‚Üë**: Diastolic dysfunction
* **Management**
  * **Lifestyle modifications (Avoid strenuous exercise), implantable cardioverter-defibrillator (ICD)**: Prevent sudden death
  * **Medications (Œ≤-blockers, CCBs, diuretics, ACE inhibitors, ARBs)**: For heart failure
  * **Antiarrhythmic drugs, anticoagulants**: For arrhythmia management
{: .notice--info}

### Hypertrophic Obstructive Cardiomyopathy / ÈñâÂ°ûÊÄßËÇ•Â§ßÂûãÂøÉÁ≠ãÁóá

* **Overview**
  * Subset of HCM with left ventricular outflow tract obstruction (about 25% of HCM cases)
* **Presentation**
  * **Symptoms of HCM**
  * **Bifid pulse**: Due to dynamic obstruction
* **Examination**
  * **[Auscultation] Ejection systolic murmur**: Outflow obstruction
  * **[Echocardiography] Systolic anterior motion of mitral valve**: Due to increased outflow speed and Venturi phenomenon
  * **[Cardiac catheterization] Brockenbrough phenomenon**: Increased LV-aorta systolic pressure gradient after premature ventricular contraction
* **Management**
  * **Treatmnents of HCM**
  * **Medications (Œ≤-blockers, CCBs, antiarrhythmics)**: Decrease LV-aorta systolic pressure gradient
  * **Surgical myectomy, pacemaker implantation, percutaneous transluminal septal myocardial ablation (PTSMA)**: For refractory cases
{: .notice--info}

### Restrictive Cardiomyopathy / ÊãòÊùüÂûãÂøÉÁ≠ãÁóá

* **Overview**
  * Characterized by reduced left ventricular compliance and diastolic dysfunction
* **Presentation**
  * **Generalized edema, pulmonary congestion, pleural effusion**: Heart failure symptoms
* **Examination**
  * **[Cardiac catheterization] Dip and plateau pattern in ventricular pressure curve**: Diastolic restriction
* **Management**
  * **Symptom management (diuretics)**
{: .notice--info}

### Cardiac Sarcoidosis / ÂøÉËáì„Çµ„É´„Ç≥„Ç§„Éâ„Éº„Ç∑„Çπ

* **Overview**
  * Part of systemic sarcoidosis, forming non-caseating epithelioid granulomas in multiple organs
* **Presentation**
  * **Complete atrioventricular block, ventricular arrhythmias**: Damage to conduction pathways and cardiac muscles
* **Examination**
  * **[Ga scintigraphy, PET] Focal uptake in heart**: Inflammation
* **Management**
  * **Corticosteroid**: Control inflammation
{: .notice--info}

### Cardiac Amyloidosis / ÂøÉ„Ç¢„Éü„É≠„Ç§„Éâ„Éº„Ç∑„Çπ

* **Overview**
  * Systemic syndrome with amyloid protein deposition in various organs (AL amyloidosis or ATTR amyloidosis)
* **Presentation**
  * **Cardiac hypertrophy, diastolic dysfunction**: Deposition of amyloid protein
* **Examination**
  * **[ECG] Low voltage, conduction disorders**: Damage to conduction pathways
  * **[Echocardiography] Cardiac hypertrophy, diastolic dysfunction**: Deposition of amyloid protein
  * **[Cardiac biopsy] Amyloid deposition in myocardium**: Confirms diagnosis
* **Management**
  * **Symptomatic treatment**: For heart failure and arrhythmias
{: .notice--info}

### Acute Myocarditis / ÊÄ•ÊÄßÂøÉÁ≠ãÁÇé

* **Overview**
  * Acute myocardial necrosis and dysfunction due to infection (mostly virus) or idiopathic, may cause of sudden death but good prognosis if overcome acute phase
* **Presentation**
  * **Flu-like symptoms, gastrointestinal symptoms**: Prodromal phase of infection
  * **Heart failure symptoms, chest pain, fever**: Acute cardiac inflammation
* **Examination**
  * **[Auscultation] S3, crackles**: Heart failure signs
  * **[ECG] ST-T changes, arrhythmia**: Myocardial injury and conduction disturbances
  * **[Echocardiography] Diffuse wall thickening, hypokinesis, small cardiac chambers, pericardial effusion**: Myocardial inflammation and dysfunction
  * **[Blood] Troponin T‚Üë, CK-MB‚Üë, AST‚Üë, LDH‚Üë, CRP‚Üë**: Myocardial injury and inflammation
  * **[Endomyocardial biopsy] Inflammatory cell infiltration, myocyte necrosis, interstitial edema**: Confirms diagnosis
* **Management**
  * **Bed rest, hospitalization**: Supportive care
  * **Diuretics, catecholamines, IABP, ECMO**: For heart failure and cardiogenic shock
  * **Pacemaker, defibrillation**: For arrhythmia
{: .notice--info}

## Pericardium Disease / ÂøÉËÜúÁñæÊÇ£

### Acute Pericarditis / ÊÄ•ÊÄßÂøÉËÜúÁÇé

* **Overview**
  * Acute inflammation of the pericardium, mostly idiopathic (90%) or viral, generally good prognosis
* **Presentation**
  * **Chest pain worsening in supine position and during inspiration**: Pericardial irritation
  * **Fever**: Inflammatory response
* **Examination**
  * **[Auscultation] Pericardial friction rub**: Inflamed pericardial surfaces rubbing together
  * **[ECG] Diffuse concave ST elevation**: Pericardial inflammation
  * **[Blood] WBC‚Üë, ESR‚Üë, CRP‚Üë**: Inflammatory response
  * **[Echocardiography] Small pericardial effusion**: May be present
  * **[Chest X-ray] Usually normal**: Distinguishes from pleuritis
* **Management**
  * **Symptomatic treatment (NSAIDs)**: Often self-resolving
  * **Treat primary cause**: If secondary to underlying disease
{: .notice--info}

### Cardiac Tamponade / ÂøÉ„Çø„É≥„Éù„Éä„Éº„Éá

* **Overview**
  * Life-threatening condition where pericardial fluid accumulation impairs cardiac filling
  * Causes include aortic dissection, cardiac rupture after MI, trauma, malignancies invading pericardium
* **Presentation**
  * **Hypotension, jugular vein distension, muffled heart sounds**: Decreased cardiac output, increased venous pressure, pericardial fluid accumulation
  * **Hepatomegaly, ascites, leg edema**: Right heart failure signs
  * **Narrow pulse pressure, tachycardia, pulsus paradoxus (systolic BP drop during inspiration)**: Decreased cardiac output, exaggerated when increased venous return compress left ventricle
* **Examination**
  * **[Chest X-ray] Enlarged flask-shaped cardiac silhouette**: Pericardial effusion
  * **[Echocardiography] Echo-free space in pericardium, ventricular free wall collapse**: Confirmatory findings
* **Management**
  * **Pericardiocentesis**: Definitive treatment to drain fluid
  * **Treat underlying cause**
{: .notice--info}

### Constrictive Pericarditis / ÂèéÁ∏ÆÊÄßÂøÉËÜúÁÇé

* **Overview**
  * Chronic inflammation causing fibrotic thickening and calcification of pericardium, impairing cardiac filling
  * Causes include idiopathic, tuberculosis, viral, post-radiation, post-cardiac surgery
* **Presentation**
  * **Dyspnea on exertion, fatigue**: Decreased cardiac output
  * **Jugular vein distension (exaggerated during inspiration = Kussmaul's sign), ascites, edema, hepatomegaly, congestive cirrhosis**: Right heart failure signs
* **Examination**
  * **[Auscultation] Pericardial knock**: Abrupt cessation of ventricular filling
  * **[ECG] Low voltage, nonspecific ST-T changes**: Thickening of pericardium
  * **[Echocardiography, Chest X-ray, CT, MRI] Thickened or calcified pericardium**: Thickening of pericardium
  * **[Cardiac catheterization] M or W-shaped RAP curve, RVP dip and plateau pattern**: Impaired ventricular filling lead to increased pressure of RA, rapid filling and termination of RV
* **Management**
  * **Pericardiectomy**: Definitive treatment
{: .notice--info}

## Congenital Heart Disease / ÂÖàÂ§©ÊÄßÂøÉÁñæÊÇ£

## Arterial Disorder / ÂãïËÑàÁñæÊÇ£

### Aortic Aneurysm / Â§ßÂãïËÑàÁò§

* **Overview**
  * Abnormal dilation of aorta due to atherosclerosis, potentially fatal if ruptured
  * More common in middle-aged and elderly men
* **Presentation**
  * **Asymptomatic**: Most common
  * **Hoarseness, Horner's syndrome**: Compression of recurrent laryngeal nerve or sympathetic nerves
  * **Dysphagia, nausea, vomiting**: Compression of esophagus
  * **Cough, hemoptysis, dyspnea**: Compression of trachea or lungs
  * **Altered consciousness, abdominal pain, leg numbness**: Organ ischemia
* **Examination**
  * **[PE] Pulsatile abdominal mass**: Expansion of abdominal aorta
  * **[Chest X-ray] Widened mediastinal shadow**: Expansion of thoracic aorta
  * **[CT, MRI, Ultrasound] Aneurysm**: Confirmation of size and location
* **Management**
  * **Lifestyle modification, blood pressure control**: Conservative management
  * **Artificial graft replacement, endovascular stent grafting**: If aneurysm >5-6 cm or rapid expansion
{: .notice--info}

### Ruptured Aortic Aneurysm / Â§ßÂãïËÑàÁò§Á†¥Ë£Ç

* **Overview**
  * Life-threatening complication of aortic aneurysm
* **Presentation**
  * **Sudden severe chest/back/lumbar pain, anemia, shock**: Rupture and rapid blood loss
  * **Hemoptysis, hematemesis**: Blood leaking into adjacent structures
* **Examination**
  * **[CT, Ultrasound] Aneurysm and hematoma**: Confirmation of rupture
* **Management**
  * **Artificial graft replacement, endovascular stent grafting, open stent grafting**: Immediate intervention required
{: .notice--info}

### Aortic Dissection / Â§ßÂãïËÑàËß£Èõ¢

* **Overview**
  * Tear in aortic intima leads to blood flow separating the medial layer and forming a false lumen, high mortality rate
  * Risk factors: Chronic hypertension, congenital connective tissue disorders
* **Presentation**
  * **Sudden severe chest/back pain**: Aortic wall disruption
  * **Hypertension, blood pressure difference between arms**: Organ ischemia
* **Examination**
  * **[ECG] No specific findings**: Rules out myocardial infarction
  * **[Blood] Elevated D-dimer**: Indicates thrombosis
  * **[Chest X-ray] Widened mediastinal shadow**: Aortic dilatation
  * **[CT] Intimal flap, true and false lumens**: Confirms diagnosis
  * **[Echocardiography] Aortic regurgitation, pericardial effusion**: Complications
* **Management**
  * **[Stanford Type A] Emergency surgical graft replacement**: Involving ascending aorta
  * **[Stanford Type B] Blood pressure and heart rate control, pain management**: Not involving ascending aorta 
  * **[Stanford Type B] Endovascular stent graft**: For complications or refractory cases
{: .notice--info}

### Takayasu's Arteritis / È´òÂÆâÂãïËÑàÁÇé

* **Overview**
  * Chronic vasculitis affecting aorta and its major branches
  * More common in young women
* **Presentation**
  * **Fever, fatigue**: Systemic inflammation
  * **Dizziness, syncope**: Common carotid artery stenosis
  * **Upper limb numbness/coldness**: Subclavian artery stenosis
  * **Heart murmur**: Often due to aortic regurgitation
* **Examination**
  * **[PE] Weak/absent pulses, BP differences, bruits**: Vascular stenosis
  * **[Blood] ESR‚Üë, CRP‚Üë, WBC‚Üë, Œ≥-globulin‚Üë**: Inflammatory markers
  * **[DSA, CT, MRA, FDG-PET] Vessel wall calcification, stenosis/occlusion/dilation**: Confirms diagnosis
* **Management**
  * **Corticosteroids, immunosuppressants**: Suppress inflammation
  * **Surgery**: For cardiac or aortic lesions
{: .notice--info}

### Arteriosclerosis Obliterans (ASO) / ÈñâÂ°ûÊÄßÂãïËÑàÁ°¨ÂåñÁóá

* **Overview**
  * Chronic occlusive disease of arteries below abdominal aorta due to atherosclerosis
  * Common in males over 50, major form of peripheral arterial disease (PAD)
* **Presentation**
  * **Intermittent claudication, rest pain, ulcers/necrosis**: Chronic lower limb ischemia
  * **Weakened or absent peripheral pulses, asymmetry**: Arterial occlusion
* **Examination**
  * **[Physical] Weakened or absent arterial sounds, ankle-brachial index (ABI) ‚â§ 0.9**: Reduced blood flow
  * **[Angiography] Irregular arterial walls, 'moth-eaten' appearance**: Arterial narrowing and occlusion
  * **[Ultrasound, MRA, CTA] Arterial stenosis or occlusion**
* **Management**
  * **Risk factor modification**: Control hypertension, diabetes, dyslipidemia; smoking cessation
  * **Exercise therapy, antiplatelet drugs, vasodilators**: For intermittent claudication
  * **Revascularization (severe ischemia or refractory claudication)**: 
    * Percutaneous transluminal angioplasty (PTA), stenting
    * Bypass surgery, thromboembolectomy


### Thromboangiitis Obliterans (TAO) / ÈñâÂ°ûÊÄßË°ÄÊ†ìË°ÄÁÆ°ÁÇé [Buerger's Disease]

* **Overview**
  * Inflammatory occlusive disease of small to medium-sized arteries and veins in distal extremities
  * Affects male smokers under 50, etiology unknown
* **Presentation**
  * **Cold sensation, numbness, Raynaud's phenomenon in extremities**: Reduced blood flow
  * **Intermittent claudication, severe ischemic symptoms (painful ulcers, necrosis) in fingers/toes**: Progressive vascular occlusion
  * **Decreased skin temperature, weakened or absent peripheral pulses**: Vascular compromise
* **Examination**
  * **[Doppler] Decreased ankle blood pressure, low ankle-brachial index (ABI)**: Reduced distal blood flow
  * **[Angiography] Abrupt vessel cutoffs, corkscrew collaterals, 'accordion-like' appearance**: Characteristic vascular changes
* **Management**
  * **Smoking cessation**: Essential for disease control
  * **Antiplatelet drugs (e.g., cilostazol), prostaglandin E1 infusion**: Improve blood flow
  * **Sympathectomy, bypass surgery (in select cases)**: Surgical interventions
  * **Amputation**: In advanced cases with severe tissue damage


### Acute Arterial Occlusive Disease / ÊÄ•ÊÄßÂãïËÑàÈñâÂ°ûÁóá

* **Overview**
  * Sudden occlusion of peripheral arteries due to embolism or thrombosis
  * High mortality rate (10-28%) if not treated promptly
* **Presentation**
  * **Sudden pain, pallor, pulselessness, paralysis, paresthesia (5 P's)**: Acute limb ischemia
* **Examination**
  * **[Physical] Irregular pulse, absent peripheral pulses**: Signs of embolism or thrombosis
  * **[ABI] Decreased ankle-brachial index**: Reduced blood flow
  * **[Doppler ultrasound, Angiography, MDCT, MRA] Arterial occlusion**: Confirm diagnosis and location
* **Management**
  * **Urgent revascularization**: 
    * Thromboembolectomy (e.g., Fogarty catheter)
    * Bypass surgery
    * Catheter-directed thrombolysis
  * **Anticoagulation therapy**: Heparin infusion
* **Etiology**
  * **Embolism**: Atrial fibrillation, cardiac myxoma
  * **Thrombosis**: Hypercoagulability, atherosclerosis


## Venous Disorder / ÈùôËÑàÁñæÊÇ£

## Blood Pressure Disorder / Ë°ÄÂúßÁï∞Â∏∏

<!-- ## Introduction / Á∑èË´ñ

### Cardiovascular Drugs / Âæ™Áí∞Âô®ÁñæÊÇ£Ê≤ªÁôÇËñ¨

* **Calcium channel blocker (DHP)**
  * **Drugs**: Amlodipine, nifedipine
  * **Mechanism**: Decrease intracellular calcium, relax smooth muscle
  * **Indication**: Hypertension, angina pectoris
  * **Adverse effect**: Tachycardia, flush
* **Calcium channel blocker (non-DHP)**
  * **Drugs**: Verapamil, diltiazem, bepridil
  * **Mechanism**: Decrease intracellular calcium, inhibit SA node and AV node
  * **Indication**: Supraventribular tachycardia
  * **Adverse effect**: Bradycardia
* **Œ≤ blockers**
* **Œ±Œ≤ blockers**
{: .notice--info}


### Adrenergic Agonist / „Ç¢„Éâ„É¨„Éä„É™„É≥‰ΩúÂãïËñ¨

* **Œ±Œ≤ agonist**
  * **Drugs**: Epinephrine, norepinephrine, dopamine
  * **Mechanism**: Œ±Œ≤ agonist (epinephrine: Œ≤>Œ±, norepinephrine: Œ±>Œ≤, dopamine: D>Œ≤>Œ±)
  * **Indication**: Shock (dopamine preserve renal blood flow), glaucoma (epinephrine)
* **Œ±1 agonist**
  * **Drugs**: Oxymetazoline, phenylephrine, midodrine
  * **Mechanism**: Œ±1 agonist
  * **Indication**: Nasal congestion (Oxymetazoline, phenylephrine), midodrine (orthostatic hypotension)
* **Œ±2 agonist**
  * **Drugs**: Clonidine, methyldopa, brimonidine
  * **Mechanism**: Œ±2 agonist
  * **Indication**: Hypertension (methyldopa: for pregnant women), glaucoma (brimonidine)
* **Œ≤ agonist**
  * **Drugs**: Isoproterenol
  * **Mechanism**: Œ≤1-Œ≤2 agonist
  * **Indication**: Bradycardia
* **Œ≤1 agonist**
  * **Drugs**: Dobutamine
  * **Mechanism**: Œ≤1 agonist
  * **Indication**: Heart failure
* **Œ≤2 agonist**
  * **Drugs**: Albuterol (salbutamol), terbutaline, fenoterol, metaproterol, procaterol, salmeterol, formoterol, ritodrine
  * **Mechanism**: Œ≤2 agonist
  * **Indication**: Asthma, COPD, tocolytic (ritodrine)
* **Œ≤3 agonist**
  * **Drugs**: Mirabegron
  * **Mechanism**: Œ≤3 agonist
  * **Indication**: Overactive bladder
* **Indirect agonist**
  * **Drugs**: Amphetamine, methylphenidate, modafinil, cocaine, amitryptiline
  * **Mechanism**: Increase catecholamine release (amphetamine), inhibit catecholamine reuptake (others)
  * **Indication**: ADHD, narcolepsy
* **Mixed agonist**
  * **Drugs**: Ephedrine, pseudoephedrine
  * **Mechanism**: Direct and indirect agonist
  * **Indication**: Nasal congestion, nocturnal neuresis
{: .notice--info}

### Adrenergic Antagonist / „Ç¢„Éâ„É¨„Éä„É™„É≥ÊãÆÊäóËñ¨

* **Œ± antagonist**
  * **Drugs**: Phentolamine, phenoxybenzamine
  * **Mechanism**: Non-selective Œ± antagonist
  * **Indication**: Pheochromocytoma diagnosis (Phentolamine), pheochromocytoma treatment (phenoxybenzamine)
* **Œ±1 antagonist**
  * **Drugs**: Prazosin, doxazosin, terazosin, tamsulosin, indoramin, urapidil
  * **Mechanism**: Œ±1 antagonist
  * **Indication**: Hypertension, BPH
* **Œ±2 antagonist**
  * **Drugs**: Mirtazapine
  * **Mechanism**: Œ±2 antagonist
  * **Indication**: Depression
* **Œ≤ antagonist**
  * **Drugs**: Nadolol, pindolol, propranolol, timolol
  * **Mechanism**: Non-selective Œ≤ antagonist
  * **Indication**: Hypertension, arrhythmia, heart failure, glaucoma (timolol)
* **Œ≤1 antagonist**
  * **Drugs**: Acebutolol, atenolol, betaxolol, bisoprolol, esmolol, metoprolol
  * **Mechanism**: Œ≤1 antagonist
  * **Indication**: Same as Œ≤ antagonist
* **Œ±Œ≤ antagonist**
  * **Drugs**: Labetalol, carvedilol
  * **Mechanism**: Œ±Œ≤ antagonist
  * **Indication**: Hypertension, heart failure
* **Indirect antagonist**
  * **Drugs**: Reserpine, guanethidene, bretylium, metyrosine
  * **Mechanism**: Deplete neurotransmitter in vesicle (reserpine), inhibit vesicle release (guanethidine, bretylium), inhibit tyrosine hydroxylase (metyrosine)
  * **Indication**: Hypertension, heart failure
{: .notice--info}

### Cholinergic Agonist / „Ç≥„É™„É≥‰ΩúÂãïËñ¨

* **Direct agonist**
  * **Drugs**: Acetylcholine, bethanechol, carbachol, methacholine, pilocarpine, cevimeline
  * **Mechanism**: Muscarinic agonist (+ nicotinic agonist: acetylcholine, carbachol)
  * **Indication**: Ileus and urinary retension, asthma diagnosis (methacholine), glaucoma (pilocarpine), Sjogren syndrome (cevimeline)
* **Indirect agonist (anti-cholinesterase)**
  * **Drugs**: Physostigmine, neostigmine, pyridostigmine, edrophonium, ambenonium
  * **Mechanism**: Inhibit cholinesterase to increase acetylcholine
  * **Indication**: Myasthenia gravis, ileus and urinary retension, glaucoma (physostigmine)
  * **Organic phosphate**: Irreversible anti-cholinesterase (treatment: pyridostigmine, atropine, pralidoxime)
{: .notice--info}

### Cholinergic Antagonist / „Ç≥„É™„É≥ÊãÆÊäóËñ¨

* **Muscarinic antagonist**
  * **Drugs and indication**
    * Reduce exocrine: Atropine
    * Ophthalmoscopic examination: Homatropine, cyclopentolate, tropicamide
    * Motion sickness: Scopolamine
    * Gastric ulcer: Pirenzepine, propantheline
    * Diarrhea and IBS: Dicyclomine, clidinium
    * Asthama and COPD: Ipratropium, tiotropium
    * Overactive bladder: Oxybutynin
    * Parkinson disease: Trihexyphenidyl, bentropine, biperidin
  * **Mechanism**: Muscarinic antagonist
* **Nitotinic antagonist (ganglion blocker)**
  * **Drugs**: Mecamylamine, trimethaphan, hexamethonium
  * **Mechanism**: Nitotinic antagonist at autonomic ganglion
  * **Indication**: Hypertension
* **Nitotinic antagonist (muscle relaxant)**
  * **Drugs**: Tubocurarine, mivacurium, atracurium, cisatracurium, pancuronium, vecuronium, rocuronium, succinylcholine, decamothonium
  * **Mechanism**: Nitotinic antagonist at neuromuscular junction (non-depolarizing: tubocurarine ~ rocuronium, depolarizing: succinylcholine, decamothonium)
  * **Indication**: Anesthesia
* **Other muscle relaxant**
  * **Drugs**: Diazepam, baclofen, tizanidine, dantroline, hemicholinium, botulinum toxin, tetrodotoxin
  * **Mechanism**: GABA-A agonist (diazepam), GABA-B agonist (baclofen), Œ±2 agonist (tizanidine), ryodine receptor blocker (dantroline), inhibit cholien uptake (hemicholinium), inhibit vesicle release (botulinum toxin), inhibit Na+ channel (tetrodotoxin)
  * **Indication**: Spasmolytic
{: .notice--info}

### Antihypertensive Drug / ÈôçÂúßËñ¨

* **ACE inhibitor**
  * **Drugs**: Captopril, enalapril, lisinopril
  * **Mechanism**: Angiotensin converting enzyme inhibitor
  * **Indication**: Hypertension (heart failure, diabetes)
  * **Adverse effect**: Nonproductive cough, angioadema
* **Angiotensin II receptor blocker**
  * **Drugs**: Losartan, valsartan, candesartan
  * **Mechanism**: Angiotensin II receptor blocker
  * **Indication**: Hypertension
* **Renin inhibitor**
  * **Drugs**: Aliskiren
  * **Mechanism**: Renin inhibitor
  * **Indication**: Hypertension
* **Œ≤-blocker**
  * **Drugs**: Acebutolol, atenolol, carvedilol, esmolol, labetalol, metoprolol, pindolol, propranolol
  * **Mechanism**: Œ≤1-blocker (reduce cardial output, inhibit renin secretion)
  * **Indication**: Hypertension
  * **Adverse effect**: Asthma
* **Calcium channel blocker**
  * **Drugs**: DHP: Amlodipine, nifedipine, felodipine / Non-DHP: verapamil, diltiazem, bepridil
  * **Mechanism**: Calcium channel blocker (vessel: DHP, heart: non-DHP)
  * **Indication**: Hypertension
* **Vasodilator**
  * **Drugs**: Minoxidil, diazoxide, hydralazine, nitroprusside
  * **Mechanism**: Activate K channel (minoxidil, diazoxide), increase cGMP (hydralazine, nitroprusside)
  * **Indication**: Hypertension
  * **Adverse effect**: Hirsutism (minoxidil), hyperglycemia (diazoxide), lupus-like syndrome (hydralazine), nitroprusside (cyanide toxicity)
* **Œ±1 antagonist**
  * **Drugs**: Prazosin, doxazosin, terazosin
  * **Mechanism**: Œ±1 antagonist 
  * **Indication**: Hypertension (with BPH)
* **Œ±2 agonist**
  * **Drugs**: Clonidine, methyldopa
  * **Mechanism**: Œ±2 agonist 
  * **Indication**: Hypertension (pregnancy)
* **D1 agonist**
  * **Drugs**: Fenoldopam
  * **Mechanism**: D1 agonist
  * **Indication**: Malignant hypertension
* **PDE5 inhibitor**
  * **Drugs**: Sildenafil, vardenafil
  * **Mechanism**: PDE5 inhibitor, increase cGMP
  * **Indication**: Pulmonary hypertension, erectile dysfunction
* **Diuretics**
  * See diuretics
{: .notice--info}

### Heart Failure Drug / ÂøÉ‰∏çÂÖ®„ÅÆËñ¨

* **Cardiac glycoside**
  * **Drugs**: Digoxin, digitoxin
  * **Mechanism**: Inhibit Na/K ATPase, elevate intreacellular Ca
  * **Indication**: Congestive heart failure
  * **Adverse effect**: GI distress, visual disturbance, digoxin toxicity (treat with potassium and antibody)
* **PDE3 inhibitor**
  * **Drugs**: Melrinone, amrinone
  * **Mechanism**: Inhibit PDE3, increase cAMP
  * **Indication**: Heart failure
* **Adrenergic agonist**
  * **Drugs**: Dobutamine
  * **Mechanism**: Œ≤1 agonist
  * **Indication**: Heart failure
* **BNP agonist**
  * **Drugs**: Nesiritide, sacubitril
  * **Mechanism**: BNP agonist (nersiritide), increase BNP (sacubitril)
  * **Indication**: Heart failure
{: .notice--info}

### Antianginal Drug / ÊäóÁã≠ÂøÉÁóáËñ¨

* **Nitrates**
  * **Drugs**: Nitroglycerin, isosorbide mononitrate, isosorbide dinitrate
  * **Mechanism**: Increase cGMP
  * **Indication**: Angina pectoris
  * **Adverse effect**: Headache, flushing
* **Ranolazine**
  * **Drugs**: Ranolazine
  * **Mechanism**: Inhibit Na current, decrease intracellular Ca
  * **Indication**: Angina pectoris
  * **Adverse effect**: QT prolongation
{: .notice--info}

### Antiarrhythmic Drug / Êäó‰∏çÊï¥ËÑàËñ¨

* **Class IA**
  * **Drugs**: Quinidine, procainamide, disopyramide
  * **Mechanism**: Na (and K) channel blocker (prolong QRS)
  * **Indication**: Arrythmia
  * **Adverse effect**: Torsade de pointes, cinchonism (quinidine), lupus-like syndrome (procainamide)
* **Class IB**
  * **Drugs**: Mexiletine, lidocaine, phenytoin
  * **Mechanism**: Na channel blocker (prolong QRS)
  * **Indication**: Arrythmia
* **Class IC**
  * **Drugs**: Flecanide, propafenone
  * **Mechanism**: Na channel blocker (prolong QRS)
  * **Indication**: Arrythmia
* **Class II**
  * **Drugs**: Propranolol, metoprolol, pindolol, esmolol
  * **Mechanism**: Œ≤ blocker (prolong PR)
  * **Indication**: Tachycardia, Post-MI
* **Class III**
  * **Drugs**: Amiodarone, dronedarone, sotalol, ibutilide, dofetilide
  * **Mechanism**: K channel blocker (prolong QT)
  * **Indication**: Arrythmia
  * **Adverse effect**: Torsade de pointes, thyroid dysfunction (amiodarone), liver dysfunction (amiodarone), pulmonary fibrosis (amiodarone)
* **Class IV**
  * **Drugs**: Verapamil, diltiazem, bepridil
  * **Mechanism**: Ca channel blocker (prolong PR)
  * **Indication**: Tachycardia
* **Class V**
  * **Drugs**: Adenosine, MgSO4
  * **Mechanism**: Gi (adenosine)
  * **Indication**: PSVT (adenosine), torsade de pointes (MgSO4)
{: .notice--info} -->

<!-- ## Heart Failure / ÂøÉ‰∏çÂÖ®

### Left-Sided Heart Failure / Â∑¶ÂøÉ‰∏çÂÖ®
### Right-Sided Heart Failure / Âè≥ÂøÉ‰∏çÂÖ®

## Arrhythmia / ‰∏çÊï¥ËÑà

### Sinus Tachycardia / Ê¥ûÊÄßÈ†ªËÑà
### Paroxysmal Supraventricular Tachycardia / Áô∫‰ΩúÊÄß‰∏äÂÆ§È†ªÊãç
### Wolff-Parkinson-White Syndrome / WPWÁóáÂÄôÁæ§
### Atrial Flutter / ÂøÉÊàøÁ≤óÂãï
### Atrial Fibrillation / ÂøÉÊàøÁ¥∞Âãï
### Atrial Premature Contraction / ÂøÉÊàøÊúüÂ§ñÂèéÁ∏Æ
### Ventricular Premature Contraction / ÂøÉÂÆ§ÊúüÂ§ñÂèéÁ∏Æ
### Ventricular Tachycardia / ÂøÉÂÆ§È†ªÊãç
### Ventricular Fibrillation / ÂøÉÂÆ§Á¥∞Âãï
### Long QT Syndrome / QTÂª∂Èï∑ÁóáÂÄôÁæ§
### Brugada Syndrome / BrugadaÁóáÂÄôÁæ§
### Sick Sinus Syndrome / Ê¥û‰∏çÂÖ®ÁóáÂÄôÁæ§
### Atrioventricular Block / ÊàøÂÆ§„Éñ„É≠„ÉÉ„ÇØ
### Bundle Branch Block / ËÑö„Éñ„É≠„ÉÉ„ÇØ

## Ischemic Heart Disease / ËôöË°ÄÊÄßÂøÉÁñæÊÇ£

### Effort Angina Pectoris / Âä¥‰ΩúÊÄßÁã≠ÂøÉÁóá
### Vasospastic Angina Pectoris / ÂÜ†Êî£Á∏ÆÊÄßÁã≠ÂøÉÁóá
### Unstable Angina Pectoris / ‰∏çÂÆâÂÆöÁã≠ÂøÉÁóá
### Acute Myocardial Infarction / ÊÄ•ÊÄßÂøÉÁ≠ãÊ¢óÂ°û
### Complication of Myocardial Infarction / ÂøÉÁ≠ãÊ¢óÂ°û„ÅÆÂêà‰ΩµÁóá

## Valvular Heart Disease / ÂøÉËáìÂºÅËÜúÁóá

### Mitral Stenosis / ÂÉßÂ∏ΩÂºÅÁã≠Á™ÑÁóá
### Mitral Regurgitation / ÂÉßÂ∏ΩÂºÅÈñâÈéñ‰∏çÂÖ®Áóá
### Mitral Valve Prolapse / ÂÉßÂ∏ΩÂºÅÈÄ∏ËÑ±Áóá
### Aortic Stenosis / Â§ßÂãïËÑàÂºÅÁã≠Á™ÑÁóá
### Aortic Regurgitation / Â§ßÂãïËÑàÂºÅÈñâÈéñ‰∏çÂÖ®Áóá
### Tricuspid Stenosis / ‰∏âÂ∞ñÂºÅÁã≠Á™ÑÁóá
### Tricuspid Regurgitation / ‰∏âÂ∞ñÂºÅÈñâÈéñ‰∏çÂÖ®Áóá

## Endocardium, Myocardium and Pericardium Disease / ÂøÉÂÜÖËÜú„ÉªÂøÉÁ≠ã„ÉªÂøÉËÜúÁñæÊÇ£

### Infectious Endocarditis / ÊÑüÊüìÊÄßÂøÉÂÜÖËÜúÁÇé
### Cardiac Myxoma / ÂøÉËáìÁ≤òÊ∂≤ËÖ´
### Dilated Cardiomyopathy / Êã°ÂºµÂûãÂøÉÁ≠ãÁóá
### Hypertrophic Cardiomyopathy / ËÇ•Â§ßÂûãÂøÉÁ≠ãÁóá
### Restrictive Cardiomyopathy / ÊãòÊùüÂûãÂøÉÁ≠ãÁóá
### Takotsubo-Type Cardiomyopathy / „Åü„Åì„Å§„ÅºÂûãÂøÉÁ≠ãÁóá
### Myocarditis / ÂøÉÁ≠ãÁÇé
### Acute Pericarditis / ÊÄ•ÊÄßÂøÉËÜúÁÇé
### Cardiac Tamponade / ÂøÉ„Çø„É≥„Éù„Éä„Éº„Éá
### Constrictive Pericarditis / ÂèéÁ∏ÆÊÄßÂøÉËÜúÁÇé

## Arterial Disease / ÂãïËÑàÁñæÊÇ£

### Arteriosclerosis / ÂãïËÑàÁ°¨Âåñ
### Aortic Aneurysm / Â§ßÂãïËÑàÁò§
### Aortic Dissection / Â§ßÂãïËÑàËß£Èõ¢
### Arterio-Venous Fistula / ÂãïÈùôËÑàÁòª
### Acute Arterial Occlusive Disease / ÊÄ•ÊÄßÂãïËÑàÈñâÂ°ûÁóá
### Arteriosclerosis Obliterans / ÈñâÂ°ûÊÄßÂãïËÑàÁ°¨ÂåñÁóá
### Thromboangiitis Obliterans / ÈñâÂ°ûÊÄßË°ÄÊ†ìË°ÄÁÆ°ÁÇé
### Raynaud Disease / RaynaudÁóÖ

## Venous Disease / ÈùôËÑàÁñæÊÇ£

### Deep Vein Thrombosis / Ê∑±ÈÉ®ÈùôËÑàË°ÄÊ†ìÁóá
### Varicose Vein / ‰∏ãËÇ¢ÈùôËÑàÁò§
### SVC Syndrome / ‰∏äÂ§ßÈùôËÑàÁóáÂÄôÁæ§
### Lymphedema / „É™„É≥„ÉëÊµÆËÖ´

## Blood Pressure Disorder / Ë°ÄÂúßÁï∞Â∏∏

### Essential Hypertension / Êú¨ÊÖãÊÄßÈ´òË°ÄÂúßÁóá
### Secondary Hypertension / ‰∫åÊ¨°ÊÄßÈ´òË°ÄÂúßÁóá
### Malignant Hypertension / ÊÇ™ÊÄßÈ´òË°ÄÂúßÁóá
### Hypotension / ‰ΩéË°ÄÂúß -->

# Pulmonology/ ÂëºÂê∏Âô®Áßë

## Introduction / Á∑èË´ñ

## Infectious Disorder / ÊÑüÊüìÊÄßÁñæÊÇ£

## Immune and Allergic Disorder / ÂÖçÁñ´„Éª„Ç¢„É¨„É´„ÇÆ„ÉºÊÄßÁñæÊÇ£

## Interstitial Lung Disease / ÈñìË≥™ÊÄßËÇ∫ÁñæÊÇ£

## Obstructive Lung Disease / ÈñâÂ°ûÊÄßËÇ∫ÁñæÊÇ£

## Lung Tumor / ËÇ∫ËÖ´Áòç

## Pulmonary Circulation Disorder / ËÇ∫Âæ™Áí∞ÈöúÂÆ≥

## Functional Respiratory Disorder / Ê©üËÉΩÁöÑÂëºÂê∏ÈöúÂÆ≥

## Pleural Disorder / ËÉ∏ËÜúÁñæÊÇ£

## Mediastinal Disorder / Á∏¶ÈöîÁñæÊÇ£

## Miscellaneous Respiratory Disorder / „Åù„ÅÆ‰ªñ„ÅÆÂëºÂê∏Âô®ÁñæÊÇ£

<!-- ### Inferior Respiratory Tract / ‰∏ãÊ∞óÈÅì

* **Bronchial tree**
  * **Structure**: Trachea, main bronchus, lobar bronchus, segmental bronchus, terminal bronchus (conduction) \| (respiratory) respiratory bronchus, alveolar duct, alveolus
  * **Trachea and broncus**: Smooth muscle, cartilage, gland, globet cell, pseudostratified columnar
  * **Bronchiole**: Smooth muscle, simple columnar to cuboid, Clara cell (surfactant)
  * **Alveoli**: Simple squamous, type I pneumocyte (septum), type II pneumocyte (surfactant), alveolar macrophate
* **Lung**
  * **Structure**: 2 left lobe (9 segment), 3 right lobe (10 segment), horizontal fissure, oblique fissure
  * **Root**: Main bronchus, pulmonary artery and vein, bronchiolar artery and vein, phrenic nerve (anterior), vagus nerve (posterior)
  * **Hilum**: Left (heart, aortic arch, thoracic aorta, aorta-bronchus-vein), right (vena cava, azygos vein, bronchus-aorta-vein)
  * **Artery**: Pulmonary artery (exchange), bronchial artery (nutrition)
  * **Nerve**: Sympathetic nerve (bronchodilation, vasoconstriction), Parasympathetic nerve (bronchoconstriction, vasodilation, sensation)
  * **Pleura**: Visceral pleura (autonomic nerve), parietal pleura (intercostal nerve, phrenic nerve), pleural cavity
  * **Inferior**: Lung (R6-R8-R10), pleura (R8-R10-R12)
{: .notice--info} -->

<!-- ## Infectious Disease / ÊÑüÊüìÊÄßÁñæÊÇ£

### Acute Bronchiolitis / ÊÄ•ÊÄßÁ¥∞Ê∞óÁÆ°ÊîØÁÇé
### Community-Acquired Pneumonia / Â∏Ç‰∏≠ËÇ∫ÁÇé
### Hospital-Acquired Pneumonia / Èô¢ÂÜÖËÇ∫ÁÇé
### Aspiration Pneumonia / Ë™§Âö•ÊÄßËÇ∫ÁÇé
### Streptococcus Penumoniae Pneumonia / ËÇ∫ÁÇéÁêÉËèåËÇ∫ÁÇé
### Haemophilus Influenzae Pneumonia / „Ç§„É≥„Éï„É´„Ç®„É≥„Ç∂ËèåËÇ∫ÁÇé
### Klebsiella Pneumoniae Pneumonia / „ÇØ„É¨„Éñ„Ç∑„Ç®„É©ËÇ∫ÁÇé
### Staphylococcus Aureus Pneumonia / ÈªÑËâ≤„Éñ„Éâ„Ç¶ÁêÉËèåËÇ∫ÁÇé
### Moraxella Catarrhalis Pneumonia / „É¢„É©„ÇØ„Çª„É©ËÇ∫ÁÇé
### Pseudomonas Aeruginosa Pneumonia / Á∑ëËÜøËèåËÇ∫ÁÇé
### Legionella Pneumophila Pneumonia / „É¨„Ç∏„Ç™„Éç„É©ËÇ∫ÁÇé
### Mycoplasma Pneumoniae Pneumonia / „Éû„Ç§„Ç≥„Éó„É©„Ç∫„ÉûËÇ∫ÁÇé
### Chlamydophila Pneumoniae Pneumonia / „ÇØ„É©„Éü„Ç∏„Ç¢ËÇ∫ÁÇé
### Psittacosis / „Ç™„Ç¶„É†ÁóÖ
### Viral Pneumonia / „Ç¶„Ç§„É´„ÇπÊÄßËÇ∫ÁÇé
### Lung Abscess / ËÇ∫ËÜøÁòç
### Pulmonary Tuberculosis / ËÇ∫ÁµêÊ†∏
### Miliary Tuberculosis / Á≤üÁ≤íÁµêÊ†∏
### Nontuberculous Mycobacteriosis / ÈùûÁµêÊ†∏ÊÄßÊäóÈÖ∏ËèåÁóá
### Simple Pulmonary Aspergilloma / ÂçòÁ¥îÊÄßËÇ∫„Ç¢„Çπ„Éö„É´„ÇÆ„É≠„Éº„Éû
### Chronic Progressive Pulmonary Aspergillosis / ÊÖ¢ÊÄßÈÄ≤Ë°åÊÄßËÇ∫„Ç¢„Çπ„Éö„É´„ÇÆ„É´„ÇπÁóá
### Invasive Pulmonary Aspergillosis / ‰æµË•≤ÊÄßËÇ∫„Ç¢„Çπ„Éö„É´„ÇÆ„É´„ÇπÁóá
### Pulmonary Cryptococcosis / ËÇ∫„ÇØ„É™„Éó„Éà„Ç≥„ÉÉ„Ç´„ÇπÁóá

## Obstructive Lung Disease / ÈñâÂ°ûÊÄßËÇ∫ÁñæÊÇ£

### Chronic Obstructive Pulmonary Disease / ÊÖ¢ÊÄßÈñâÂ°ûÊÄßËÇ∫ÁñæÊÇ£
### Diffuse Panbronchiolitis / „Å≥„Åæ„ÇìÊÄßÊ±éÁ¥∞Ê∞óÁÆ°ÊîØÁÇé
### Lymphangioleiomyomatosis / „É™„É≥„ÉëËÑàÁÆ°Á≠ãËÖ´Áóá

## Interstitial Lung Disease / ÈñìË≥™ÊÄßËÇ∫ÁñæÊÇ£

### Idiopathic Pulmonary Fibrosis / ÁâπÁô∫ÊÄßËÇ∫Á∑öÁ∂≠Áóá
### Non-Specific Interstitial Pneumonia / ÈùûÁâπÁï∞ÊÄßÈñìË≥™ÊÄßËÇ∫ÁÇé
### Cryptogenic Organizing Pneumonia / ÁâπÁô∫ÊÄßÂô®Ë≥™ÂåñËÇ∫ÁÇé
### Asbestosis / Áü≥Á∂øËÇ∫
### Silicosis / Áè™ËÇ∫
### Radiation Pneumonitis / ÊîæÂ∞ÑÁ∑öËÇ∫ÁÇé
### Drug-Induced Pneumonia / Ëñ¨Ââ§ÊÄßËÇ∫ÁÇé

## Immune and Allergic Lung Disease / ÂÖçÁñ´„Éª„Ç¢„É¨„É´„ÇÆ„ÉºÊÄßËÇ∫ÁñæÊÇ£

### Bronchial Asthma / Ê∞óÁÆ°ÊîØÂñòÊÅØ
### Aspirin-Induced Asthma / „Ç¢„Çπ„Éî„É™„É≥ÂñòÊÅØ
### Acute Eosinophilic Pneumonia / ÊÄ•ÊÄßÂ•ΩÈÖ∏ÁêÉÊÄßËÇ∫ÁÇé
### Chronic Eosinophilic Pneumonia / ÊÖ¢ÊÄßÂ•ΩÈÖ∏ÁêÉÊÄßËÇ∫ÁÇé
### Allergic Bronchopulmonary Aspergillosis / „Ç¢„É¨„É´„ÇÆ„ÉºÊÄßÊ∞óÁÆ°ÊîØËÇ∫„Ç¢„Çπ„Éö„É´„ÇÆ„É´„ÇπÁóá
### Hypersensitivity Pneumonitis / ÈÅéÊïèÊÄßËÇ∫ÁÇé

## Lung and Bronchus Malformation / ËÇ∫„ÉªÊ∞óÁÆ°ÊîØ„ÅÆÂΩ¢ÊÖãÁï∞Â∏∏
### Bronchiectasis / Ê∞óÁÆ°ÊîØÊã°ÂºµÁóá
### Atelectasis / ÁÑ°Ê∞óËÇ∫
### Pulmonary Sequestration / ËÇ∫ÂàÜÁîªÁóá
### Pulmonary Cystic Disease / ËÇ∫Âö¢ËÉûÁóá
### Pulmonary Alveolar Proteinosis / ËÇ∫ËÉûËõãÁôΩÁóá

## Lung Tumor / ËÇ∫ËÖ´Áòç

### Pulmonary Hamartoma / ËÇ∫ÈÅéË™§ËÖ´
### Squamous Cell Carcinoma / ÊâÅÂπ≥‰∏äÁöÆÁôå
### Adenocarcinoma / ËÖ∫Áôå
### Small Cell Lung Carcinoma / Â∞èÁ¥∞ËÉûËÇ∫Áôå
### Metastatic Lung Tumor / Ëª¢ÁßªÊÄßËÇ∫ËÖ´Áòç

## Pulmonary Circulation Disorder / ËÇ∫Âæ™Áí∞ÈöúÂÆ≥

### Pulmonary Thromboembolism / ËÇ∫Ë°ÄÊ†ìÂ°ûÊ†ìÁóá
### Idiopathic Pulmonary Arterial Hypertension / ÁâπÁô∫ÊÄßËÇ∫ÂãïËÑàÊÄßËÇ∫È´òË°ÄÂúßÁóá
### Cor Pulmonale / ËÇ∫ÊÄßÂøÉ
### Pulmonary Arteriovenous Fistula / ËÇ∫ÂãïÈùôËÑàÁòª
### Pulmonary Edema / ËÇ∫Ê∞¥ËÖ´
### Acute Respiratory Distress Syndrome / ÊÄ•ÊÄßÂëºÂê∏Á™ÆËø´ÁóáÂÄôÁæ§

## Functional Respiratory Disease / Ê©üËÉΩÁöÑÂëºÂê∏ÈöúÂÆ≥

### Hyperventilation Syndrome / ÈÅéÊèõÊ∞óÁóáÂÄôÁæ§
### CO2 Narcosis / CO2„Éä„É´„Ç≥„Éº„Ç∑„Çπ
### Sleep Apnea Syndrome / Áù°Áú†ÊôÇÁÑ°ÂëºÂê∏ÁóáÂÄôÁæ§

## Pleural Disease / ËÉ∏ËÜúÁñæÊÇ£

### Pneumothorax / Ê∞óËÉ∏
### Pleuritis / ËÉ∏ËÜúÁÇé
### Pyothorax / ËÜøËÉ∏
### Chylothorax / ‰π≥„Å≥ËÉ∏
### Pleural Mesothelioma / ËÉ∏ËÜú‰∏≠ÁöÆËÖ´

## Mediastinal Disease / Á∏¶ÈöîÁñæÊÇ£

### Acute Mediastinitis / ÊÄ•ÊÄßÁ∏¶ÈöîÁÇé
### Mediastinal Emphysema / Á∏¶ÈöîÊ∞óËÖ´
### Thymoma / ËÉ∏ËÖ∫ËÖ´
### Neurogenic Tumor / Á•ûÁµåÂéüÊÄßËÖ´Áòç
### Germ Cell Tumor / ËÉöÁ¥∞ËÉûËÖ´Áòç -->

# Gastroenterology / Ê∂àÂåñÂô®Áßë

## Introduction / Á∑èË´ñ

## Esophagus Disorder / È£üÈÅìÁñæÊÇ£

## Stomach Disorder / ËÉÉÁñæÊÇ£

## Intestine Disorder / ËÖ∏ÁñæÊÇ£

## Anus Disorder / ËÇõÈñÄÁñæÊÇ£

## Peritoneum Disorder / ËÖπËÜúÁñæÊÇ£

## Liver Disorder / ËÇùÁñæÊÇ£

## Biliary Tract Disorder / ËÉÜÈÅìÁñæÊÇ£

### Cholelithiasis / ËÉÜÁü≥Áóá

* **Overview**
  * Stones in gallbladder, bile duct or liver
  * Commonly in middle-aged and older adults
* **Presentation**
  * **Asymptomatic**
  * **Sudden pain in right upper quadrant, lasting for hours**: Gallstone temporarily obstructs cystic or bile duct, leading to increased pressure in gallbladder
  * **Radiating pain to right shoulder or back**: Irritation of phrenic nerve
  * **Nausea, vomiting**: Irritation of vagus nerve
* **Examination**
  * **[Blood] ALP‚Üë, Œ≥-GT‚Üë, bilirubin‚Üë**: Bile stasis and bile duct damage
  * **[Ultrasound] High-echoic image with acoustic shodows**: Stone reflects sound waves
  * **[CT] High-density stone**
  * **[MRCP, ERCP] Defect images of stone**
* **Management**
  * **NSAIDs, anticholinergic drugs**: Relieve pain
  * **[Gallbladder stone] Observation (asymptomatic), laparoscopic cholecystectomy (symptomatic)**: Remove gallbladder and stones
  * **[Common bile duct stone] Endoscopic sphincterotomy or endoscopic papillary balloon dilation, endoscopic lithotripsy**: Widen sphincter of Oddi and remove stones
  * **[Intrahepatic stone] Percutaneous transhepatic cholangioscopy, hepatectomy (liver atrophy or intrahepatic cholangiocarcinoma)**: Remove stones, remove liver lobe if necessary
{: .notice--info}

### Acute Cholecystitis / ÊÄ•ÊÄßËÉÜÂö¢ÁÇé

* **Overview**
  * Acute inflammation and infection of gallbladder, due to blockage of cystic duct by stones
  * Commonly in middle-aged and older adults, with history of gallstones
* **Presentation**
  * **Pain in right upper quadrant, Murphy's sign**: Increased pressure and inflammation of gallbladder
  * **Fever**: Infection
  * **Abdominal tenderness, muscle guarding**: Irritation of peritoneum
* **Examination**
  * **[Blood] WBC‚Üë, CRP‚Üë**: Infection
  * **[Blood] ALP‚Üë, Œ≥-GT‚Üë, bilirubin‚Üë**: Bile stasis and bile duct damage
  * **[Ultrasound, CT] Gallbladder wall thickening, gallbladder enlargement, debris, gallstones**: Inflammation and bile stasis
* **Management**
  * **[Initial treatment] Fasting, IV fluids, antibiotics (IV), analgesics**: For infection and pain
  * **[Unstable state] Percutaneous transhepatic gallbladder drainage**: Reduce gallbladder pressure and infection
  * **[Stable state] Laparoscopic cholecystectomy**: Remove gallbladder
{: .notice--info}

### Acute Cholangitis / ÊÄ•ÊÄßËÉÜÁÆ°ÁÇé

* **Overview**
  * Acute inflammation and infection of bile duct, due to blockage of common bile duct by stones or tumor, may progress to sepsis if endotoxin enters bloodstream through liver retrogradely
  * Commonly in middle-aged and older adults, with history of gallstones
* **Presentation**
  * **Abdominal pain**: Increased pressure and inflammation of biliary system
  * **Fever (with chills)**: Infection
  * **Jaundice**: Obstruction of bile duct
  * **Shock, altered consciousness**: Sepsis leads to drop in BP
* **Examination**
  * **[Blood] WBC‚Üë, CRP‚Üë**: Infection
  * **[Blood] ALP‚Üë, Œ≥-GT‚Üë, bilirubin‚Üë**: Bile stasis and bile duct damage
  * **[Blood] AST‚Üë, ALT‚Üë**: Liver damage
  * **[Ultrasound, CT] Dilated bile ducts, gallstones**: Obstruction of bile flow
* **Management**
  * **[Initial treatment] Fasting, IV fluids, antibiotics (IV), analgesics**: For infection and pain
  * **[Unstable state] Endoscopic biliary drainage or percutaneous transhepatic biliary drainage**: Reduce biliary tract pressure and infection
  * **[Stable state] Endoscopic sphincterotomy or endoscopic papillary balloon dilation, endoscopic lithotripsy**: Remove stones
{: .notice--info}

### Primary Biliary Cholangitis / ÂéüÁô∫ÊÄßÁ°¨ÂåñÊÄßËÉÜÁÆ°ÁÇé

* **Overview**
  * Chronic inflammation of intraphepatic and extrahepatic biles ducts, leading to fibrous thickening of bile ducts and eventually liver cirrhosis
  * Bimodal peaks in 20s and 60s, more in men, associated with ulcerative colitis
* **Presentation**
  * **Asymptomatic**
  * **Fluctuating jaundice and puritis**: Bile stasis leads to bilirubin and bile acids accumulation
* **Examination**
  * **[Blood] ALP‚Üë, Œ≥-GT‚Üë, bilirubin‚Üë**: Bile stasis and bile duct damage
  * **[Blood] AST‚Üë, ALT‚Üë (slightly)**: Liver damage
  * **[Blood] P-ANCA(+)**: Autoimmune nature
  * **[ERCP, MRCP] Multiple strictures and irregularities of intrehepatic and extrahepatic bile ducts**: Narrowing due to fibrosis, dilatation due to obstruction
* **Management**
  * **UDCA, bezafibrate**: Improve bile flow
  * **Cholestyramine, antihistamine**: Relieve puritis
  * **Biliary drainage**: Relieve jaundice
  * **Liver transplantation**: Only treatment for advanced cases
{: .notice--info}

### Congenital Biliary Dilatation / ÂÖàÂ§©ÊÄßËÉÜÈÅìÊã°ÂºµÁóá

* **Overview**
  * Congenital dilatation of extrahepatic bile ducts, often accompanied by abnormal pancreaticobiliary junction, with high incidence of biliary tract carcinoma
  * Commonly in younger individuals, more in females and Asians
* **Presentation**
  * **Asymptomatic**
  * **Abdominal pain**: Inflammation caused by pancreatic enzyme reflux
  * **Jaundice**: Bile stasis
  * **Abdominal mass**: Dilated bile ducts
* **Examination**
  * **[Blood] ALP‚Üë, Œ≥-GT‚Üë**: Bile duct damage
  * **[Blood] Amylase‚Üë**: Pancreatic enzyme reflux to bile ducts
  * **[Ultrasound, CT] Dilated common bile duct**
  * **[MRCP, ERCP] Cystic or fusiform dilatation of common bile duct, abnormal junction of pancreatic duct and common bile duct outside duodenal wall**
* **Management**
  * **Extrahepatic duct resection, cholecystectomy, biliary reconstruction**: Prevent biliary tract carcinoma
{: .notice--info}

## Pancreas Disorder / ËÜµÁñæÊÇ£

<!-- 
## Esophageal Disease / È£üÈÅìÁñæÊÇ£

### Achalasia / È£üÈÅì„Ç¢„Ç´„É©„Ç∑„Ç¢
### Gastroesophageal Reflux Disease / ËÉÉÈ£üÈÅìÈÄÜÊµÅÁóá
### Eosinophilic Esophagitis / Â•ΩÈÖ∏ÁêÉÊÄßÈ£üÈÅìÁÇé
### Esophageal Candidiasis / È£üÈÅì„Ç´„É≥„Ç∏„ÉÄÁóá
### Mallory-Weiss Syndrome / Mallory-WeissÁóáÂÄôÁæ§
### Spontaneous Rupture of the Esophagus / ÁâπÁô∫ÊÄßÈ£üÈÅìÁ†¥Ë£Ç
### Esophageal Cancer / È£üÈÅìÁôå
### Esophagogastric Varices / È£üÈÅì„ÉªËÉÉÈùôËÑàÁò§
### Esophageal Diverticulum / È£üÈÅìÊÜ©ÂÆ§

## Gastric and Duodenal Disease / ËÉÉ„ÉªÂçÅ‰∫åÊåáËÖ∏ÁñæÊÇ£

### Acute Gastric Mucosal Lesion / ÊÄ•ÊÄßËÉÉÁ≤òËÜúÁóÖÂ§â
### Chronic Gastritis / ÊÖ¢ÊÄßËÉÉÁÇé
### Functional Dyspepsia / Ê©üËÉΩÊÄß„Éá„Ç£„Çπ„Éö„Éó„Ç∑„Ç¢
### Gastro-Duodenal Ulcer / ËÉÉ„ÉªÂçÅ‰∫åÊåáËÖ∏ÊΩ∞Áòç
### Gastro-Duodenal Ulcer Perforation / ËÉÉ„ÉªÂçÅ‰∫åÊåáËÖ∏ÊΩ∞ÁòçÁ©øÂ≠î
### Gastric Polyp / ËÉÉ„Éù„É™„Éº„Éó
### GIST / Ê∂àÂåñÁÆ°ÈñìË≥™ËÖ´Áòç
### Gastrointestinal Malignant Lymphoma / Ê∂àÂåñÁÆ°ÊÇ™ÊÄß„É™„É≥„ÉëËÖ´
### Gastric Cancer / ËÉÉÁôå
### Dumping Syndrome / „ÉÄ„É≥„Éî„É≥„Ç∞ÁóáÂÄôÁæ§
### Gastro-Duodenal Diverticulum / ËÉÉ„ÉªÂçÅ‰∫åÊåáËÖ∏ÊÜ©ÂÆ§
### Superior Mesenteric Artery Syndrome / ‰∏äËÖ∏ÈñìËÜúÂãïËÑàÁóáÂÄôÁæ§
### M√©n√©trier's Disease / M√©n√©trierÁóÖ

## Intestinal and Colonic Disease / Â∞èËÖ∏„ÉªÂ§ßËÖ∏ÁñæÊÇ£

### Crohn's Disease / CrohnÁóÖ
### Ulcerative Colitis / ÊΩ∞ÁòçÊÄßÂ§ßËÖ∏ÁÇé
### Intestinal Tuberculosis / ËÖ∏ÁµêÊ†∏
### Infectious Enterocolitis / ÊÑüÊüìÊÄßËÖ∏ÁÇé
### Pseudomembranous Colitis / ÂÅΩËÜúÊÄßÂ§ßËÖ∏ÁÇé
### Antibiotic-Associated Hemorrhagic Colitis / ÊäóËèåËñ¨Èñ¢ÈÄ£Âá∫Ë°ÄÊÄßÂ§ßËÖ∏ÁÇé
### MRSA Enteritis / MRSAËÖ∏ÁÇé
### Irritable Bowel Syndrome / ÈÅéÊïèÊÄßËÖ∏ÁóáÂÄôÁæ§
### Colonic Polyp / Â§ßËÖ∏„Éù„É™„Éº„Éó
### Colorectal Cancer / Â§ßËÖ∏Áôå
### Lynch Syndrome / LynchÁóáÂÄôÁæ§
### Small Intestine Tumor / Â∞èËÖ∏ËÖ´Áòç
### Gastrointestinal Neuroendocrine Neoplasm / Ê∂àÂåñÁÆ°Á•ûÁµåÂÜÖÂàÜÊ≥åËÖ´Áòç
### Familial Adenomatous Polyposis / ÂÆ∂ÊóèÊÄßËÖ∫ËÖ´ÊÄß„Éù„É™„Éù„Éº„Ç∑„Çπ
### Peutz-Jeghers Syndrome / Peutz-JeghersÁóáÂÄôÁæ§
### Malabsorption Syndrome / Âê∏Âèé‰∏çËâØÁóáÂÄôÁæ§
### Protein-Losing Gastroenteropathy / ËõãÁôΩÊºèÂá∫ÊÄßËÉÉËÖ∏Áóá
### Ischemic Colitis / ËôöË°ÄÊÄßÂ§ßËÖ∏ÁÇé
### Acute Mesenteric Artery Occlusion / ÊÄ•ÊÄßËÖ∏ÈñìËÜúÂãïËÑàÈñâÂ°ûÁóá
### Occlusive Ileus / ÈñâÂ°ûÊÄßËÖ∏ÈñâÂ°û
### Strangulation Ileus / ÁµûÊâºÊÄßËÖ∏ÈñâÂ°û
### Paralytic Ileus / È∫ªÁó∫ÊÄß„Ç§„É¨„Ç¶„Çπ
### Colonic Diverticulum / Â§ßËÖ∏ÊÜ©ÂÆ§
### Acute Appendicitis / ÊÄ•ÊÄßËô´ÂûÇÁÇé

## Anal Disease / ËÇõÈñÄÁñæÊÇ£

### Hemorrhoids / ÁóîÊ†∏
### Anal Fissure / Ë£ÇËÇõ
### Perianal Abscess / ËÇõÈñÄÂë®Âõ≤ËÜøÁòç
### Anal Fistula / ÁóîÁòª
### Rectal Prolapse / Áõ¥ËÖ∏ËÑ±

## Peritoneal Disease / ËÖπËÜúÁñæÊÇ£

### Inguinal Hernia / Èº†ÂæÑ„Éò„É´„Éã„Ç¢
### Femoral Hernia / Â§ßËÖø„Éò„É´„Éã„Ç¢
### Obturator Hernia / ÈñâÈéñÂ≠î„Éò„É´„Éã„Ç¢
### Abdominal Incisional Hernia / ËÖπÂ£ÅÁò¢Áóï„Éò„É´„Éã„Ç¢
### Umbilical Hernia / Ëáç„Éò„É´„Éã„Ç¢
### Esophageal Hiatal Hernia / È£üÈÅìË£ÇÂ≠î„Éò„É´„Éã„Ç¢
### Acute Peritonitis / ÊÄ•ÊÄßËÖπËÜúÁÇé
### Spontaneous Bacterial Peritonitis / ÁâπÁô∫ÊÄßÁ¥∞ËèåÊÄßËÖπËÜúÁÇé
### Cancerous Peritonitis / ÁôåÊÄßËÖπËÜúÁÇé
### Pseudomyxoma Peritonei / ËÖπËÜúÂÅΩÁ≤òÊ∂≤ËÖ´

## Liver Disease / ËÇùÁñæÊÇ£

### Hepatitis A / AÂûãËÇùÁÇé
### Hepatitis B / BÂûãËÇùÁÇé
### Hepatitis C / CÂûãËÇùÁÇé
### Hepatitis D / DÂûãËÇùÁÇé
### Hepatitis E / EÂûãËÇùÁÇé
### Acute Viral Hepatitis / ÊÄ•ÊÄß„Ç¶„Ç§„É´„ÇπÊÄßËÇùÁÇé
### Chronic Viral Hepatitis / ÊÖ¢ÊÄß„Ç¶„Ç§„É´„ÇπÊÄßËÇùÁÇé
### Drug-Induced Liver Injury / Ëñ¨Ââ§ÊÄßËÇùÈöúÂÆ≥
### Acute Liver Failure / ÊÄ•ÊÄßËÇù‰∏çÂÖ®
### Fatty Liver / ËÑÇËÇ™ËÇù
### Nonalcoholic Steatohepatitis / Èùû„Ç¢„É´„Ç≥„Éº„É´ÊÄßËÑÇËÇ™ÊÄßËÇùÁÇé
### Alcoholic Liver Disease / „Ç¢„É´„Ç≥„Éº„É´ÊÄßËÇùÈöúÂÆ≥
### Autoimmune Hepatitis / Ëá™Â∑±ÂÖçÁñ´ÊÄßËÇùÁÇé
### Primary Biliary Cholangitis / ÂéüÁô∫ÊÄßËÉÜÊ±ÅÊÄßËÉÜÁÆ°ÁÇé
### Primary Sclerosing Cholangitis / ÂéüÁô∫ÊÄßÁ°¨ÂåñÊÄßËÉÜÁÆ°ÁÇé
### Liver Cirrhosis / ËÇùÁ°¨Â§â
### Hepatocellular Carcinoma / ËÇùÁ¥∞ËÉûÁôå
### Intrahepatic Cholangiocarcinoma / ËÇùÂÜÖËÉÜÁÆ°Áôå
### Metastatic Liver Tumor / Ëª¢ÁßªÊÄßËÇùÁôå
### Hepatic Hemangioma / ËÇùË°ÄÁÆ°ËÖ´
### Hepatic Cyst / ËÇùÂö¢ËÉû
### Liver Abscess / ËÇùËÜøÁòç
### Idiopathic Portal Hypertension / ÁâπÁô∫ÊÄßÈñÄËÑàÂúß‰∫¢ÈÄ≤Áóá
### Budd-Chiari Syndrome / Budd-ChiariÁóáÂÄôÁæ§

## Biliary Disease / ËÉÜÈÅìÁñæÊÇ£

### Cholelithiasis / ËÉÜÁü≥Áóá
### Acute Cholecystitis / ÊÄ•ÊÄßËÉÜÂö¢ÁÇé
### Acute Cholangitis / ÊÄ•ÊÄßËÉÜÁÆ°ÁÇé
### Gallbladder Adenomyomatosis / ËÉÜÂö¢ËÖ∫Á≠ãËÖ´Áóá
### Gallbladder Cancer / ËÉÜÂö¢Áôå
### Bile Duct Cancer / ËÉÜÁÆ°Áôå
### Cancer of Pipilla of Vator / ‰π≥È†≠ÈÉ®Áôå

## Pancreatic Disease / ËÜµÁñæÊÇ£

### Acute Pancreatitis / ÊÄ•ÊÄßËÜµÁÇé
### Chronic Pancreatitis / ÊÖ¢ÊÄßËÜµÁÇé
### Autoimmune Pancreatitis / Ëá™Â∑±ÂÖçÁñ´ÊÄßËÜµÁÇé
### Pancreatic Carcinoma / ËÜµÁôå
### Pancreatic Psuedocyst / ËÜµ‰ªÆÊÄßÂö¢ËÉû
### Intraductal Papillary Mucinous Neoplasm / ËÜµÁÆ°ÂÜÖ‰π≥È†≠Á≤òÊ∂≤ÊÄßËÖ´Áòç
### Mucinous Cystic Neoplasm / Á≤òÊ∂≤ÊÄßÂö¢ËÉûËÖ´Áòç
### Serous Cystic Neoplasm / ÊºøÊ∂≤ÊÄßÂö¢ËÉûËÖ´Áòç
### Pancreatic Neuroendocrine Neoplasm / ËÜµÁ•ûÁµåÂÜÖÂàÜÊ≥åËÖ´Áòç -->

# Endocrinology / ÂÜÖÂàÜÊ≥åÁßë

## Introduction / Á∑èË´ñ

## Pituitary Gland Disorder / ‰∏ãÂûÇ‰ΩìÁñæÊÇ£

## Thyroid Gland Disorder / Áî≤Áä∂ËÖ∫ÁñæÊÇ£

## Parathyroid Gland Disorder / ÂâØÁî≤Áä∂ËÖ∫ÁñæÊÇ£

## Adrenal Gland Disorder / ÂâØËÖéÁñæÊÇ£

## Neuroendocrine Tumor / Á•ûÁµåÂÜÖÂàÜÊ≥åËÖ´Áòç

## Carbohydrate and Lipid Metabolism Disorder / Á≥ñ„ÉªËÑÇË≥™‰ª£Ë¨ùÁï∞Â∏∏

## Uric Acid and Bone Metabolism Disorder / Â∞øÈÖ∏„ÉªÈ™®‰ª£Ë¨ùÁï∞Â∏∏

## Congenital Metabolism Disorder / ÂÖàÂ§©‰ª£Ë¨ùÁï∞Â∏∏

## Nutritional Disorder / Ê†ÑÈ§äÁï∞Â∏∏

<!-- ### Endocrine Organ / ÂÜÖÂàÜÊ≥åÂô®

* **Pituitary gland**
  * **Structure**: Anterior lobe (adenophysis), posterior lobe (neurophysis)
  * **Artery**: Superior hypophyseal artery (anterior lobe, hypophyseal portal system), inferior hypophyseal artery (posterior lobe)
  * **Cell (anterior)**: Acidophil (GH, PRL), basophil (TSH, FSL, LH, ACTH), chromophobe
  * **Cell (posterior)**: Nerve fiber (ADH, oxytocin from hypothalamus), pituicyte
* **Thyroid gland**
  * **Structure**: 2 lobes, isthmus
  * **Artery**: Superior thyroid artery (external carotid artery), inferior thyroid artery (thyrocervical trunk)
  * **Vein**: Superior thyroid vein (internal carotid vein), middle thyroid vein (internal carotid vein), inferior thyroid vein (brachiocephalic vein)
  * **Cell**: Follicular cell (thyroid hormone), parafollicular cell (calcitonin)
* **Parathyroid gland**
  * **Structure**: 2 upper glands, 2 lower glands
  * **Cell**: Chief cell (parathyroid hormone), oxyphil cell
* **Adrenal gland**
  * **Structure**: Adrenal cortex, adrenal medulla
  * **Artery**: Superior suprarenal artery (inferior phrenic artery), middle suprarenal artery (abdominal aorta), inferior suprarenal artery (renal artery)
  * **Vein**: Right suprarenal vein (inferior vena cava), left suprarenal vein (left renal vein)
  * **Adrenal cortex**: Zona glomerulosa (mineralcorticoid), zona fasciculata (glucocorticoid), zona reticulata (sex hormone)
  * **Adrenal medulla**: Chromaffin cell (epinephrine, norepinephrine), sympathetic presynaptic fiber
{: .notice--info} -->

<!-- ### Hypothalamus and Pituitary Hormone / Ë¶ñÂ∫ä‰∏ãÈÉ®„Éª‰∏ãÂûÇ‰Ωì„Éõ„É´„É¢„É≥

* **Somatostatin analog**
  * **Drugs**: Octreotide, lantreotide
  * **Mechanism**: Somatostatin analog (decrease GH)
  * **Indication**: Acromegaly, esophageal variceal bleeding
* **GH agonist**
  * **Drugs**: Somatropin, somatrem, mecasermin
  * **Mechanism**: recombinant GH (somatropin, somatrem), recombinant IGF-1 (mecasermin)
  * **Indication**: Acromegaly, variceal bleeding
* **GH antagonist**
  * **Drugs**: Pegvisomant
  * **Mechanism**: GH antagonist
  * **Indication**: Acromegaly
* **Dopamine analog**
  * **Drugs**: Bromocriptine, cabergoline
  * **Mechanism**: Dopamine analog (decrease prolactin)
  * **Indication**: Hyperprolactenemia
* **GnRH agonist**
  * **Drugs**: Leuprolide, goserelin
  * **Mechanism**: GnRH agonist (pulsatile: increase FSH and LH, chronic: decrease FSH and LH)
  * **Indication**: Prostate cancer, endometriosis
* **GnRH antagonist**
  * **Drugs**: Abarelix, ganirelix
  * **Mechanism**: GnRH antagonist (decrease FSH and LH)
  * **Indication**: Prostate cancer, controlled ovarian stimulation
* **ADH agonist**
  * **Drugs**: Desmopressin
  * **Mechanism**: ADH V2 agonist
  * **Indication**: Central diabetes indipidus, hemophilia A
* **ADH antagonist**
  * **Drugs**: Conivaptan, tolvaptan, demeclocycline
  * **Mechanism**: ADH V1/2 antagonist
  * **Indication**: SIADH
{: .notice--info}

### Thyroid Hormone / Áî≤Áä∂ËÖ∫„Éõ„É´„É¢„É≥

* **Thyroid hormone**
  * **Drugs**: Liothyronine (T3), levothyroxine (T4), liotrix (mix)
  * **Mechanism**: Thyroid hormone
  * **Indication**: Hypothyroidism
* **Thioamide**
  * **Drugs**: Propylthiouracil, methimazole, carbimazole
  * **Mechanism**: Inhibit T4/T3 synthesis and conversion
  * **Indication**: Hyperthyroidism
  * **Adverse effect**: Agranulocytosis
* **Iodide**
  * **Drugs**: Iodide, lithium
  * **Mechanism**: Inhibit T4/T3 release, decrease thyroid vascularity
  * **Indication**: Before thyroid surgery 
* **Radioactive iodide**
  * **Drugs**: I-131
  * **Mechanism**: Destruct thyroid gland
  * **Indication**: Hyperthyroidism, thyroid carcinoma
* **Anion inhibitor**
  * **Drugs**: Perchlorate, pertechnetate, thriocyanate
  * **Mechanism**: Inhibit iodide entry
  * **Indication**: Hyperthyroidism
* **Other therapy**
  * **Drugs**: Œ≤-blocker, hydrocortisone
  * **Mechanism**: Inhibit T4/T3 conversion, release symptom
{: .notice--info}

### Adrenal Cortical Hormone / ÂâØËÖéÈ´ÑË≥™„Éõ„É´„É¢„É≥

* **Glucocorticoid**
  * **Drugs**: Short-acting: Cortisol, cortisone / Intermediate-acting: Prednisone, prednisolone, methylprednisolone, triamcinolone / Long-acting: Betamethasone, dexamethasone
  * **Mechanism**: GR receptor agonist
  * **Indication**: Inflammation, replacement therapy, Cushing syndrome diagnosis (dexamethasone)
  * **Adverse effect**: Adrenal suppression, hyperglycemia, osteoporosis, peptic ulcer
* **Mineralcorticoid**
  * **Drugs**: Desoxycorticosterone, fludrocortisone
  * **Mechanism**: MR receptor agonist
  * **Indication**: Replacement therapy
* **Synthesis inhibitor**
  * **Drugs**: Ketoconazole, metyrapone, aminoglutethimide
  * **Mechanism**: 17Œ±-hydroxylase inhibitor (ketoconazole), 11Œ≤-hydroxylase inhibitor (metyrapone), cholesterol side chain cleaving enzyme inhibitor (aminoglutethimide)
  * **Indication**: Cushing syndrome, pituitary function test (metyrapone)
{: .notice--info}

### Sex Hormone / ÊÄß„Éõ„É´„É¢„É≥

* **Estrogen**
  * **Drugs**: Estradiol, mestranol
  * **Mechanism**: Estrogen
  * **Indication**: Menopausal therapy, contraception
  * **Adverse effect**: Endometrial cancer, breast cancer
* **SERM**
  * **Drugs**: Clomiphene, raloxifene, tamoxifen
  * **Mechanism**: Selective estrogen receptor modulator
  * **Indication**: Ovary dysfunction infertility (clomiphene), osteoporosis (raloxifene), breast cancer (tamoxifen)
* **Estrogen antagonist**
  * **Drugs**: Fulvestrant
  * **Mechanism**: Estrogen antagonist
  * **Indication**: Breast cancer
* **Aromatase inhibitor**
  * **Drugs**: Letrozole, anastrolzole, exemestane
  * **Mechanism**: Aromatase inhibitor (decrease estrogen)
  * **Indication**: Breast cancer
* **Progestin**
  * **Drugs**: Norgestrel, desogestrol
  * **Mechanism**: Progestin
  * **Indication**: Endometriosis, contraception (with estrogen)
* **Progestin antagonist**
  * **Drugs**: Mifepristone
  * **Mechanism**: Progestin antagonist
  * **Indication**: Abortion
* **Androgen**
  * **Drugs**: Testosterone, oxandrolone, danazol
  * **Mechanism**: Androgen
  * **Indication**: Hypogonadism, endometriosis (danazol)
  * **Adverse effect**: Decreased testicular function
* **Androgen antagonist**
  * **Drugs**: Cyproterone, flutamide, bicalutamide, spironolactone
  * **Mechanism**: Androgen antagonist
  * **Indication**: Prostate cancer
* **5Œ±-reductase inhibitor**
  * **Drugs**: Finasteride
  * **Mechanism**: 5Œ±-reductase inhibitor (decrease DHT)
  * **Indication**: BPH, male-pattern baldness
{: .notice--info}

### Glucose Homeostasis / Á≥ñ‰ª£Ë¨ù„ÅÆËñ¨

* **Insulin**
  * **Drugs**: Rapid-acting: insulin lispro, insulin aspart / Short-acting: Regular insulin / Intermediate-acting: NPH / Long-acting: insulin glargine, insulin detemir, insulin degludec
  * **Mechanism**: Insulin
  * **Indication**: Diabetes mellitus
* **Sulfonylurea**
  * **Drugs**: Glyburide, glipizide, glimepiride, tolbutamide
  * **Mechanism**: Inhibit ATP-dependent K channel (increase insulin secretion)
  * **Indication**: Diabetes mellitus
* **Meglitinide**
  * **Drugs**: Rapaglinide, nateglinide
  * **Mechanism**: Inhibit ATP-dependent K channel (increase insulin secretion)
  * **Indication**: Diabetes mellitus
* **GLP-1 agonist**
  * **Drugs**: Exenatide, liraglutide
  * **Mechanism**: GLP-1 analog (increase insulin secretion)
  * **Indication**: Diabetes mellitus
* **DPP-4 inhibitor**
  * **Drugs**: Sitagliptin, saxagliptin
  * **Mechanism**: DPP-4 inhibitor (increase GLP-1, increase insulin secretion)
  * **Indication**: Diabetes mellitus
* **Biguanide**
  * **Drugs**: Metformin
  * **Mechanism**: Reduce hepatic gluconeogenesis
  * **Indication**: Diabetes mellitus
* **Thiazolidinedione**
  * **Drugs**: Troglitazone, rosiglitazone
  * **Mechanism**: Activate PPARŒ≥ (decrease insulin resistance)
  * **Indication**: Diabetes mellitus
* **Œ±-glucosidase inhibitor**
  * **Drugs**: Acarbose
  * **Mechanism**: Œ±-glucosidase inhibitor (decrease intestinal glucose absorption)
  * **Indication**: Diabetes mellitus
* **SGLT2 inhibitor**
  * **Drugs**: Canagliflozin, empagliflozin
  * **Mechanism**: SGLT2 inhibitor (decrease renal glucose reabsorption)
  * **Indication**: Diabetes mellitus
* **Amylin analog**
  * **Drugs**: Pramlintide
  * **Mechanism**: Amylin analog
  * **Indication**: Diabetes mellitus
{: .notice--info}

### Calcium Homeostasis Drug / „Ç´„É´„Ç∑„Ç¶„É†‰ª£Ë¨ù„ÅÆËñ¨

* **Bisphosphonate**
  * **Drugs**: Alendronate, risedronate, pamidronate
  * **Mechanism**: Inhibit osteoclast
  * **Indication**: Osteoporosis
* **Anti-RANKL antibody**
  * **Drugs**: Denosumab
  * **Mechanism**: Anti-RANKL antibody (inhibit osteoclast)
  * **Indication**: Osteoporosis
* **Parathyroid hormone**
  * **Drugs**: Teriparatide
  * **Mechanism**: Stimulate osteoblast
  * **Indication**: Osteoporosis
* **Calcitonin**
  * **Drugs**: Calcitonin
  * **Mechanism**: Inhibit osteoclast
  * **Indication**: Paget disease
* **Vitamin D**
  * **Drugs**: Cholecalciferol
  * **Mechanism**: Increase Ca absorption and reabsorption
  * **Indication**: Osteomalacia
* **SERM**
  * **Drugs**: Raloxifene, estrogen
  * **Mechanism**: Inhibit osteoclast
  * **Indication**: Postmenopausal osteoporosis
{: .notice--info}

### Retinoic Acid / „É¨„ÉÅ„Éé„Ç§„É≥ÈÖ∏

* **Tretinoin**
  * **Drugs**: Tretinoin
  * **Mechanism**: Modify epithelial growth and turnover
  * **Indication**: Acne, photo-aged skin, acute promyelocytic leukemia
  * **Adverse effect**: Sunburn
* **Isotretinoin**
  * **Drugs**: Isotretinoin
  * **Mechanism**: Reduce sebaceous gland size
  * **Indication**: Severe cystic acne
  * **Adverse effect**: Teratogenic
* **Acitretin**
  * **Drugs**: Acitretin
  * **Mechanism**: Inhibit proinflammatory cytokine expression
  * **Indication**: Psoriases
  * **Adverse effect**: Skin and nail abnormality, teratogenic
{: .notice--info} -->

<!-- ## Hypothalamus and Pituitary Gland Disease / Ë¶ñÂ∫ä‰∏ãÈÉ®„Éª‰∏ãÂûÇ‰ΩìÁñæÊÇ£

### Hyperprolactinemia / È´ò„Éó„É≠„É©„ÇØ„ÉÅ„É≥Ë°ÄÁóá
### Acromegaly / ÂÖàÁ´ØËÇ•Â§ßÁóá
### Cushing's Disease / CushingÁóÖ
### Hypopituitarism / ‰∏ãÂûÇ‰ΩìÂâçËëâÊ©üËÉΩ‰Ωé‰∏ãÁóá
### Central Diabetes Insipidus / ‰∏≠Êû¢ÊÄßÂ∞øÂ¥©Áóá
### SIADH / „Éê„Çæ„Éó„É¨„Ç∑„É≥‰∏çÈÅ©ÂêàÂàÜÊ≥åÁóáÂÄôÁæ§

## Thyroid Gland Disease / Áî≤Áä∂ËÖ∫ÁñæÊÇ£

### Grave's Disease / BasedowÁóÖ
### Plummer Disease / PlummerÁóÖ
### Acute Thyroiditis / ÊÄ•ÊÄßÁî≤Áä∂ËÖ∫ÁÇé
### Subacute Thyroiditis / ‰∫úÊÄ•ÊÄßÁî≤Áä∂ËÖ∫ÁÇé
### Painless Thyroiditis / ÁÑ°ÁóõÊÄßÁî≤Áä∂ËÖ∫ÁÇé
### Chronic Thyroiditis / ÊÖ¢ÊÄßÁî≤Áä∂ËÖ∫ÁÇé
### Simple Goiter / ÂçòÁ¥îÊÄßÁî≤Áä∂ËÖ∫ËÖ´
### Multinodular Goiter / Â§öÁµêÁØÄÊÄßÁî≤Áä∂ËÖ∫ËÖ´
### Thyroid Cancer / Áî≤Áä∂ËÖ∫Áôå

## Parathyroid Gland Disease / ÂâØÁî≤Áä∂ËÖ∫ÁñæÊÇ£

### Primary Hyperparathyroidism / ÂéüÁô∫ÊÄßÂâØÁî≤Áä∂ËÖ∫Ê©üËÉΩ‰∫¢ÈÄ≤Áóá
### Renal Hyperparathyroidism / ËÖéÊÄßÂâØÁî≤Áä∂ËÖ∫Ê©üËÉΩ‰∫¢ÈÄ≤Áóá
### Malignancy-Related Hypercalcemia / ÊÇ™ÊÄßËÖ´ÁòçÈñ¢ÈÄ£È´ò„Ç´„É´„Ç∑„Ç¶„É†Ë°ÄÁóá
### Hypoparathyroidism / ÂâØÁî≤Áä∂ËÖ∫Ê©üËÉΩ‰Ωé‰∏ãÁóá
### Pseudohypoparathyroidism / ÂÅΩÊÄßÂâØÁî≤Áä∂ËÖ∫Ê©üËÉΩ‰Ωé‰∏ãÁóá

## Adrenal Gland Disease / ÂâØËÖéÁñæÊÇ£

### Cushing's Syndrome / CushingÁóáÂÄôÁæ§
### Primary Aldosteronism / ÂéüÁô∫ÊÄß„Ç¢„É´„Éâ„Çπ„ÉÜ„É≠„É≥Áóá
### Addison's Disease / AddisonÁóÖ
### Acute Adrenal Insufficiency / ÊÄ•ÊÄßÂâØËÖé‰∏çÂÖ®
### Pheochromocytoma / Ë§êËâ≤Á¥∞ËÉûËÖ´

## Other Endocrine Disease / „Åù„ÅÆ‰ªñ„ÅÆÂÜÖÂàÜÊ≥åÁñæÊÇ£

### MEN / Â§öÁô∫ÊÄßÂÜÖÂàÜÊ≥åËÖ∫ËÖ´Áóá
### Insulinoma / „Ç§„É≥„Çπ„É™„Éé„Éº„Éû
### Gastrinoma / „Ç¨„Çπ„Éà„É™„Éé„Éº„Éû
### Glucagonoma / „Ç∞„É´„Ç´„Ç¥„Éé„Éº„Éû
### VIPoma / VIPoma

## Glucose Metabolism Disorder / Á≥ñ‰ª£Ë¨ùÁï∞Â∏∏

### Type 1 Diabetes Mellitus / 1ÂûãÁ≥ñÂ∞øÁóÖ
### Type 2 Diabetes Mellitus / 2ÂûãÁ≥ñÂ∞øÁóÖ
### Maturity-Onset Diabetes of the Young / Ëã•Âπ¥Áô∫ÁóáÊàê‰∫∫ÂûãÁ≥ñÂ∞øÁóÖ
### Gestational Diabetes Mellitis / Â¶äÂ®†Á≥ñÂ∞øÁóÖ
### Diabetic Ketoacidosis / Á≥ñÂ∞øÁóÖÊÄß„Ç±„Éà„Ç¢„Ç∑„Éâ„Éº„Ç∑„Çπ
### Hyperosmolar Hyperglycemic Syndrome / È´òÊµ∏ÈÄèÂúßÈ´òË°ÄÁ≥ñÁóáÂÄôÁæ§
### Diabetic Foot / Á≥ñÂ∞øÁóÖË∂≥ÁóÖÂ§â
### Hypoglycemia / ‰ΩéË°ÄÁ≥ñÁóá

## Lipid and Nutrition Metabolism Disorder / ËÑÇË≥™„ÉªÊ†ÑÈ§ä‰ª£Ë¨ùÁï∞Â∏∏

### Dyslipidemia / ËÑÇË≥™Áï∞Â∏∏Áóá
### Familial Hypercholesterolemia / ÂÆ∂ÊóèÊÄßÈ´ò„Ç≥„É¨„Çπ„ÉÜ„É≠„Éº„É´Ë°ÄÁóá
### Obesity Disease / ËÇ•Ê∫ÄÁóá
### Metabolic Syndrome / „É°„Çø„Éú„É™„ÉÉ„ÇØ„Ç∑„É≥„Éâ„É≠„Éº„É†
### Vitamin A Deficiency / „Éì„Çø„Éü„É≥AÊ¨†‰πèÁóá
### Vitamin B1 Deficiency / „Éì„Çø„Éü„É≥B1Ê¨†‰πèÁóá
### Vitamin B3 Deficiency / „Éì„Çø„Éü„É≥B3Ê¨†‰πèÁóá
### Vitamin B6 Deficiency / „Éì„Çø„Éü„É≥B6Ê¨†‰πèÁóá
### Vitamin B12 Deficiency / „Éì„Çø„Éü„É≥B12Ê¨†‰πèÁóá
### Vitamin C Deficiency / „Éì„Çø„Éü„É≥CÊ¨†‰πèÁóá
### Vitamin D Deficiency / „Éì„Çø„Éü„É≥DÊ¨†‰πèÁóá
### Vitamin E Deficiency / „Éì„Çø„Éü„É≥EÊ¨†‰πèÁóá
### Vitamin K Deficiency / „Éì„Çø„Éü„É≥KÊ¨†‰πèÁóá
### Zinc Deficiency / ‰∫úÈâõÊ¨†‰πèÁóá
### Copper Deficiency / ÈäÖÊ¨†‰πèÁóá
### Malnutrition Syndrome / Ê†ÑÈ§ä‰∏çËâØÁóáÂÄôÁæ§

## Other Metabolism Disorder / „Åù„ÅÆ‰ªñ„ÅÆ‰ª£Ë¨ùÁï∞Â∏∏

### Hyperuricemia / È´òÂ∞øÈÖ∏Ë°ÄÁóá
### Gout / ÁóõÈ¢®
### Pseudogout / ÂÅΩÁóõÈ¢®
### Osteoporosis / È™®Á≤óÈ¨ÜÁóá
### Osteopetrosis / È™®Á°¨ÂåñÁóá
### Paget's Disease of Bone / È™®PagetÁóÖ
### Hemochromatosis / „Éò„É¢„ÇØ„É≠„Éû„Éà„Éº„Ç∑„Çπ
### Acute Intermittent Porphyria / ÊÄ•ÊÄßÈñìÊ¨†ÊÄß„Éù„É´„Éï„Ç£„É™„É≥Áóá
### Porphyria Cutanea Tarda / Êô©Áô∫ÊÄßÁöÆËÜö„Éù„É´„Éï„Ç£„É™„É≥Áóá
### Amyloidosis / „Ç¢„Éü„É≠„Ç§„Éâ„Éº„Ç∑„Çπ -->

# Nephrology / ËÖéËáìÁßë

## Introduction / Á∑èË´ñ

## Electrolytes Metabolism Disorder / ÈõªËß£Ë≥™‰ª£Ë¨ùÁï∞Â∏∏

## Glomerular Disorder / Á≥∏ÁêÉ‰ΩìÁñæÊÇ£

## Tubulointerstitial Disorder / Â∞øÁ¥∞ÁÆ°„ÉªÈñìË≥™ÊÄßÁñæÊÇ£

## Renal Injury with Systemic Disorder / ÂÖ®Ë∫´ÊÄßÁñæÊÇ£„Å´‰º¥„ÅÜËÖéÈöúÂÆ≥

## Renal Vascular Disorder / ËÖéË°ÄÁÆ°ÊÄßÁñæÊÇ£

## Renal Failure / ËÖé‰∏çÂÖ®

<!-- ## Introduction /„ÄÄÁ∑èË´ñ

### Diuretics / Âà©Â∞øËñ¨

* **Carbonic anhydrase inhibitor**
  * **Drugs**: Acetazolamide
  * **Mechanism**: Inhibit carbonic anhydrase
  * **Indication**: Glaucoma, urine alkalinization
  * **Adverse effect**: Acidosis, renal calculi
* **Loop diuretics**
  * **Drugs**: Furosemide, bumetanide, torsemide, ethacrynic acid
  * **Mechanism**: Inhibit Na-K-2Cl contransporter
  * **Indication**: Acute pulmonary edema, congestive heart failure
  * **Adverse effect**: Hypokalemia, hypocalcemia, alkalosis, ototoxicity (with aminoglycoside)
* **Thiazide diuretics**
  * **Drugs**: Hydrochlorothiazide, chlorothiazide
  * **Mechanism**: Inhibit Na-Cl contransporter
  * **Indication**: Hypertension, nephrogenic diabetes insipidus
  * **Adverse effect**: Hypokalemia, hypercalcemia, alkalosis, hyperuricemia, hyperglycemia
* **Potassium-sparing diuretics**
  * **Drugs**: Spironolactone, eplerenone, amiloride, triamterene
  * **Mechanism**: Aldosterone antagonist (spironolactone, eplerenone), ENac blocker (amiloride, triamterene)
  * **Indication**: Hyperaldosteronism, prevent K+ loss
  * **Adverse effect**: Hyperkalemia, acidosis, gynecomastia (spironolactone)
* **Osmotic diuretics**
  * **Drugs**: Mannitol
  * **Mechanism**: Inhibit water reabsorption
  * **Indication**: Reduce intracranial and intraocular pressure 
* **ADH antagonist**
  * **Drugs**: Conivaptan, tolvaptan, demeclocycline
  * **Mechanism**: V1 and/or V2 antagonist
  * **Indication**: SIADH
{: .notice--info} -->

<!-- ## Water and Electrolytes Metabolism Disorder / Ê∞¥„ÉªÈõªËß£Ë≥™‰ª£Ë¨ùÁï∞Â∏∏

### Hyponatremia / ‰Ωé„Éä„Éà„É™„Ç¶„É†Ë°ÄÁóá
### Hypernatremia / È´ò„Éä„Éà„É™„Ç¶„É†Ë°ÄÁóá
### Hypokalemia / ‰Ωé„Ç´„É™„Ç¶„É†Ë°ÄÁóá
### Hyperkalemia / È´ò„Ç´„É™„Ç¶„É†Ë°ÄÁóá
### Hypocalcemia / ‰Ωé„Ç´„É´„Ç∑„Ç¶„É†Ë°ÄÁóá
### Hypercalcemia / È´ò„Ç´„É´„Ç∑„Ç¶„É†Ë°ÄÁóá
### Hypophosphatemia / ‰Ωé„É™„É≥Ë°ÄÁóá
### Hyperphosphatemia / È´ò„É™„É≥Ë°ÄÁóá
### Hypomagnesemia / ‰Ωé„Éû„Ç∞„Éç„Ç∑„Ç¶„É†Ë°ÄÁóá
### Hypermagnesemia / È´ò„Éû„Ç∞„Éç„Ç∑„Ç¶„É†Ë°ÄÁóá
### Metabolic Acidosis / ‰ª£Ë¨ùÊÄß„Ç¢„Ç∑„Éâ„Éº„Ç∑„Çπ
### Metabolic Alkalosis / ‰ª£Ë¨ùÊÄß„Ç¢„É´„Ç´„É≠„Éº„Ç∑„Çπ
### Respiratory Acidosis / ÂëºÂê∏ÊÄß„Ç¢„Ç∑„Éâ„Éº„Ç∑„Çπ
### Respiratory Alkalosis / ÂëºÂê∏ÊÄß„Ç¢„É´„Ç´„É≠„Éº„Ç∑„Çπ

## Glomerular Disease / Á≥∏ÁêÉ‰ΩìÁñæÊÇ£

### Acute Glomerulonephritis / ÊÄ•ÊÄßÁ≥∏ÁêÉ‰ΩìËÖéÁÇé
### Rapid Progressive Glomerulonephritis / ÊÄ•ÈÄüÈÄ≤Ë°åÊÄßÁ≥∏ÁêÉ‰ΩìËÖéÁÇé
### IgA Nephropathy / IgAËÖéÁóá
### Minimal Change Nephrotic Syndrome / ÂæÆÂ∞èÂ§âÂåñÂûã„Éç„Éï„É≠„Éº„ÇºÁóáÂÄôÁæ§
### Membranous Nephropathy / ËÜúÊÄßËÖéÁóá
### Focal Segmental Glomerulosclerosis / Â∑£Áä∂ÂàÜÁØÄÊÄßÁ≥∏ÁêÉ‰ΩìÁ°¨ÂåñÁóá
### Membranoproliferative Glomerulonephritis / ËÜúÊÄßÂ¢óÊÆñÊÄßÁ≥∏ÁêÉ‰ΩìËÖéÁÇé
### Alport's Syndrome / AlportÁóáÂÄôÁæ§
### Benign Familial Hematuria / ËâØÊÄßÂÆ∂ÊóèÊÄßË°ÄÂ∞ø

## Tubulointerstitial Disease / Â∞øÁ¥∞ÁÆ°„ÉªÈñìË≥™ÊÄßÁñæÊÇ£

### Fanconi Syndrome / FanconiÁóáÂÄôÁæ§
### Bartter's Syndrome / BartterÁóáÂÄôÁæ§
### Pseudo-Bartter's Syndrome / ÂÅΩÊÄßBartterÁóáÂÄôÁæ§
### Gitelman's Syndrome / GitelmanÁóáÂÄôÁæ§
### Liddle's Syndrome / LiddleÁóáÂÄôÁæ§
### Nephrogenic Diabetes Insipidus / ËÖéÊÄßÂ∞øÂ¥©Áóá
### Renal Tubular Acidosis / Â∞øÁ¥∞ÁÆ°ÊÄß„Ç¢„Ç∑„Éâ„Éº„Ç∑„Çπ
### Tubulointerstitial Nephritis / Â∞øÁ¥∞ÁÆ°ÈñìË≥™ÊÄßËÖéÁÇé

## Renal Injury with Systemic Disease / ÂÖ®Ë∫´ÊÄßÁñæÊÇ£„Å´‰º¥„ÅÜËÖéÈöúÂÆ≥

### Diabetic Nephropathy / Á≥ñÂ∞øÁóÖÊÄßËÖéÁóá
### Gouty Kidney / ÁóõÈ¢®ËÖé
### Myeloma Kidney / È™®È´ÑËÖ´ËÖé
### Cryoglobulin Nephropathy / „ÇØ„É™„Ç™„Ç∞„É≠„Éñ„É™„É≥Ë°ÄÁóáÊÄßËÖéÁóá
### Amyloid Nephropathy / „Ç¢„Éü„É≠„Ç§„ÉâËÖéÁóá
### Lupus Nephritis / „É´„Éº„Éó„ÇπËÖéÁÇé
### Scleroderma Kidney / Âº∑ÁöÆÁóáËÖé
### Drug-Induced Kidney Injury / Ëñ¨Ââ§ÊÄßËÖéÈöúÂÆ≥

## Renal Vascular Disease / ËÖéË°ÄÁÆ°ÊÄßÁñæÊÇ£

### Renovascular Hypertension / ËÖéË°ÄÁÆ°ÊÄßÈ´òË°ÄÂúß
### Benign Nephrosclerosis / ËâØÊÄßËÖéÁ°¨ÂåñÁóá
### Malignant Nephrosclerosis / ÊÇ™ÊÄßËÖéÁ°¨ÂåñÁóá
### Renal Infarction / ËÖéÊ¢óÂ°û
### Renal Papillary Necrosis / ËÖé‰π≥È†≠Â£äÊ≠ª
### Renal Cortical Necrosis / ËÖéÁöÆË≥™Â£äÊ≠ª
### Renal Vein Thrombosis / ËÖéÈùôËÑàË°ÄÊ†ìÁóá

## Renal Failure / ËÖé‰∏çÂÖ®

### Acute Kidney Injury / ÊÄ•ÊÄßËÖéÈöúÂÆ≥
### Chronic Kidney Disease / ÊÖ¢ÊÄßËÖéËáìÁóÖ
### Disequilibrium Syndrome / ‰∏çÂùáË°°ÁóáÂÄôÁæ§
### CKD Mineral and Bone Disorder / CKD„Å´‰º¥„ÅÜÈ™®„Éü„Éç„É©„É´‰ª£Ë¨ùÁï∞Â∏∏
### Dialysis Amyloidosis / ÈÄèÊûê„Ç¢„Éü„É≠„Ç§„Éâ„Éº„Ç∑„Çπ
### Renal Anemia / ËÖéÊÄßË≤ßË°Ä -->

# Hematology / Ë°ÄÊ∂≤Áßë

## Introduction / Á∑èË´ñ

## Hemostasis Disorder (Primary) / Ê≠¢Ë°Ä„ÅÆÁï∞Â∏∏Ôºà‰∏ÄÊ¨°Ôºâ

## Hemostasis Disorder (Secondary) / Ê≠¢Ë°Ä„ÅÆÁï∞Â∏∏Ôºà‰∫åÊ¨°Ôºâ

## Red Blood Cell Disorder (Nonehemolysis) / Ëµ§Ë°ÄÁêÉ„ÅÆÁï∞Â∏∏ÔºàÈùûÊ∫∂Ë°ÄÔºâ

## Red Blood Cell Disorder (Hemolysis) / Ëµ§Ë°ÄÁêÉ„ÅÆÁï∞Â∏∏ÔºàÊ∫∂Ë°ÄÔºâ

## White Blood Cell Disorder / ÁôΩË°ÄÁêÉ„ÅÆÁï∞Â∏∏

## Myeloid Neoplasm / È™®È´ÑÁ≥ªËÖ´Áòç

## Lymphoid Neoplasm / „É™„É≥„ÉëÁ≥ªËÖ´Áòç

<!-- ## Introduction /„ÄÄÁ∑èË´ñ

### Alkylating Drug / „Ç¢„É´„Ç≠„É´ÂåñËñ¨

* **Nitrogen mustard**
  * **Drug**: Cyclophosphamide, ifosfamide
  * **Mechanism**: Directly damage DNA
  * **Indication**: Various cancer
  * **Adverse effect**: Myelosuppression, hemorrhagic cystitis (due to acrolein, prevented by mesna)
* **Nitrosoureas**
  * **Drug**: Carmustine, lomustine
  * **Mechanism**: Directly damage DNA
  * **Indication**: Brain tumor (cross BBB)
  * **Adverse effect**: Myelosuppression, pulmonary toxicity
* **Alkyl sulfonate**
  * **Drug**: Busfulfan
  * **Mechanism**: Directly damage DNA
  * **Indication**: Before bone marrow transplantation
  * **Adverse effect**: Myelosuppression, pulmonary fibrosis, hyperpigmentation
* **Platinum analog**
  * **Drug**: Cisplatin, carboplatin, oxaliplatin
  * **Mechanism**: Directly damage DNA
  * **Indication**: Various tumor
  * **Adverse effect**: Myelosuppresion, nephrotoxicity, otoxicity, peripheral neuropathy
{: .notice--info}

### Antimetabolte / ‰ª£Ë¨ùÊãÆÊäóËñ¨

* **Folic acid analog**
  * **Drug**: Methotrexate, pemetrexed
  * **Mechanism**: Inhibit dihydrofolate reductase, inhibit thymidylate synthetase (pemetrexed)
  * **Indication**: Leukemia and lymphoma, autoimmune disease (methotrexate), mesothelioma, non-small cell lung cancer (pemetrexed)
  * **Adverse effect**: Myelosuppresion, mucositis, nephrotoxicity (rescued by leucovorin)
* **5-Fluorouracil**
  * **Drug**: 5-Fluorouracil, capecitabine
  * **Mechanism**:  Inhibit thymidylate synthetase (5F-dUMP)
  * **Indication**: Various cancer
  * **Adverse effect**: Myelosuppression, hand-and-foot syndrome
* **Pyrimidine analog**
  * **Drug**: Cytarabine, gemticabine
  * **Mechanism**: Inhibit DNA polymerase
  * **Indication**: Various cancer
  * **Adverse effect**: Myelosuppression
* **Purine analog**
  * **Drug**: 6-Mercaptopurine, cladribine
  * **Mechanism**: Inhibit DNA polymerase
  * **Indication**: Leukemia
  * **Adverse effect**: Myelosuppression, interact with allopurinol
* **Hydroxyuria**
  * **Drug**: Hydroxyuria
  * **Mechanism**: Inhibit ribonucleoside diphosphate reductase
  * **Indication**: Leukemia, sickle cell anemia
  * **Adverse effect**: Myelosuppression, GI distress
{: .notice--info}

### Microtubule Damaging Drug / ÂæÆÂ∞èÁÆ°ÈòªÂÆ≥Ëñ¨

* **Vinca alkaloids**
  * **Drug**: Vinblastine, vincristine, vinorelbine
  * **Mechanism**: Inhibit microtubule polymerization
  * **Indication**: Various cancer
  * **Adverse effect**: Myelosuppression, peripheral neuropathy
* **Taxanes**
  * **Drug**: Paclitaxel, docltaxel, cabazitaxel
  * **Mechanism**: Inhibit microtubule depolymerization
  * **Indication**: Various cancer
  * **Adverse effect**: Myelosuppression, peripheral neuropathy, hypersensitivity (paclitaxel), fluid retention (docetaxel)
{: .notice--info}

### Topoisomerase Inhibitor / „Éà„Éù„Ç§„ÇΩ„É°„É©„Éº„ÇºÈòªÂÆ≥Ëñ¨

* **Topoisomerase I inhibitor**
  * **Drug**: Topotecan, irinotecan
  * **Mechanism**: Topoisomerase I inhibitor
  * **Indication**: Various cancer
  * **Adverse effect**: Myelosuppression, diarrhea, secondary leukemia
* **Topoisomerase II inhibitor**
  * **Drug**: Etoposide
  * **Mechanism**: Topoisomerase II inhibitor
  * **Indication**: Various cancer
  * **Adverse effect**: Myelosuppression
{: .notice--info}

### Antitumor Antibiotics / ÊäóËÖ´ÁòçÊÄßÊäóÁîüÁâ©Ë≥™

* **Antrhacyclines**
  * **Drug**: Doxorubicin, daunorubicin, idarubicin, epirubicin
  * **Mechanism**: Inhibit topoisomerase II, intercalate between DNA base pairs, form oxygen free radical
  * **Indication**: Various cancer
  * **Adverse effect**: Myelosuppression, cardiotoxicity (dexrazoxane protect)
* **Dactinomycin**
  * **Drug**: Dactinomycin
  * **Mechanism**: Intercalate between DNA base pairs
  * **Indication**: Pediatric cancer
  * **Adverse effect**: Myelosuppression
* **Bleomycin**
  * **Drug**: Bleomycin
  * **Mechanism**: Form oxygen free radical
  * **Indication**: Testicular cancer
  * **Adverse effect**: Pulmonary toxicity, hyperpigmentation
{: .notice--info}

### Target Therapy / ÂàÜÂ≠êÊ®ôÁöÑËñ¨

* **Monoclonal antibody (CD20)**
  * **Drug**: Rituximab
  * **Mechanism**: Anti-CD20
  * **Indication**: Non-Hodgkin lymphoma, chronic lymphocytic leukemia
* **Monoclonal antibody (CD30)**
  * **Drug**: Brentuximab vedotin
  * **Mechanism**: Anti-CD30
  * **Indication**: Hodgkin lymphoma
* **Monoclonal antibody (HER2)**
  * **Drug**: Trastuzumab, pertuzumab
  * **Mechanism**: Anti-HER2
  * **Indication**: Breast cancer, gastric cancer
* **Monoclonal antibody (EGFR)**
  * **Drug**: Cetuximab, panitumumab, necitumumab
  * **Mechanism**: Anti-EGFR
  * **Indication**: Metastatic colorectal cancer (KRAS wild-type)
* **Monoclonal antibody (VEGF)**
  * **Drug**: Bevacizumab, ramucirumab
  * **Mechanism**: Anti-VEGF (inhibit microvascular growth)
  * **Indication**: Various cancer
* **Tyrosine kinase inhibitor (BCR-ABL)**
  * **Drug**: Imatinib, dasatinib, nilotinib, and ponatinib
  * **Mechanism**: BCR-ABL inhibitor
  * **Indication**: Leukemia and lymphoma (Philadelphia chromosome-positive) 
* **Tyrosine kinase inhibitor (EGFR)**
  * **Drug**: Gatitinib, erlotinib
  * **Mechanism**: EFGR inhibitor
  * **Indication**: NSCLC
* **Tyrosine kinase inhibitor (BRAF)**
  * **Drug**: Vemurafenib
  * **Mechanism**: BRAF inhibitor
  * **Indication**: Melanoma (BRAF V600E)
* **Immune checkpoint inhibitor (CTLA-4)**
  * **Drug**: Ipilimumab
  * **Mechanism**: Anti-CTLA-4, enhance T-cell activation
  * **Indication**: Melanoma
* **Immune checkpoint inhibitor (PD-1)**
  * **Drug**: Pembrolizumab, nivolumab, cemiplimab
  * **Mechanism**: Anti-PD-1, enhance T-cell activation
  * **Indication**: Various cancer
* **Immune checkpoint inhibitor (PD-L1)**
  * **Drug**: Atezolizumab, durvalumab, avelumab
  * **Mechanism**: Anti-PD-L1, enhance T-cell activation
  * **Indication**: Various cancer
* **Immunomodulator**
  * **Drug**: Thalidomide, lenalidomide
  * **Mechanism**: Inhibit proinflammatory cytokines secretion, enhance call-mediated immunity
  * **Indication**: Multiple myeloma
  * **Adverse effect**: Birth defect
{: .notice--info} -->

<!-- ## Nonhemolytic Anemia / ÈùûÊ∫∂Ë°ÄÊÄßË≤ßË°Ä

### Iron Deficiency Anemia / ÈâÑÊ¨†‰πèÊÄßË≤ßË°Ä
### Sideroblastic Anemia / ÈâÑËäΩÁêÉÊÄßË≤ßË°Ä
### Secondary Anemia / ‰∫åÊ¨°ÊÄßË≤ßË°Ä
### Aplastic Anemia / ÂÜçÁîü‰∏çËâØÊÄßË≤ßË°Ä
### Pure Red Cell Aplasia / Ëµ§ËäΩÁêÉÁôÜ
### Megaloblastic Anemia / Â∑®Ëµ§ËäΩÁêÉÊÄßË≤ßË°Ä

## Hemolytic Anemia / Ê∫∂Ë°ÄÊÄßË≤ßË°Ä

### Hereditary Spherocytosis / ÈÅ∫‰ºùÊÄßÁêÉÁä∂Ëµ§Ë°ÄÁêÉÁóá
### Thalassemia / „Çµ„É©„Çª„Éü„Ç¢
### Sickle Cell Disease / ÈéåÁä∂Ëµ§Ë°ÄÁêÉÁóá
### G6PD Deficiency / G6PDÁï∞Â∏∏Áóá
### Pyruvate Kinase Deficiency / PKÁï∞Â∏∏Áóá
### Paroxysmal Nocturnal Hemoglobinuria / Áô∫‰ΩúÊÄßÂ§úÈñì„Éò„É¢„Ç∞„É≠„Éì„É≥Â∞øÁóá
### Autoimmune Hemolytic Anemia / Ëá™Â∑±ÂÖçÁñ´ÊÄßÊ∫∂Ë°ÄÊÄßË≤ßË°Ä
### Red Cell Fragmentation Syndrome / Ëµ§Ë°ÄÁêÉÁ†¥Á†ïÁóáÂÄôÁæ§

## Leukemia / ÁôΩË°ÄÁóÖ

### Acute Myeloid Leukemia / ÊÄ•ÊÄßÈ™®È´ÑÊÄßÁôΩË°ÄÁóÖ
### Acute Lymphoblastic Leukemia / ÊÄ•ÊÄß„É™„É≥„ÉëÊÄßÁôΩË°ÄÁóÖ
### Chronic Myeloid Leukemia / ÊÖ¢ÊÄßÈ™®È´ÑÊÄßÁôΩË°ÄÁóÖ
### Chronic Lymphocytic Leukemia / ÊÖ¢ÊÄß„É™„É≥„ÉëÊÄßÁôΩË°ÄÁóÖ
### Hairy Cell Leukemia / ÊúâÊØõÁ¥∞ËÉûÁôΩË°ÄÁóÖ
### Adult T-cell Leukemia/Lymphoma / Êàê‰∫∫TÁ¥∞ËÉûÁôΩË°ÄÁóÖ„Éª„É™„É≥„ÉëËÖ´

## Malignant Lymphoma / ÊÇ™ÊÄß„É™„É≥„ÉëËÖ´

### Hodgkin Lymphoma / Hodgkin„É™„É≥„ÉëËÖ´
### Diffuse Large B-cell Lymphoma / „Å≥„Åæ„ÇìÊÄßÂ§ßÁ¥∞ËÉûÂûãBÁ¥∞ËÉû„É™„É≥„ÉëËÖ´
### Follicular Lymphoma / ÊøæËÉûÊÄß„É™„É≥„ÉëËÖ´
### MALT Lymphoma / MALT„É™„É≥„ÉëËÖ´
### Mantle Cell Lymphoma / „Éû„É≥„Éà„É´Á¥∞ËÉû„É™„É≥„ÉëËÖ´
### Burkitt lymphoma / Burkitt„É™„É≥„ÉëËÖ´
### Peripheral T-cell Lymphoma / Êú´Ê¢¢ÊÄßTÁ¥∞ËÉû„É™„É≥„ÉëËÖ´
### Mycosis Fungoides and S√©zary Syndrome / ËèåÁä∂ÊÅØËÇâÁóá„ÉªS√©zaryÁóáÂÄôÁæ§

## Other Hematopoietic Tumors / „Åù„ÅÆ‰ªñ„ÅÆÈÄ†Ë°ÄÂô®ËÖ´Áòç

### Myelodysplastic Syndrome / È™®È´ÑÁï∞ÂΩ¢ÊàêÁóáÂÄôÁæ§
### Polycythemia Vera / ÁúüÊÄßËµ§Ë°ÄÁêÉÂ¢óÂä†Áóá
### Essential Thrombocythemia / Êú¨ÊÖãÊÄßË°ÄÂ∞èÊùøË°ÄÁóá
### Primary Myelofibrosis / ÂéüÁô∫ÊÄßÈ™®È´ÑÁ∑öÁ∂≠Áóá
### Multiple Myeloma / Â§öÁô∫ÊÄßÈ™®È´ÑËÖ´
### MGUS / MGUS
### Waldenstr√∂m's Macroglobulinemia / ÂéüÁô∫ÊÄß„Éû„ÇØ„É≠„Ç∞„É≠„Éñ„É™„É≥Ë°ÄÁóá
### Heavy-Chain Disease / HÈéñÁóÖ

## Other Blood Cell Disorder / „Åù„ÅÆ‰ªñ„ÅÆË°ÄÁêÉÁï∞Â∏∏

### Erythrocytosis / Ëµ§Ë°ÄÁêÉÂ¢óÂä†Áóá
### Leukemoid Reaction / È°ûÁôΩË°ÄÁóÖÂèçÂøú
### Agranulocytosis / ÁÑ°È°ÜÁ≤íÁêÉÁóá
### Infectious Mononucleosis / ‰ºùÊüìÊÄßÂçòÊ†∏Áóá
### Langerhans Cell Histiocytosis / LangerhansÁ¥∞ËÉûÁµÑÁπîÁêÉÁóá
### Hemophagocytic Syndrome / Ë°ÄÁêÉË≤™È£üÁóáÂÄôÁæ§

## Hemostasis and Coagulation Disorder / Ê≠¢Ë°Ä„ÉªÂáùÂõ∫Á≥ª„ÅÆÁï∞Â∏∏

### Immune Thrombocytopenic Purpura / ÂÖçÁñ´ÊÄßË°ÄÂ∞èÊùøÊ∏õÂ∞ëÊÄßÁ¥´ÊñëÁóÖ
### Thrombotic Thrombocytopenic Purpura / Ë°ÄÊ†ìÊÄßË°ÄÂ∞èÊùøÊ∏õÂ∞ëÊÄßÁ¥´ÊñëÁóÖ
### Hemolytic Uremic Syndrome / Ê∫∂Ë°ÄÊÄßÂ∞øÊØíÁóáÁóáÂÄôÁæ§
### Disseminated Intravascular Coagulation / Êí≠Á®ÆÊÄßË°ÄÁÆ°ÂÜÖÂáùÂõ∫
### Vitamin K Deficiency / „Éì„Çø„Éü„É≥KÊ¨†‰πèÁóá -->

# Rheumatology / „É™„Ç¶„Éû„ÉÅÁßë

## Introduction / Á∑èË´ñ

## Immunodeficiency / ÂÖçÁñ´‰∏çÂÖ®

## Allergy / „Ç¢„É¨„É´„ÇÆ„Éº

## Collagen Disease (Arthritis) / ËÜ†ÂéüÁóÖÔºàÈñ¢ÁØÄÁÇéÔºâ

## Collagen Disease (Systemic) / ËÜ†ÂéüÁóÖÔºàÂÖ®Ë∫´ÊÄßÔºâ

## Collagen Disease (Vasculitis) / ËÜ†ÂéüÁóÖÔºàË°ÄÁÆ°ÁÇéÔºâ

<!-- ## Introduction /„ÄÄÁ∑èË´ñ

### Antiallergic Drug / Êäó„Ç¢„É¨„É´„ÇÆ„ÉºËñ¨

* **H1 antagonist (1st generation)**
  * **Drug**: Chlorpheniramine, dimenhydrinate, diphenhydramine, doxylamine, meclizine, promethazine
  * **Mechanism**: H1 receptor antagonist (pass BBB)
  * **Indication**: Allergic symptoms, insomnia, motion sickness, nausea and vomiting
  * **Adverse effect**: Sedation, anticholinergic
* **H1 antagonist (2st generation)**
  * **Drug**: Loratadine, cetirizine, clemastine, fexofenadine, desloratadine
  * **Mechanism**: H1 receptor antagonist (not pass BBB)
  * **Indication**: Allergic rhinitis
{: .notice--info}

### NSAID / Èùû„Çπ„ÉÜ„É≠„Ç§„ÉâÊÄßÊäóÁÇéÁóáËñ¨

* **Aspirin**
  * **Drug**: Aspirin
  * **Mechanism**: Inactivate COX-1 and COX-2 (irreversible)
  * **Indication**: Inflammation, pain, fever, reduce thrombi formation
  * **Adverse effect**: Gastrointestinal event, hypersensitivity, Reye syndrome (during viral infection)
* **NSAID**
  * **Drug**: Ibuprofen, naproxen, fenoprofen, ketoprofen / indomethacin, sulindac, ketorolac, diclofenac / peroxicam, mefenamate, meclofenamate, nabumetone / celecoxib (COX-2 selective)
  * **Mechanism**: Inactivate COX-1 and COX-2 (reversible)
  * **Indication**: Inflammation (indomethacin, diclofenac), pain (ketorolac), fever (ibuprogen, naproxen)
  * **Adverse effect**: Gastrointestinal event, hypersensitivity, cardiovascular event (COX-2 selective)
* **Acetaminophen**
  * **Drug**: Acetaminophen
  * **Mechanism**: Inactivate COX (centrally acting)
  * **Indication**: Pain, fever
  * **Adverse effect**: Hepatotoxicity (due to NAPQI, treat with N-acetylcystein)
* **PGE1 agonist**
  * **Drug**: Misoprostol, alprostadil
  * **Mechanism**: PGE1 agonist
  * **Indication**: NSAID-induced ulcer (misoprostol), erectile dysfunction (alprostadil), ductus arteriosus maintenance (alprostadil)
* **PGE2 agonist**
  * **Drug**: Dinoprostone
  * **Mechanism**: PGE2 agonist
  * **Indication**: Pregnancy termination
* **PGF2Œ± agonist**
  * **Drug**: Carboprost, latanoprost
  * **Mechanism**: PGF2Œ± agonist
  * **Indication**: Pregnancy termination (carboprost), glaucoma (latanoprost)
* **PGI2 agonist**
  * **Drug**: Epoprostenol, treprostinil, iloprost
  * **Mechanism**: PGI2 agonist
  * **Indication**: Pulmonary hypertension
{: .notice--info}

### Gout Drug / ÁóõÈ¢®„ÅÆËñ¨

* **Colchicine**
  * **Drug**: Colchicine
  * **Mechanism**: Prevent tubulin polymerization, interfere neutrophil migration
  * **Indication**: Acute gouty arthritis
  * **Adverse effect**: Gatrointestinal distress
* **Allopurinol**
  * **Drug**: Allopurinol, feboxostat
  * **Mechanism**: Xanthine oxidase inhibitor
  * **Indication**: Chronic gout
  * **Adverse effect**: Skin rash, GI distress
* **Porbenecid**
  * **Drug**: Compatitively inhibits reabaorption
of urate
  * **Mechanism**: Chronic gout
  * **Indication**: Urolithiasis
  * **Adverse effect**: Reduct other drugs excretion (penicillin)
* **Pegloticase**
  * **Drug**: Pegloticase
  * **Mechanism**: Recombinant uricase
  * **Indication**: Chronic gout
  * **Adverse effect**: Anaphylaxis
{: .notice--info}

### Immunosuppressive Drug / ÂÖçÁñ´ÊäëÂà∂Ëñ¨

* **Calcineurin inhibitor**
  * **Drug**: Cyclosporine, tacralimus
  * **Mechanism**: Calcineurin inhibitor
  * **Indication**: Solid-organ transplant, autoimmune disease
  * **Adverse effect**: Nephrotoxicity, gingival hyperplasia (cyclosporine)
* **mTOR inhibitor**
  * **Drug**: Sirolimus
  * **Mechanism**: mTOR inhibitor
  * **Indication**: Solid-organ transplant, autoimmune disease
  * **Adverse effect**: Anemia, increased cholesterol
* **Antimetabolite**
  * **Drug**: Azathioprine, mycophenolate mofetil, leflunomide
  * **Mechanism**: Inhibit DNA synthesis (Azathioprine: converted to 6-MP) (Mycophenolate mofetil: inhibit inosine monophosphate dehydrogenase) (Leflunomide: inhibit dihydroorotate dehydrogenase)
  * **Indication**: Solid-organ transplant, autoimmune disease
  * **Adverse effect**: GI distress, leukopenia, interact with allopurinol (azathioprine)
* **Biologic agent (TNF-Œ±)**
  * **Drug**: Infliximab, adalimumab, certolizumab, golimumab, etanercept
  * **Mechanism**: Block TNF-Œ± 
  * **Indication**: Autoimmune diseases
* **Biologic agent (IL-1)**
  * **Drug**: Anakinra
  * **Mechanism**: IL-1 receptor antagonist
  * **Indication**: Rheumatold arthritis
* **Biologic agent (IL-6 receptor)**
  * **Drug**: Tocilizumab
  * **Mechanism**: IL-6 receptor antagonist
  * **Indication**: Rheumatold arthritis
* **Biologic agent (JAK-STAT)**
  * **Drug**: Tofacitinib
  * **Mechanism**: Block JAK-STAT signaling
  * **Indication**: Rheumatold arthritis
* **Biologic agent (CD80/86)**
  * **Drug**: Abatacept
  * **Mechanism**: Block costimulatory signal
  * **Indication**: Rheumatold arthritis
* **Biologic agent (CD20)**
  * **Drug**: Rituximab
  * **Mechanism**: Anti-CD20 antibody
  * **Indication**: Rheumatoid arthritis, leukemia and lymphoma
* **Biologic agent (CD25)**
  * **Drug**: Basiliximab
  * **Mechanism**: Anti-CD25 antibody
  * **Indication**: Acute transplant rejection
* **Biologic agent (Œ±4 integrin)**
  * **Drug**: Natalizumab
  * **Mechanism**: Anti-Œ±4 integrin antibody
  * **Indication**: Multiple sclerosis, Crohn disease.
* **Antithymocyte globulin**
  * **Drug**: Antithymocyte globulin
  * **Mechanism**: Elimination of T lymphocyte
  * **Indication**: Aplastic anemia, graft-versus-host disease
{: .notice--info} -->

<!-- ## Allergy / „Ç¢„É¨„É´„ÇÆ„Éº

### Anaphylaxis / „Ç¢„Éä„Éï„Ç£„É©„Ç≠„Ç∑„Éº
### Food Allergy / È£üÁâ©„Ç¢„É¨„É´„ÇÆ„Éº
### Drug Allergy / Ëñ¨Áâ©„Ç¢„É¨„É´„ÇÆ„Éº
### Serem Sickness / Ë°ÄÊ∏ÖÁóÖ

## Collagen Disease (Arthritis) / ËÜ†ÂéüÁóÖÔºàÈñ¢ÁØÄÁÇéÔºâ

### Rheumatoid Arthritis / Èñ¢ÁØÄ„É™„Ç¶„Éû„ÉÅ
### Juvenile Idiopathic Arthritis / Ëã•Âπ¥ÊÄßÁâπÁô∫ÊÄßÈñ¢ÁØÄÁÇé
### Adult Still's Disease / Êàê‰∫∫StillÁóÖ
### Ankylosing Spondylitis / Âº∑Áõ¥ÊÄßËÑäÊ§éÁÇé
### Psoriatic Arthritis / ‰πæÁô¨ÊÄßÈñ¢ÁØÄÁÇé
### Reactive Arthritis / ÂèçÂøúÊÄßÈñ¢ÁØÄÁÇé

## Collagen Disease (Systemic) / ËÜ†ÂéüÁóÖÔºàÂÖ®Ë∫´ÊÄßÔºâ

### Systemic Lupus Erythematosus / ÂÖ®Ë∫´ÊÄß„Ç®„É™„ÉÜ„Éû„Éà„Éº„Éá„Çπ
### Scleroderma / Âº∑ÁöÆÁóá
### Polymyositis and Dermatomyositis / Â§öÁô∫ÊÄßÁ≠ãÁÇé„ÉªÁöÆËÜöÁ≠ãÁÇé
### Mixed Connective Tissue Disease / Ê∑∑ÂêàÊÄßÁµêÂêàÁµÑÁπîÁóÖ
### Polymyalgia Rheumatica / „É™„Ç¶„Éû„ÉÅÊÄßÂ§öÁô∫Á≠ãÁóõÁóá
### Fibromyalgia / Á∑öÁ∂≠Á≠ãÁóõÁóá
### Sj√∂gren's Syndrome / Sj√∂grenÁóáÂÄôÁæ§
### Behcet's Disease / BehcetÁóÖ
### Rheumatic Fever / „É™„Ç¶„Éû„ÉÅÁÜ±
### Antiphospholipid Syndrome / Êäó„É™„É≥ËÑÇË≥™Êäó‰ΩìÁóáÂÄôÁæ§
### IgG4-Related Disease / IgG4Èñ¢ÈÄ£ÁñæÊÇ£
### Goodpasture Syndrome / GoodpastureÁóáÂÄôÁæ§
### Sarcoidosis / „Çµ„É´„Ç≥„Ç§„Éâ„Éº„Ç∑„Çπ

## Collagen Disease (Vasculitis) / ËÜ†ÂéüÁóÖÔºàË°ÄÁÆ°ÁÇéÔºâ

### Giant Cell Arteritis / Â∑®Á¥∞ËÉûÊÄßÂãïËÑàÁÇé
### Takayasu's Arteritis / È´òÂÆâÂãïËÑàÁÇé
### Polyarteritis Nodosa / ÁµêÁØÄÊÄßÂ§öÁô∫ÂãïËÑàÁÇé
### Kawasaki Disease / Â∑ùÂ¥éÁóÖ
### Microscopic Polyangiitis / È°ïÂæÆÈè°ÁöÑÂ§öÁô∫Ë°ÄÁÆ°ÁÇé
### Granulomatosis with Polyangiitis / Â§öÁô∫Ë°ÄÁÆ°ÁÇéÊÄßËÇâËäΩËÖ´Áóá
### Eosinophilic Granulomatosis with Polyangiitis / Â•ΩÈÖ∏ÁêÉÊÄßÂ§öÁô∫Ë°ÄÁÆ°ÁÇéÊÄßËÇâËäΩËÖ´Áóá
### IgA Vasculitis / IgAË°ÄÁÆ°ÁÇé -->

# Infectious Diseases / ÊÑüÊüìÁóáÁßë

## Introduction / Á∑èË´ñ

## Gram-Positive Bacteria Infection / „Ç∞„É©„É†ÈôΩÊÄßËèåÊÑüÊüìÁóá

## Gram-Negative Bacteria Infection / „Ç∞„É©„É†Èô∞ÊÄßËèåÊÑüÊüìÁóá

## Miscellaneous Bacteria Infection / „Åù„ÅÆ‰ªñ„ÅÆÁ¥∞ËèåÊÑüÊüìÁóá

## DNA Virus Infection / DNA„Ç¶„Ç§„É´„ÇπÊÑüÊüìÁóá

## RNA Virus Infection / RNA„Ç¶„Ç§„É´„ÇπÊÑüÊüìÁóá

## Fungus Infection / ÁúüËèåÊÑüÊüìÁóá

## Parasite Infection / ÂØÑÁîüËô´ÊÑüÊüìÁóá

<!-- ## Introduction /„ÄÄÁ∑èË´ñ

### Cell Wall Synthesis Inhibitor / Á¥∞ËÉûÂ£ÅÂêàÊàêÈòªÂÆ≥Ëñ¨

* **Penicillins**
  * **Drug**: (Original) penicillin G, penicillin V, benzathine penicillin / (Œ≤-lactamase resistant) oxacillin, dicloxacillin, methicillin, nafcillin / (Extended-spectrum) ampicillin, amoxicillin, piperacillin, ticarcillin / (Œ≤-lactamase inhibitor) clavulanate, sulbactam, tazobactam
  * **Mechanism**: Inhibit transpeptidase, resistance from Œ≤-lactamase, synergistic with aminoglycoside
  * **Indication**: Various bacteria, pseudomonas (piperacillin, ticarcillin)
  * **Adverse effect**: Hypersensitivity, GI disturbances
* **Cephalosporins**
  * **Drug**: (1st generation) cephalexin, cefazolin, cefadroxil / (2nd generation) cefoxitin, cefaclor, cefuroxime, cefotetan, cefprozil / (3rd generation)
  ceftazidime, cefperazone, ceftriazone, cefixime, cefdinir, cefotaxime / (4th generation) cefepime / (5th generation) ceftaroline
  * **Mechanism**: Inhibit transpeptidase, Œ≤-lactamase resistant, penetrate CSF (cefuroxime, 3rd generation)
  * **Indication**: Various bacteria, pseudomonas (cefoperazone, ceftazidime, cefepime), gonorrhea (ceftriaxone, cefixime), MRSA (ceftaroline)
  * **Adverse effect**: Hypersensitivity, GI disturbances
* **Carbapenems**
  * **Drug**: Imipenem (+ cilastatin), ertapenem, meropenem, doripenem
  * **Mechanism**: Inhibit transpeptidase, Œ≤-lactamase resistant, (cilastin: inhibit renal dehydropeptidase)
  * **Indication**: Various bacteria
  * **Adverse effect**: Hypersensitivity
* **Monobactam**
  * **Drug**: Aztreonam
  * **Mechanism**: Inhibit transpeptidase, Œ≤-lactamase resistant
  * **Indication**: Gram-negative (penicillin hypersensitivity)
* **Glycopeptides**
  * **Drug**: Vancomycin, telavancin, dalbavancin, oritavancin
  * **Mechanism**: Inhibit transglycosylase
  * **Indication**: Gram-positive (penicillin hypersensitivity), MRSA
  * **Adverse effect**: Red man syndrome, nephrotoxicity
* **Daptomycin**
  * **Drug**: Daptomycin
  * **Mechanism**: Disrupt cell membrane
  * **Indication**: Gram-positive, MRSA
  * **Adverse effect**: Myopathy
* **Polymyxin**
  * **Drug**: Polymyxin
  * **Mechanism**: Disrupt cell membrane
  * **Indication**: Gram-negative
  * **Adverse effect**: Nephrotoxicity, neurotoxicity
{: .notice--info}

### Protein Synthesis Inhibitor / „Çø„É≥„Éë„ÇØË≥™ÂêàÊàêÈòªÂÆ≥Ëñ¨

* **Aminoglycosides**
  * **Drug**: Streptomycin, gentamicin, tobramycin, neomycin, amikacin
  * **Mechanism**: Inhibit 30S ribosomal subunit, require active transport (anaerobe resistant), synergistic with Œ≤-lactam
  * **Indication**: Gram-negative, aerobe
  * **Adverse effect**: Nephrotoxic, ototoxic, neuromuscular blockade
* **Tetracyclines**
  * **Drug**: Tetracycline, demeclocycline, doxycycline, minocycline, tigecycline
  * **Mechanism**: Inhibit 30S ribosomal subunit
  * **Indication**: Rickatlsia, chlamydia, mycoplasma, acne vulgaris, MRSA (tigecycline)
  * **Adverse effect**: Tooth discoloration, growth inhibition, photosensitivity, calcium impair absorption
* **Macrolides**
  * **Drug**: Azithromycin, clarithromycin, erythromycin, telithromycin
  * **Mechanism**: Inhibit 50S subunit
  * **Indication**: Legionella, mycoplasma
  * **Adverse effect**: QT prolongation, inhibit CYP450
* **Lincosamide**
  * **Drug**: Clindamycin
  * **Mechanism**: Inhibit 50S subunit
  * **Indication**: Anaerobe, ance
  * **Adverse effect**: Pseudomembranous colitis
* **Oxazolidinones**
  * **Drug**: Linezolid
  * **Mechanism**: Inhibit 50S subunit
  * **Indication**: Gram-positive, VRE
  * **Adverse effect**: Thrombocytopenia, serotonin syndrome
* **Amphenicol**
  * **Drug**: Chloramphenicol
  * **Mechanism**: Inhibit 50S subunit
  * **Indication**: Various bacteria
  * **Adverse effect**: Aplastic anemia, hemolytic anemia (G6PD deficienct), gray baby syndrome
* **Streptogramins**
  * **Drug**: Quinupristin, dalfopristin
  * **Mechanism**: Inhibit 50S subunit
  * **Indication**: VRE, MRSA
{: .notice--info}

### DNA Synthesis Inhibitor / Ê†∏ÈÖ∏ÂêàÊàêÈòªÂÆ≥Ëñ¨

* **Antifolate drug**
  * **Drug**: Trimethoprim + sulfamethoxazole
  * **Mechanism**: Inhibit dihydropteroate synthase (sulfamethoxazole), inhibit dihydrofolate reductase (trimethoprim)
  * **Indication**: Urinary tract infections, pneumocystis pneumonia
  * **Adverse effect**: Hypenensitivity, Stevens-Johnson syndrome, hemolytic anemia (G6PD deficiency)
* **Fluoroquinolones**
  * **Drug**: Ciprofloxacin, norfloxacin, ofloxacin, levofloxacin, moxifloxacin, gemifloxacin
  * **Mechanism**: Inhibit DNA gyrase, inhibit topoisomerase IV
  * **Indication**: Urinary tract infections, respiratory tract infections
  * **Adverse effect**: QT prolongation, tendon rupture
* **Metronidazole**
  * **Drug**: Metronidazole
  * **Mechanism**: Form free radical
  * **Indication**: Trichomonas vaginalis, pseudomembranous colitis
  * **Adverse effect**: Peripheral neuropathy, ditulfiram-like reaction
{: .notice--info}

### Antimycobacterial Drug / ÊäóÁµêÊ†∏Ëñ¨

* **Isoniazid**
  * **Drug**: Isoniazid
  * **Mechanism**: Inhibit mycobactarial call wall synthesis
  * **Indication**: Tuberculosis (combination), prophylaxis
  * **Adverse effect**: Peripheral nauropathy (minimized by pyridoxine), hepatotoxicity
* **Rifampin**
  * **Drug**: Rifampin
  * **Mechanism**: Inhibits RNA polymerase
  * **Indication**: Tuberculosis (combination), atypical mycobactaria, meningitis
  * **Adverse effect**: Orange-color urine
* **Ethambutol**
  * **Drug**: Ethambutol
  * **Mechanism**: Inhibit arabinosyl transfarase
  * **Indication**: Tuberculosis (combination)
  * **Adverse effect**: Visual disturbance
* **Pyrazinamide**
  * **Drug**: Pyrazinamide
  * **Indication**: Tuberculosis (combination)
  * **Adverse effect**: Hepatotoxicity
* **Dapsone**
  * **Drug**: Dapsone
  * **Mechanism**: Inhibit dihydropteroate synthase
  * **Indication**: Leprosy, pneumocystis pneumonia
  * **Adverse effect**: Hemolysis, methemoglobinemia
{: .notice--info}

### Antifungal Drug / ÊäóÁúüËèåËñ¨

* **Polyene**
  * **Drug**: Amphotericin B, nystatin
  * **Mechanism**: Bind to ergosterol, form pores
  * **Indication**: Various fungus, cryptococcal meningitis (with flucytosine)
  * **Adverse effect**: Infusion-related reactions, nephrotoxicity
* **Azoles**
  * **Drug**: Itraconazole, ketoconazole, miconazole, fluconazole, clotrimazole, voriconazole, isavuconazole, posaconazole
  * **Mechanism**: Inhibit ergosterol synthesis (inhibit lanosterol methylation)
  * **Indication**: Various fungus, cryptococcal meningitis (fluconazole)
  * **Adverse effect**: Hepatotoxicity
* **Echinocandins**
  * **Drug**: Caspofungin, micafungin, anidulafungin
  * **Mechanism**: Inhibit cell wall synthesis
  * **Indication**: Candida, aspergillus
* **Flucytosine**
  * **Drug**: Flucytosine
  * **Mechanism**: Inhibit nucleic acid synthesis (converted to 5-fluorauracil)
  * **Indication**: Cryptococcal meningitis (with amphotericin B)
  * **Adverse effect**: Bone marrow supression
* **Griseofulvin**
  * **Drug**: Griseofulvin
  * **Mechanism**: Prevents spindle formation
  * **Indication**: Dermatophyte
{: .notice--info}

### Antiviral Drug / Êäó„Ç¶„Ç§„É´„ÇπËñ¨

* **Antiherpetic drug**
  * **Drug**: Acyclovir, valacyclovir, famiciclovir / ganciclovir, valganciclovir / foscarnet / cidofovir
  * **Mechanism**: Inhbit DNA polymerase (acyclovir, valacyclovir, famiciclovir: activated by viral thymidine kinase)
  * **Indication**: HSV, VZV, EBV, CMV
  * **Adverse effect**: Nephrotoxicity, neurotoxicity, bone marrow suppression
* **Anti-influenza drug**
  * **Drug**: Amantadine, rimantadine / zanamivir, neltamivir / baloxavir marboxil
  * **Mechanism**: M2 protein inhibitor / neuraminidase inhibitor / PA protein inhibitor
  * **Indication**: Influenza, prophylaxis
  * **Adverse effect**: CNS effect, GI dysfunction
* **Anti-HCV durg (direct-acting antiviral)**
  * **Drug**: Glecaprevir, grazoprevir, paritaprevir, simeprevir / daclatasvir, elbasvir, ledipasvir, ombitasvir, pibrentasvir, velpatasvir / sofosbubir, dasabuvir
  * **Mechanism**: NS3/4A inhibitor, NS5A inhibitor, NS5B inhibitor
  * **Indication**: HCV
* **Anti-HBV drug**
  * **Drug**: Lamivudine, adefovir, entecavir, tenofovir / interferon alpha
  * **Mechanism**: Inhibit DNA polymerase
  * **Indication**: HBV
{: .notice--info}

### Antiretroviral Drug / ÊäóHIVËñ¨

* **Nucleoside reverse transcriptase inhibitor**
  * **Drug**: Tenofovir, abacavir, zidovudine, emtricitabine, lamivudine, didanosine, stavudine
  * **Mechanism**: Competitively inhibit reverse transcriptase (require phosphorylation)
  * **Indication**: HIV
  * **Adverse effect**: Leukopenia, neuropathy, pancreatitis
* **Nonnucleoside reverse transcriptase inhibitor**
  * **Drug**: Efavirenz, nevirapine, rilpivirine, etravirine, delavirdine
  * **Mechanism**: Noncompetitively inhibit reverse transcriptase (not require phosphorylation)
  * **Indication**: HIV
  * **Adverse effect**: GI dysfunction, skin reaction
* **Protease inhibitor**
  * **Drug**: Ritonavir, darunavir, atazanavir, lopinavir
  * **Mechanism**: Inhibit polyprotein cleavage
  * **Indication**: HIV
  * **Adverse effect**: Hyperglycemia, hyparlipidemia lipodystrophy
* **Integrase inhibitor**
  * **Drug**: Raltegravir, elvitegravir, dolutegravir bictegravir.
  * **Mechanism**: Prevent viral DNA integration
  * **Indication**: HIV
* **Fusion inhibitor**
  * **Drug**: Enfuvirtida
  * **Mechanism**: Block viral entry (bind gp41)
  * **Indication**: HIV
* **CCR5 antagonist**
  * **Drug**: Maraviroc
  * **Mechanism**: Block viral entry (bind CCR5)
  * **Indication**: HIV
{: .notice--info}

### Antiparasitic Drug / ÊäóÂØÑÁîüËô´Ëñ¨

* **Anti-malaria drug**
  * **Drug**: Cloroquine, primaquine, quinine, atovaquone, artemether, mefloquine
  * **Indication**: Plasmodium vivax/ovale (chloroquine, primaquine), Plasmodium malaria (chloroquine), Plasmodium falciparum (quinine, atovaquone, artemther, mefloquine)
* **Anti-protozoa drug**
  * **Drug**: Metronidazole, stibogluconate sodium, nifurtimox, suramin
  * **Indication**: Entamoeba & Giardia & Trichomonas (metronidazole), Leishmania (stibogluconate sodium), trypanosoma (nifurtimox, suramin)
* **Anti-metazoa drug**
  * **Drug**: Albendazole, pyrantel pamoate, ivermectin, diethylcarbamazine, praziquantel, 
  * **Indication**: Nematode (albendazole, pyrantel pamoate, ivermectin), filaria (diethylcarbamazine), trematode & cestode (praziquantel)
{: .notice--info} -->

<!-- 

## Gram-Positive Bacterial Infection / „Ç∞„É©„É†ÈôΩÊÄßËèåÊÑüÊüìÁóá

### Staphylococcus Aureus Infection / ÈªÑËâ≤„Éñ„Éâ„Ç¶ÁêÉËèåÊÑüÊüìÁóá
### Staphylococcus Epidermidis Infection / Ë°®ÁöÆ„Éñ„Éâ„Ç¶ÁêÉËèåÊÑüÊüìÁóá
### Streptococcus Pyogenes Infection / ÂåñËÜø„É¨„É≥„ÇµÁêÉËèåÊÑüÊüìÁóá
### Streptococcus Agalactiae Infection / BÁæ§„É¨„É≥„ÇµÁêÉËèåÊÑüÊüìÁóá
### Streptococcus Pneumoniae Infection / ËÇ∫ÁÇéÁêÉËèåÊÑüÊüìÁóá
### Viridans Streptococci Infection / Á∑ëËâ≤„É¨„É≥„ÇµÁêÉËèåÊÑüÊüìÁóá
### Enterococcus Infection / ËÖ∏ÁêÉËèåÊÑüÊüìÁóá
### Diphtheria / „Ç∏„Éï„ÉÜ„É™„Ç¢
### Listeriosis / „É™„Çπ„ÉÜ„É™„Ç¢Áóá
### Anthrax / ÁÇ≠ÁñΩ
### Botulism / „Éú„ÉÑ„É™„Éå„ÇπÁóá
### Tetanus / Á†¥ÂÇ∑È¢®
### Clostridium Perfringens Infection / „Ç¶„Çß„É´„Ç∑„É•ËèåÊÑüÊüìÁóá
### Clostridioides Difficile Infection / „Éá„Ç£„Éï„Ç£„Ç∑„É´ËèåÊÑüÊüìÁóá
### Non-Sporeforming Anaerobe Infection / ÁÑ°ËäΩËÉûÂ´åÊ∞óÊÄßËèåÊÑüÊüìÁóá

## Gram-Negative Bacterial Infection / „Ç∞„É©„É†Èô∞ÊÄßËèåÊÑüÊüìÁóá

### Escherichia Coli Infection / Â§ßËÖ∏ËèåÊÑüÊüìÁóá
### Shigellosis / Á¥∞ËèåÊÄßËµ§Áó¢
### Typhoid Fever / ËÖ∏„ÉÅ„Éï„Çπ
### Salmonellosis / „Çµ„É´„É¢„Éç„É©Áóá
### Plague / „Éö„Çπ„Éà
### Yersinia Enterocolitica Infection / „Ç®„É´„Ç∑„Éã„Ç¢ÊÑüÊüìÁóá
### Klebsiella Pneumoniae Infection / „ÇØ„É¨„Éñ„Ç∑„Ç®„É©ÊÑüÊüìÁóá
### Serratia Marcescens Infection / „Çª„É©„ÉÅ„Ç¢ÊÑüÊüìÁóá
### Cholera / „Ç≥„É¨„É©
### Vibrio Parahaemolyticus Infection / ËÖ∏ÁÇé„Éì„Éñ„É™„Ç™ÊÑüÊüìÁóá
### Vibrio Vulnificus Infection / „Éê„É´„Éã„Éï„Ç£„Ç´„ÇπËèåÊÑüÊüìÁóá
### Campylobacter Jejuni Infection / „Ç´„É≥„Éî„É≠„Éê„ÇØ„Çø„ÉºÊÑüÊüìÁóá
### Helicobacter Pylori Infection / „Éî„É≠„É™ËèåÊÑüÊüìÁóá
### Haemophilus Influenzae Infection / „Ç§„É≥„Éï„É´„Ç®„É≥„Ç∂ËèåÊÑüÊüìÁóá
### Pertussis / ÁôæÊó•Âí≥
### Pseudomonas Aeruginosa Infection / Á∑ëËÜøËèåÊÑüÊüìÁóá
### Acinetobacter Baumannii Infection / „Ç¢„Ç∑„Éç„Éà„Éê„ÇØ„Çø„ÉºÊÑüÊüìÁóá
### Legionellosis / „É¨„Ç∏„Ç™„Éç„É©Áóá
### Brucellosis / „Éñ„É´„Çª„É©Áóá
### Tularemia / ÈáéÂÖéÁóÖ
### Cat-Scratch Disease / „Å≠„Åì„Å≤„Å£„Åã„ÅçÁóÖ
### Neisseria Gonorrhoeae Infection / Ê∑ãËèåÊÑüÊüìÁóá
### Neisseria Meningitidis Infection / È´ÑËÜúÁÇéËèåÊÑüÊüìÁóá
### Moraxella Catarrhalis Infection / „É¢„É©„ÇØ„Çª„É©ÊÑüÊüìÁóá

## Other Bacterial Infection / „Åù„ÅÆ‰ªñ„ÅÆÁ¥∞ËèåÊÑüÊüìÁóá

### Actinomycosis / ÊîæÁ∑öËèåÁóá
### Nocardiosis / „Éé„Ç´„É´„Ç∏„Ç¢Áóá
### Tuberculosis / ÁµêÊ†∏
### Nontuberculous Mycobacteriosis / ÈùûÁµêÊ†∏ÊÄßÊäóÈÖ∏ËèåÁóá
### Leprosy / HansenÁóÖ
### Syphilis / Ê¢ÖÊØí
### Borreliosis / „Éú„É¨„É™„Ç¢Áóá
### Leptospirosis / „É¨„Éó„Éà„Çπ„Éî„É©Áóá
### Chlamydia Infection / „ÇØ„É©„Éü„Ç∏„Ç¢ÊÑüÊüìÁóá
### Mycoplasma Infection / „Éû„Ç§„Ç≥„Éó„É©„Ç∫„ÉûÊÑüÊüìÁóá
### Rickettsia Infection / „É™„Ç±„ÉÉ„ÉÅ„Ç¢ÊÑüÊüìÁóá

## DNA Viral Infection / DNA„Ç¶„Ç§„É´„ÇπÊÑüÊüìÁóá

### Herpes Simplex Virus Infection / ÂçòÁ¥î„Éò„É´„Éö„Çπ„Ç¶„Ç§„É´„ÇπÊÑüÊüìÁóá
### Varicella-Zoster Virus Infection / Ê∞¥ÁóòÂ∏ØÁä∂Áñ±Áñπ„Ç¶„Ç§„É´„ÇπÊÑüÊüìÁóá
### Epstein-Barr Virus Infection / EB„Ç¶„Ç§„É´„ÇπÊÑüÊüìÁóá
### Cytomegalovirus Infection / „Çµ„Ç§„Éà„É°„Ç¨„É≠„Ç¶„Ç§„É´„ÇπÊÑüÊüìÁóá
### Human Herpesvirus 6 & 7 Infection / „Éí„Éà„Éò„É´„Éö„Çπ„Ç¶„Ç§„É´„ÇπÊÑüÊüìÁóá
### Human Papillomavirus Infection / „Éí„Éà„Éë„Éî„É≠„Éº„Éû„Ç¶„Ç§„É´„ÇπÊÑüÊüìÁóá
### Poxvirus Infection / „Éù„ÉÉ„ÇØ„Çπ„Ç¶„Ç§„É´„ÇπÊÑüÊüìÁóá
### Parvovirus Infection / „Éë„É´„Éú„Ç¶„Ç§„É´„ÇπÊÑüÊüìÁóá
### Adenovirus Infection / „Ç¢„Éá„Éé„Ç¶„Ç§„É´„ÇπÊÑüÊüìÁóá
### Hepatitis B / BÂûãËÇùÁÇé

## RNA Viral Infection / RNA„Ç¶„Ç§„É´„ÇπÊÑüÊüìÁóá

### Influenza / „Ç§„É≥„Éï„É´„Ç®„É≥„Ç∂
### COVID-19 / Êñ∞Âûã„Ç≥„É≠„Éä„Ç¶„Ç§„É´„ÇπÊÑüÊüìÁóá
### SARS / ÈáçÁóáÊÄ•ÊÄßÂëºÂê∏Âô®ÁóáÂÄôÁæ§
### MERS / ‰∏≠Êù±ÂëºÂê∏Âô®ÁóáÂÄôÁæ§
### Norovirus Infection / „Éé„É≠„Ç¶„Ç§„É´„ÇπÊÑüÊüìÁóá
### Rotavirus Infection / „É≠„Çø„Ç¶„Ç§„É´„ÇπÊÑüÊüìÁóá
### Enterovirus Infection / „Ç®„É≥„ÉÜ„É≠„Ç¶„Ç§„É´„ÇπÊÑüÊüìÁóá
### Measles Virus Infection / È∫ªÁñπ„Ç¶„Ç§„É´„ÇπÊÑüÊüìÁóá
### Rubella Virus Infection / È¢®Áñπ„Ç¶„Ç§„É´„ÇπÊÑüÊüìÁóá
### Mumps Virus Infection / „É†„É≥„Éó„Çπ„Ç¶„Ç§„É´„ÇπÊÑüÊüìÁóá
### Japanese Encephalitis / Êó•Êú¨ËÑ≥ÁÇé
### West Nile Encephalitis / „Ç¶„Ç®„Çπ„Éà„Éä„Ç§„É´ËÑ≥ÁÇé
### Rabies / ÁãÇÁä¨ÁóÖ
### Dengue Fever / „Éá„É≥„Ç∞ÁÜ±
### Chikungunya Fever / „ÉÅ„ÇØ„É≥„Ç∞„Éã„Ç¢ÁÜ±
### Zika Fever / „Ç∏„Ç´ÁÜ±
### Ebola Hemorrhagic Fever / „Ç®„Éú„É©Âá∫Ë°ÄÁÜ±
### SFTS / ÈáçÁóáÁÜ±ÊÄßË°ÄÂ∞èÊùøÊ∏õÂ∞ëÁóáÂÄôÁæ§
### HIV Infection / HIVÊÑüÊüìÁóá
### HTLV-1 Infection / HTLV-1ÊÑüÊüìÁóá
### Hepatitis A / AÂûãËÇùÁÇé
### Hepatitis C / CÂûãËÇùÁÇé
### Hepatitis D / DÂûãËÇùÁÇé
### Hepatitis E / EÂûãËÇùÁÇé

## Fungal Infection / ÁúüËèåÊÑüÊüìÁóá

### Candidiasis / „Ç´„É≥„Ç∏„ÉÄÁóá
### Aspergillosis / „Ç¢„Çπ„Éö„É´„ÇÆ„É´„ÇπÁóá
### Mucormycosis / „É†„Éº„Ç≥„É´Áóá
### Cryptococcosis / „ÇØ„É™„Éó„Éà„Ç≥„ÉÉ„ÇØ„ÇπÁóá
### Pneumocystis Infection / „Éã„É•„Éº„É¢„Ç∑„Çπ„ÉÅ„ÇπÊÑüÊüìÁóá
### Histoplasmosis / „Éí„Çπ„Éà„Éó„É©„Çπ„ÉûÁóá
### Coccidioidomycosis / „Ç≥„ÇØ„Ç∑„Ç∏„Ç™„Ç§„Éá„ÇπÁóá
### Blastomycosis / „Éñ„É©„Çπ„Éà„Éü„Çª„ÇπÁóá

## Protozoal Infection / ÂéüËô´ÊÑüÊüìÁóá

### Amebiasis / „Ç¢„É°„Éº„ÉêËµ§Áó¢
### Giardiasis / „É©„É≥„Éñ„É´Èû≠ÊØõËô´Áóá
### Cryptosporidiosis / „ÇØ„É™„Éó„Éà„Çπ„Éù„É™„Ç∏„Ç¶„É†Áóá
### Malaria / „Éû„É©„É™„Ç¢
### Babesiosis / „Éê„Éô„Ç∑„Ç¢Áóá
### Toxoplasmosis / „Éà„Ç≠„ÇΩ„Éó„É©„Ç∫„ÉûÁóá
### Leishmaniasis / „É™„Éº„Ç∑„É•„Éû„Éã„Ç¢Áóá
### African Sleeping Sickness / „Ç¢„Éï„É™„Ç´Áù°Áú†ÁóÖ
### Chagas Disease / „Ç∑„É£„Éº„Ç¨„ÇπÁóÖ
### Trichomoniasis / „Éà„É™„Ç≥„É¢„Éä„ÇπÁóá

## Helminthic Infection / Ë†ïËô´ÊÑüÊüìÁóá

### Ascariasis / ÂõûËô´Áóá
### Enterobiasis / ËüØËô´Áóá
### Trichuriasis / Èû≠Ëô´Áóá
### Hookworm Infection / Èâ§Ëô´Áóá
### Strongyloidiasis / Á≥ûÁ∑öËô´Áóá
### Anisakiasis / „Ç¢„Éã„Çµ„Ç≠„Çπ
### Filariasis / „Éï„Ç£„É©„É™„Ç¢Áóá
### Onchocerciasis / „Ç™„É≥„Ç≥„Çª„É´„Ç´Áóá
### Loiasis / „É≠„Ç¢Á≥∏Áä∂Ëô´Áóá
### Gnathostomiasis / È°éÂè£Ëô´Áóá
### Angiostrongyliasis / Â∫ÉÊù±‰ΩèË°ÄÁ∑öËô´Áóá
### Trichinellosis / ÊóãÊØõËô´Áóá
### Schistosomiasis / ‰ΩèË°ÄÂê∏Ëô´Áóá
### Clonorchiasis / ËÇùÂê∏Ëô´Áóá
### Metagonimiasis / Ê®™Â∑ùÂê∏Ëô´Áóá
### Paragonimiasis / ËÇ∫Âê∏Ëô´Áóá
### Diphyllobothriasis / Ë£ÇÈ†≠Êù°Ëô´Áóá
### Taeniasis Saginata / ÁÑ°Èâ§Êù°Ëô´Áóá
### Taeniasis Solium / ÊúâÈâ§Êù°Ëô´Áóá
### Echinococcosis / ÂåÖËô´Áóá

-->

# Neurology / Á•ûÁµåÁßë

## Introduction / Á∑èË´ñ

## Cerebrovascular Disorder / ËÑ≥Ë°ÄÁÆ°ÈöúÂÆ≥

### Cerebral Infarction / ËÑ≥Ê¢óÂ°û

* **Overview**
  * Thrombus or embolus obstruct cerebral artery, ischemia and necrosis in the supplied areas, various neurological symptoms and permanent disabilities 
  * [Atherothrombotic infarction] Thrombus forms due to atherosclerosis of carotid or cerebral arteries; hypertension, diabetes, dyslipidemia, smoking, and heavy drinking increase the risk
  * [Cardioembolic infarction] Embolus forms in heart due to heart diseases (atrial fibrillation, valvular heart disease, myocardial infarction)
  * [Lacunar infarction] Lipohyalinosis (blood vessel degeneration due to prolonged hypertension) or microatheroma block small penetrating arteries (to basal ganglia, internal capsule, thalamus)
* **Presentation**
  * **Contralateral hemiplegia, sensory disturbances, dysarthria**: Damage to primary motor or somatosensory cortex
  * **Aphasia, agnosia**: Damage to association cortex
  * **Consciousness disorder**: Widespread cortical damage
  * **Dizziness, nausea, vomiting, cerebellar ataxia, dysarthria (in case of cerebellar infarction)**: Damage to cerebellar balancing and coordinating functions
  * **Temperature and pain sensation impairment of ipsilateral face and contralateral limbs, nystagmus, hoarseness, dysarthria (in case of brainstem infarction, particularly Wallenberg syndrome)**: Damage to spinothalamic tract and cranial nerve nucleus at lateral medulla
  * **Motor disturbance, sensory disturbance, bladder and rectal disturbance, with proprioception preserved (in case of spinal cord infarction, particularly anterior spinal artery syndrome)**
  * **[Atherothrombotic infarction] Occur at rest (often sleeping) and gradually worsen; sometimes preceded by transient ischemic attack**: Stasis of blood flow promotes thrombus formation, thrombus gradually enlarge and progressively block the blood flow
  * **[Cardioembolic infarction] Occur suddenly during activity and develop rapidly, often with large infarct area and severe symptoms**: Increased blood flow during activity dislodge the thrombus,  thrombus rapidly block a major cerebral artery
  * **[Lacunar infarction] Mild motor disturbances, sensory disturbances or dysarthria, without cortical symptoms**: Blockage of small penetrating artery resulting in small infarction area in deep brain
* **Examination**
  * **[CT] No obvious abnormalities in hyperacute phase, low-density region in acute and chronic phase**: No enough structural changes in hyperacute phase, edema in acute phase, liquefactive necrosis in chronic phase
  * **[MRI] High-signal on DWI in hyperacute phase, high signal on T2 and FLAIR in acute and chronic phase**: Water accumulate in cells with restricted diffusion in hyperacute phase, edema in acute phase, liquefactive necrosis in chronic phase
  * **[CTA, MRA, cerebral angiography] Vascular stenosis or occlusion**
* **Management**
  * **[Acute phase] Respiration management (intubation as needed), circulation management (avoid aggressively lowering BP), metabolism management (fluid, glucose)**: Control respiration, circulation, metabolism
  * **[Acute phase] Thrombolytics (rt-PA) or thrombectomy**: Activate plasminogen and dissolve clot, or directly remove clot endovascularly
  * **[Acute phase] Antiplatelet drugs (ozagrel, aspirin) and anticoagulants (heparin, argatroban), neuroprotective drugs (edaravone), anti-cerebral adema drugs (glycerol)**: Prevent thrombus enlargement, prevent free radical damage, prevent brain herniation
  * **[Chronic phase] Control hypertension, diabetes, dyslipidemia, obesity**: Control risk factors
  * **[Chronic phase] Antiplatelet drugs (clopidogrel, cilostazol, aspirin) for atherothrombotic and lacunar infarction, anticoagulants (dabigatran, rivaroxaban, warfarin) for cardioembolic infarction**: Prevent thrombus or embolus formation
  * **[Chronic phase] Rehabilitation**
{: .notice--info}

### Transient Ischemic Attack / ‰∏ÄÈÅéÊÄßËÑ≥ËôöË°ÄÁô∫‰Ωú

* **Overview**
  * Thrombus or embolus obstruct peripheral arteries, transient neurological symptoms, thrombus dissolves and vessels reopen soon after, may precede cerebral infarction due to larger thrombus formation
* **Presentation**
  * **Temporary loss of vision, weakness and hemiplegia, numbness, aphasia (resolve within 2 ~ 15 minutes)**: Temporary ischemia of eye, motor cortex, sensory cortex, language cortex
  * **May develop to cerebral infarction**
* **Examination**
  * **[CT, MRI] No findings of cerebral infarction**
* **Management**
  * **[Preventive] Antiplatelet drugs (clopidogrel, cilostazol, aspirin), anticoagulants (dabigatran, rivaroxaban, warfarin), carotid edarterectomy or carotid artery stenting, control risk factors**: Prevent thrombus or embolus formation
{: .notice--info}

### Carotid Artery Stenosis / È†∏ÂãïËÑàÁã≠Á™ÑÁóá

* **Overview**
  * Narrowing of carotid artery due to atherosclerosis, may lead to TIA or cerebral infarction due to dislodged thrombus
* **Presentation**
  * **Asymptomatic**
  * **May cause TIA or cerebral infarction**
* **Examination**
  * **[Carotid ultrasound] Stenosis of internal carotid artery**
  * **[MRA, CTA, cerebral angiography] Stenosis of internal carotid artery**
* **Management**
  * **[Preventive] Antiplatelet drugs (clopidogrel, cilostazol, aspirin), control hypertension, diabetes, dyslipidemia**: Prevent thrombus formation
  * **[Surgical] Carotid edarterectomy, carotid artery stenting**: Directly remove plaque or prevent plaque breaking off
{: .notice--info}

### Cerebral Hemorrhage / ËÑ≥Âá∫Ë°Ä

* **Overview**
  * Prolonged hypertension weakens vessels walls, leading to rupture and bleeding
  * [Putaminal hemorrhage] Rupture of lenticulostriate artery
  * [Thalamic hemorrhage] Rupture of thalamoperforating or thalamogeniculate artery
  * [Brainstem hemorrhage] Rupture of pontine arteries
  * [Cerebellar hemorrhage] Rupture of superior cerebellar artery
  * [Subcortical hemorrhage] Rupture of cortical branches
* **Presentation**
  * **Headache, impaired consciousness**: Increased intracranial pressure lead to pain and brain herniation
  * **Contralateral hemiplegia, sensory disturbances**: Damage to descending or ascending fibers in internal capsule
  * **[Putaminal hemorrhage] Conjugate deviation of eyes towards affected side**: Damage to corticobulbar fibers to contralateral PPRF (horizontal gaze center)
  * **[Thalamic hemorrhage] Downward and inward deviation of eyes**: Damage to superior colliculus (vertical gaze center)
  * **[Brainstem hemorrhage] Respiratory distress,quadriplegia, fixed midline eyes, pinpoint pupils**: Damage to respiratory center, bilateral corticospinal tract, PPRF and superior colliculus, sympathetic tract
  * **[Cerebellar hemorrhage] Rotational vertigo and repeated vomiting, standing and walking difficulty**: Damage to cerebellar balancing function and coordination function
  * **[Subcortical hemorrhage] Motor disturbances, sensory disturbances, visual field defects, sensory aphasia**: Damage to frontal lobe, parietal lobe, occipital lobe, temporal lobe
* **Examination**
  * **[CT] High-density region**: Fresh blood has higher density
* **Management**
  * **[Clear consciousness] Respiration management (intubation as needed),  circulation management (systolic pressure < 140 mmHg), metabolism management (fluid), anti-cerebral adema drugs (glycerol, mannitol)**: Control respiration, circulation, metabolism, cerebral edema
  * **[Impaired consciousness] Hematoma removal surgery, ventricular drainage**: Relieve brain herniation due to hematoma or hydrocephalus
  * **[Chronic phase] Control hypertension, rehabilitation**
{: .notice--info}

### Arteriovenous Malformation / ËÑ≥ÂãïÈùôËÑàÂ•áÂΩ¢

* **Overview**
  * Congenital cerebrovascular abnormality where arteries and veins directly connect without capillaries, result in a cluster of dilated and tortuous vessels (nidus), may lead to cerebral hemorrhage and secondary subarachnoid hemorrhage due to rupture
  * More common in children and young adults
* **Presentation**
  * **Headache, seizures, progressive hemiplegia**: Abnormal connection bypass capillaries and cause ischemia
  * **Motor disturbance, sensory disturbance, bladder and rectal disturbance (in case of spinal AVM)**
  * **May cause cerebral hemorrhage and secondary subarachnoid hemorrhage**
* **Examination**
  * **[Cerebral angiography, MRA] Cluster of dilated and tortuous vessels**
  * **[MRI] Multiple flow void (no signal) region**: MRI cannot capture fast-moving blood in abnormal vessels
* **Management**
  * **[Hemorrhage or symptomatic] Resection of nidus, embolization of nidus, gamma knife**: Prevent hemorrhage
  * **[Non-hemorrhage] Anticonvulsants**: Symptomatic treatment
{: .notice--info}

### Subarachnoid Hemorrhage / „Åè„ÇÇËÜú‰∏ãÂá∫Ë°Ä

* **Overview**
  * Bleeding into subarachnoid space due to rupture of vascular lesions, underlying diseases include cerebral aneurysm (80%) and arteriovenous malformations
* **Presentation**
  * **Sudden severe pain**: Increased intracranial pressure trigger pain
  * **Nausea, vomiting, impaired consciousness**: Increased intracranial pressure irritates brainstem
  * **Neck stiffness, Kernig sign, Brudzinski sign, positive neck flexion test**: Blood in subarachnoid space irritates meninges
  * **[Complication] Rebleeding**: Dislodge of the initial clot due to fluctuation of blood pressure
  * **[Complication] Cerebral vasospasm**: Blood breakdown products irritate and trigger contractions of vessels
  * **[Complication] Normal pressure hydrocephalus**: Blood breakdown products obstruct CSF absorption pathway
* **Examination**
  * **[CT] Star-shaped high-density area around suprasellar region**: Fresh blood pooling in subarachnoid space (which has star-shaped anatomy around suprasellar region)
  * **[MRI] High signal on FLAIR**: FLAIR suppress CSF signal but highlight abnormal fluid (blood)
  * **[CSF analysis] Blood-stained CSF or xanthochromia (yellowish CSF)**: RBC or bilirubin in CSF
  * **[DSA (4-vessel study), MRA, 3D-CTA] Cerebral aneurysm (preoperative)**
* **Management**
  * **[Preoperative] Blood pressure management (antihypertensive drugs), intracranial pressure management (anti-cerebral edema drugs), pain relief and sedation (diazepam, pentazocine)**: Prevent rebleeding and brain herniation
  * **[Surgical] Aneurysm neck clipping, aneurysm coil embolization**: Prevent rebleeding
  * **[Postoperative] Vasodilator (fasudil), antiplatelet drug (ozagrel)**: Prevent vasospasm
{: .notice--info}

### Cerebral Aneurysm / ËÑ≥ÂãïËÑàÁò§

* **Overview**
  * Bulge in brain vessels (particularly in branching points) due to congenital defects in tunica media and acquired factors such as hypertension and arteriosclerosis; usually asymptomatic but may lead to subarachnoid hemorrhage due to rupture
  * More common in middle age adults
* **Presentation**
  * **Asymptomatic in most cases**
  * **Mydriasis, diplopia, ptosis**: Compression of oculomotor nerve by aneurysm
  * **Vision and visual field defects**: Compression of optic nerve by aneurysm
  * **May cause subarchnoid hemorrhage** 
* **Examination**
  * **[MRA, 3D-CTA, DSA] Cerebral aneurysm**
* **Management**
  * **[Observation]**: If asymptomatic 
  * **[Surgical] Aneurysm neck clipping, aneurysm coil embolization**: If symptomatic or high risk of rupture
{: .notice--info}

### Moyamoya Disease / „ÇÇ„ÇÑ„ÇÇ„ÇÑÁóÖ

* **Overview**
  * Narrowing or occlusion of arteries in circle of Willis lead to ischemia, fragility of compensating collateral circulation lead to hemorrhage
  * More common in children under 10s and adults in 30s ~ 40s
* **Presentation**
  * **[Childhood] Temporary hemiplegia, sensory disturbances, altered consciousness, seizures after cooling hot food by blowing, playing wind instruments, intense crying**: Hypoventilation cause decreased CO2 levels, lead to cerebral vasoconstriction and ischemia
  * **[Adulthood] May lead to cerebral hemorrhage**
* **Examination**
  * **[DSA, MRA] Narrowing or occlusion near terminal portion of internal carotid artery, presence of moyamoya vessles near basal ganglia**
  * **[MRI] Punctate or linear flow void (no signal) region near basal ganglia**: MRI cannot capture fast-moving blood in abnormal vessels
* **Management**
  * **[Surgical] STA-MCA bypass**: Revascularization by connecting superficial temporal artery and middle cerebral artery
  * **[Medical] Antiplatelet drugs, anticonvulsants**: Infarction prevention and symptomatic treatment 
{: .notice--info}

### Carotid-Cavernous Fistula / ÂÜÖÈ†∏ÂãïËÑà-Êµ∑Á∂øÈùôËÑàÊ¥ûÁòª

* **Overview**
  * Arteriovenous fistula forms between internal carotid artery and cavernous sinus due to trauma or rupture of aneurysm, lead to increased pressure in cavernous sinus and ophthalmic veins
  * [Dural arteriovenous fistula] Arteriovenous fistula can also form in transverse sinus and sigmoid sinus
* **Presentation**
  * **Pulsatile exophthalmos, conjunctival congestion and edema**: Increased pressure in ophthalmic veins in a pulsatile fashion 
  * **Pulsatile bruit in orbital region, extraocular muscle paralysis**: Increased pressure in cavernous sinus in a pulsatile fashion 
* **Examination**
  * **[Cerebral angiography ] Visualization of cavernous sinus during arterial phase**: Arterial blood flows directly into cavernous sinus
* **Management**
  * **Endovascular embolization using coil**: Occlusion of the fistula
{: .notice--info}

### Sinus Thrombosis / ÈùôËÑàÊ¥ûË°ÄÊ†ìÁóá

* **Overview**
  * Thrombus forms in venous sinus and obstructs blood return, due to dural arteriovenous fistula or hypercoagulability
* **Presentation**
  * **Headache, vomiting**: Increased intracranial pressure
* **Examination**
  * **[MRV] Narrowing or occlusion of venous sinus**
* **Management**
  * **Anticoagulants (heparin)**: Prevent further thrombus formation
{: .notice--info}

### Hypertensive Encephalopathy / È´òË°ÄÂúßÊÄßËÑ≥Áóá

* **Overview**
  * Sudden or severe increase in blood pressure impairs brain‚Äôs autoregulation and blood-brain barrier, lead to cerebral edema and neurological symptoms 
* **Presentation**
  * **Headache, nausea, vomiting, consciousness disturbances**: Increased intracranial pressure
* **Examination**
  * **[MRI] High signal in localized area**: Edema
  * **[CT] Low-density in localized area**: Edema
* **Management**
  * **Calcium channel blockers (nicardipine), anti-cerebral edema drugs (glycerol, mannitol)**: Reduce blood pressure, relieve cerebral edema
{: .notice--info}

## Dementia / Ë™çÁü•Áóá

### Alzheimer‚Äôs Dementia / AlzheimerÂûãË™çÁü•Áóá

* **Overview**
  * Degeneration of cerebral cortex due to accumulation of amyloid Œ≤ and phosphorylated tau protein, leading to cognitive impairment
  * Common in elderly individuals, most common type of dementia
  * Pathology shows cerebral atrophy grossly, senile plaques and neurofibrillary tangles microscopically 
* **Presentation**
  * **[Core symptoms] Memory impairment, disorientation, executive dysfunction, aphasia, apraxia, agnosia**: Degeneration of cerebral cortex, mainly temporal lobe (hippocampus) and parietal lobe 
  * **[BPSD] Insomnia, hallucinations/delusions, depressive states, anxiety/agitation, excitement/violence, unclean behavior, wandering, pica/overeating, dependency**: Disruption of normal brain functions
* **Examination**
  * **[Cognitive function test] HDS-R score <= 20, MMSE <= 23**: Cognitive impairment
  * **[CT, MRI] Atrophy, mainly temporal lobe and hippocampus**: Degeneration of temporal lobe
  * **[SPECT, PET] Reduced blood flow, mainly temporal lobe and parietal lobe**: Reduced neuronal activity leads to reduced blood flow
* **Management**
  * **Cholinesterase inhibitor (donepezil, galantamine, rivastigmine)**: Reduce breakdown and increase level of acetylcholine, improve signal transduction
  * **NMDA receptor antagonist (memantin)**: Inhibit excessive glutamate activity, reduce neuronal damage 
{: .notice--info}

### Dementia With Lewy Bodies / LewyÂ∞è‰ΩìÂûãË™çÁü•Áóá

* **Overview**
  * Degeneration of cerebral cortex due to accumulation of Œ±-synuclein, leading to cognitive impairment and Parkinsonism
Pathology shows Lewy bodies
* **Presentation**
  * **Cognitive impairment, visual hallucinations (with daily or weekly fluctuation)**: Degeneration of cerebral cortex, mainly occipital lobe
  * **Parkinsonism, REM sleep behavior disorder**: Degeneration of basal ganglia and brainstem
* **Examination**
  * **[SPECT, PET] Reduced blood flow, mainly occipital lobe**: Degeneration of occipital lobe
  * **[MIBG myocardial scintigraphy] Decreased uptake**: Degeneration of postganglionic sympathetic nerve fiber
  * **[Dopamine reuptake test] Loss of dopamine neuron in basal ganglia**
* **Management**
  * **Cholinesterase inhibitor (donepezil)**: For cognitive impairment
  * **Levodopa**: For Parkinsonism
  * **Benzodiazepine (clonazepam)**: For REM sleep behavior disorder
{: .notice--info}

### Frontotemporal Dementia / ÂâçÈ†≠ÂÅ¥È†≠ÂûãË™çÁü•Áóá

* **Overview**
  * Degeneration of cerebral cortex (mainly frontal and temporal lobe), leading to cognitive impairment, personality changes and behavioral abnormalities 
* **Presentation**
  * **Decreased spontaneity, emotional blunting, disinhibition, stereotyped behaviors**: Degeneration of cerebral cortex, mainly frontal lobe and temporal lobe 
* **Examination**
  * **[CT, MRI] Atrophy, mainly frontal lobe and temporal lobe**: Degeneration of frontal lobe and temporal lobe
  * **[SPECT, PET] Reduced blood flow, mainly frontal lobe and temporal lobe**: Degeneration of frontal lobe and temporal lobe
* **Management**
  * **Symptomatic treatment**
{: .notice--info}

### Vascular Dementia / Ë°ÄÁÆ°ÊÄßË™çÁü•Áóá

* **Overview**
  * Cerebrovascular diseases damage the brain, leading to cognitive impairment
* **Presentation**
  * **Gradual and patchy decline in cognitive function**: Gradual and partial damage to cerebral cortex
  * **Motor and sensory disturbances**: Other symptoms of cerebral infarction or hemorrhage
* **Examination**
  * **[CT, MRI] Cerebral infarction or hemorrhage**
* **Management**
  * **Control hypertension, antiplatelet drugs, anticoagulants**: Prevent relapse of infarction
{: .notice--info}

## Neurodegenerative Disorder / Á•ûÁµåÂ§âÊÄßÁñæÊÇ£

### Parkinson‚Äôs Disease / ParkinsonÁóÖ

* **Overview**
  * Degeneration of dopamine neuron in substantia nigra pars compacta lead to dopamine deficiency, the direct pathway of basal ganglia (striatum - globus pallidus internum - thalamus) cannot be excited and making movement difficult
  * More common in middle-aged to elderly individuals 
  * Pathology reveals loss of neuromelanin-containing cells in substantia nigra and appearance of Lewy bodies in nerve cells (due to accumulation of Œ±-synuclein)
* **Presentation**
  * **Akinesia (slow movement, difficulty initiating walking and short-step gait, masked face)**: Dopamine depletion disrupts movement control
  * **Resting tremor  (pill-rolling tremor, tapping tremor)**: Dopamine depletion disrupts movement control
  * **Muscle rigidity (cogwheel or lead-pipe)**: Dopamine depletion disrupts muscle tone control
  * **Postural instability (increased tendency to fall when pushed)**: Dopamine depletion disrupts balance maintenance 
  * **Depression, dementia, sleep disorder**: Dopamine depletion disrupts mood and cognition
  * **Orthostatic hypotension, urinary dysfunction, chronic constipation**: Dopamine depletion disrupts autonomic system
* **Examination**
  * **[CT, MRI] No specific findings**
  * **[MIBG myocardial scintigraphy] Decreased uptake**: Degeneration of postganglionic sympathetic nerve fibers
  * **[Dopamine transporter imaging] Loss of dopamine neuron in basal ganglia**
* **Management**
  * **Dopamine precursor (levodopa) + dopamine decarboxylase inhibitor (carbidopa)**: Levodopa cross blood-brain barrier and convert to dopamine (carbidopa inhibit the conversion in peripheral tissue)
  * **Dopamine agonist (bromocriptine, pergolide, cabergoline, pramipexole, ropinirole, rotigotine, apomorphine)**: Stimulate dopamine receptor
  * **Anticholinergic drugs (trihexyphenidyl, biperiden, prophenamine)**: Balance acetylcholine and dopamine level
  * **Dopamine release promoter (amantadine)**: Increase dopamine release
  * **Monoamine oxidase B inhibitor (selegiline, rasagiline)**: Inhibit breakdown of dopamine
  * **COMT inhibitor (Entacapone)**: Inhibit breakdown of levodopa
  * **Deep brain stimulation (subthalamic nucleus or globus pallidus)**: Modulate abnormal neural activity caused by dopamine deficiency 
{: .notice--info}

### Progressive Supranuclear Palsy / ÈÄ≤Ë°åÊÄßÊ†∏‰∏äÊÄßÈ∫ªÁó∫

* **Overview**
  * Degeneration of basal ganglia and brainstem due to abnormal accumulation of tau protein
* **Presentation**
  * **Increased neck muscle tone, akinesia, muscle rigidity, postural instability, (resting tremor is absent)**: Degeneration of basal ganglia
  * **Vertical gaze palsy, speech and swallowing impairment**: Degeneration of brain stem
  * **Mental disturbances**: Degeneration of frontal lobe
* **Examination**
  * **[CT, MRI] Atrophy of midbrain tegmentum (hummingbird sign)**
* **Management**
  * **No established treatment, similar to medication for Parkinson‚Äôs disease**: Limited response
{: .notice--info}

### Corticobasal Degeneration / Â§ßËÑ≥ÁöÆË≥™Âü∫Â∫ïÊ†∏Â§âÊÄßÁóá

* **Overview**
  * Degeneration of cerebral cortex and basal ganglia due to abnormal accumulation of tau protein
* **Presentation**
  * **Motor clumsiness, apraxia, alien hand syndrome, dementia, involuntary movements (asymmetry between two sides)**: Degeneration of cerebral cortex
  * **Akinesia, muscle rigidity, postural instability, (resting tremor is absent)**: Degeneration of basal ganglia
* **Examination**
  * **[CT, MRI] Asymmetric cortical atrophy**
* **Management**
  * **No established treatment, similar to medication for Parkinson‚Äôs disease**: Limited response
{: .notice--info}

### Huntington‚Äôs Disease / HuntingtonÁóÖ

* **Overview**
  * Degeneration of striatum lead to overactivity of dopaminergic neurons, causing involuntary movements
Autosomal dominant inheritance, due to abnormal expansion of CAG repeats
* **Presentation**
  * **Rapid involuntary movements of limbs**: Degeneration of striatum disruptions inhibition of involuntary movements
  * **Personality change, dementia**: Degeneration of cerebral cortex
* **Examination**
  * **[CT, MRI] Atrophy of caudate nucleus, enlargement of anterior horns of lateral ventricles**
  * **[Genetic test] Abnormal expansion of CAG repeats**
* **Management**
  * **Tetrabenazine**: For involuntary movements
  * **Antipsychotics (haloperidol)**: For psychiatric symptoms
{: .notice--info}

### Amyotrophic Lateral Sclerosis / Á≠ãËêéÁ∏ÆÊÄßÂÅ¥Á¥¢Á°¨ÂåñÁóá

* **Overview**: 
  * Degeneration of upper and lower motor neurons leads to progressive muscular atrophy; mostly sporadic but sometimes hereditary 
  * More common in middle-aged to elderly individuals 
  * Pathology shows atrophy of pyramidal tract and anterior horn, with TDP-43 positive inclusions
* **Presentation**
  * **Muscle weakness, muscle atrophy, fasciculations**: Degeneration of lower motor neurons lead to reduced stimulation on muscles
  * **Increased tendon reflexes, positive Babinski sign**: Degeneration of upper motor neurons lead to reduced inhibition on lower motor neurons
  * **Dysphagia, dysarthria, tongue atrophy**: Degeneration of cranial nerves lead to bulbar palsy
  * **No eye movement disorders, sensory impairments, bladder or rectal dysfunction, pressure sores**: Cranial nerves III IV VI, sensory neurons, autonomic neurons are spared
* **Examination**
  * **[EMG] Denervation potentials at rest**: Denervation from lower motor neurons leads to spontaneous electrical activity
  * **[EMG] High-amplitude potentials during voluntary contraction**: Degeneration of lower motor neurons leads to formation of larger motor units by remaining neurons
  * **[Muscle biopsy] Grouped atrophy**: Denervation of motor units
* **Management**
  * **No cure**: Progress to requiring mechanical ventilation or death in 3~5 years
  * **[Medication] Riluzole, edaravone**: Protect neurons by reducing glutamate activity or scavenging free radicals
{: .notice--info}

### Spinal Muscular Atrophy / ËÑäÈ´ÑÊÄßÁ≠ãËêéÁ∏ÆÁóá

* **Overview**
  * Degeneration of lower motor neurons leads to progressive muscular atrophy; autosomal recessive inheritance
  * Type I onset at birth and die within one year, type III onset at 2~18 years and have good prognosis
* **Presentation**
  * **Muscle weakness (floppy infant, Gowers‚Äô sign), fasciculations, absent tendon reflexes**: Degeneration of lower motor neurons cause reduced stimulation on muscles
* **Examination**
  * **[Genetic test] SMN gene mutation**
* **Management**
  * **Symptomatic treatment**: Type I die within one year, type III and IV have good prognosis
{: .notice--info}

### Bulbospinal Muscular Atrophy / ÁêÉËÑäÈ´ÑÊÄßÁ≠ãËêéÁ∏ÆÁóá

* **Overview**
  * Degeneration of lower motor neurons leads to progressive muscular atrophy; X-linked recessive inheritance, due to abnormal expansion of CAG repeats in androgen receptor gene
* **Presentation**
  * **Muscle weakness, muscle atrophy (primarily proximal muscles), fasciculations, tremors**: Degeneration of lower motor neurons cause reduced stimulation on muscles
  * **Dysphagia, dysarthria, tongue atrophy**: Degeneration of cranial nerves cause bulbar palsy
  * **Gynecomastia, impotence, testicular atrophy**: Abnormal androgen receptor lead to reduced sensitivity to androgen
* **Examination**
  * **[Genetic test] Abnormal expansion of CAG repeats**
* **Management**
  * **Symptomatic treatment**: Prognosis depends on CAG repeats number
{: .notice--info}

### Multiple System Atrophy / Â§öÁ≥ªÁµ±ËêéÁ∏ÆÁóá

* **Overview**
  * Degeneration of olivo-ponto-cerebellar system, striatonigral system, and autonomic nervous system; sporadic
  * More common in middle-aged to elderly individuals 
  * Pathology shows glial cytoplasmic inclusion (due to accumulation of Œ±-synuclein)
  * [MSA-C] Cerebellar ataxia as predominant early symptom, but other symptoms present later
  * [MSA-P] Parkinsonism as predominant early symptom, but other symptoms present later
  * [Shy-Drager syndrome] Autonomic dysfunction as predominant early symptom, but other symptoms present later
* **Presentation**
  * **[Cerebellar ataxia] Truncal ataxia (staggering gait), limb coordination problems (abnormal finger-to-nose test), dysarthria**: Degeneration of olivo-ponto-cerebellar system
  * **[Parkinsonism] Bradykinesia, muscle rigidity, shuffling gait (resting tremor are rare)**: Degeneration of striatonigral system
  * **[Autonomic dysfunction] Orthostatic hypotension, bladder and rectal dysfunction, erectile dysfunction, sweating abnormalities, horner syndrome**: Degeneration of autonomic nervous system
* **Examination**
  * **[CT, MRI] Atrophy of cerebellum and brainstem, cross sign in pons**: Degeneration of olivo-ponto-cerebellar system, degeneration of transverse and longitudinal pontocerebellar fibers
  * **[CT, MRI] Atrophy of putamen, linear area of high-signal on lateral side of putamen**: Degeneration of striatonigral system, gliosis of lateral side of putamen
* **Management**
  * **[Cerebellar ataxia] TRH analog (protirelin, taltirelin)**: Stimulate neurotransmission and enhance motor control
  * **[Parkinsonism] Dopamine precursor (levodopa)**: Converted to dopamine and alleviate Parkinsonism
  * **[Autonomic dysfunction] Alpha-agonists (midodrine, droxidopa), alpha-blockers**: For orthostatic hypotension or urinary retention 
{: .notice--info}

### Spinocerebellar Ataxia / ËÑäÈ´ÑÂ∞èËÑ≥Â§±Ë™øÁóá

* **Overview**
  * Degeneration of cerebellum or spinal cord; hereditary
  * [SCA-3] Abnormal expansion of CAG repeats in ataxia-3 gene, autosomal dominant
  * [SCA-6] Abnormal expansion of CAG repeats in CACNA1A gene, autosomal dominant
  * [Dentato-rubro-pallido-luysian atrophy] Abnormal expansion of atrophin-1 gene, autosomal dominant
  * [Friedreich ataxia] Abnormal expansion of GAA repeats in frataxin genes, autosomal recessive
* **Presentation**
  * **Cerebellar ataxia, startled expression (SCA-3)**: Degeneration of cerebellum 
  * **Spinal ataxia, deep sensory loss (Friedreich ataxia)**: Degeneration of spinal cord
* **Examination**
  * **[CT. MRI] Degeneration of cerebellum and spinal cord**
* **Management**
  * **Symptomatic treatment**
{: .notice--info}

### Wernicke Encephalopathy / WernickeËÑ≥Áóá

* **Overview**
  * Vitamin B1 deficiency (chronic alcoholism, malnutrition, inappropriate IV infusion) damage neurons and cause necrosis (mainly around cerebral ventricles)
* **Presentation**
  * **Consciousness disturbances (somnolence, delirium)**: Impairment of thalamus
  * **Ocular movement disorders (abducens nerve palsy, nystagmus)**: Impairment of brainstem (cranial nerve nucleus)
  * **Cerebellar dysfunction (ataxic gait)**: Impairment of cerebellum 
  * **Korsakoff syndrome (memory impairment, confabulation, disorientation)**: Irreversible damage to brain if untreated
* **Examination**
  * **[MRI] High signal in third ventricle, cerebral aqueduct, fourth ventricle, mammillary body**: Neuronal damage around cerebral ventricles
  * **[Blood test] Vitamin B1 decrease**: Vitamin B1 deficiency
* **Management**
  * **Large intravenous administration of Vitamin B1**
  * **[Don‚Äôt] Glucose administration alone during Vitamin B1 deficiency is contraindicated**: Further consume Vitamin B12
{: .notice--info}

### Subacute Combined Degeneration of Spinal Cord / ‰∫úÊÄ•ÊÄßËÑäÈ´ÑÈÄ£ÂêàÂ§âÊÄßÁóá

* **Overview**
  * Vitamin B12 deficiency (total gastrectomy, autoimmune atrophic gastritis) cause degeneration of posterior column, lateral column and peripheral nerve
* **Presentation**
  * **Deep sensory impairment, positive Romberg‚Äôs sign**: Impairment of posterior column
  * **Increased tendon reflexes, positive Babinski sign, spastic paralysis**: Impairment of lateral column
  * **Numbness, muscle weakness**: Impairment of peripheral nerves
  * **Anemia, Hunter‚Äôs glossitis**: Impairment of DNA synthesis 
* **Examination**
  * **[Blood test] Megaloblastic anemia, vitamin B12 decrease, methylmalonic acid increase, homocysteine increase**: Vitamin B12 is crucial for DNA synthesis (RBC production), conversion of methylmalonyl-CoA to succinyl-CoA, conversion of homocysteine to methionine
  * **[MRI] High-signal in posterior column and lateral column**
* **Management**
  * **IV and oral administration of Vitamin B12**
  * **[Don‚Äôt] Folic acid administration alone is contraindicated**: Mask the neurological symptoms and further consume Vitamin B12
{: .notice--info}

## Demyelinating Disorder / ËÑ±È´ÑÊÄßÁñæÊÇ£

### Multiple Sclerosis / Â§öÁô∫ÊÄßÁ°¨ÂåñÁóá

* **Overview**
  * Autoimmune-related Inflammatory demyelination throughout white matter of CNS (spatial dissemination), leading to various neurological symptoms that recur and remit (temporal dissemination); PNS usually spared
  * Relapsing-remitting type (more) characterized by relapse and remission at first and progress without remission later; primary progressive type (less) progress without remission from onset
  * More common in young women (autoimmune) and high latitude region
* **Presentation**
  * **Vision loss, central scotomas (recover in 1-2 weeks, relapse latter)**: Impairment of optic nerve (optic neuritis)
  * **Internuclear ophthalmoplegia**: Impairment of medial longitudinal fasciculus
  * **Ataxia, tremor, nystagmus, dysarthria**: Impairment of cerebellum
  * **Weakness of extremities, spasticity, hyperreflexia, clonus**: Impairment of motor pathway
  * **Numbness, electric shock-like sensation during neck movement (Lhermitte‚Äôs sign), trigeminal neuralgia**: Impairment of sensory pathway
  * **Bladder and bowel dysfunction**: Impairment of autonomic nervous system
* **Examination**
  * **[MRI] Multiple high-signal plaque lesion in brain and spinal cord**: Demyelination of CNS white matter
  * **[CSF analysis] Lymphocytes increased, IgG increased, oligoclonal band present, myelin binding protein present**: Autoimmune destruction of myelin in CNS
  * **Abnormal evoked potential (especially visual)**: Demyelination of the corresponding pathway
* **Management**
  * **[Acute exacerbation] Steroid pulse therapy, plasmapheresis**: Suppress acute inflammation
  * **[Relapse prevention] Interferon-beta, glatiramer (MBP-mimicking peptide), natalizumab (anti-Œ±4 integrin antibody), fingolimod (S1PR modulator)**: Immunomodulatory or immunosuppressive drugs
  * **[Symptomatic treatment] Muscle relaxant, anticonvulsant (gabapentin, pregabalin), anticholinergic drugs or alpha-blockers**: For spasticity, neuropathic pain, urinary symptoms
{: .notice--info}

### Neuromyelitis Optica / Ë¶ñÁ•ûÁµåËÑäÈ´ÑÁÇé

* **Overview**
  * Anti-AQP4 autoantibody damage astrocytes, lead to inflammatory demyelination causing relapsing optic neuritis and myelitis
More common in middle age women (autoimmune)
* **Presentation**
  * **Vision loss, visual field defects**: Impairment of optic nerve (optic neuritis)
  * **Motor disturbances, sensory disturbances, bladder and bowel dysfunction**: Impairment of spinal cord (myelitis)
* **Examination**
  * **[MRI] High-signal lesion in brain and spinal cord (>3 vertebral segments)**: Demyelination of optic nerve and spinal cord
  * **[Blood] Anti-AQP4 antibody positive**: Autoimmune nature
* **Management**
  * **[Acute exacerbation] Steroid pulse therapy, plasmapheresis**: Suppress acute inflammation
  * **[Relapse prevention] Steroid, immunosuppressant, rituximab (anti -CD20 antibody)**
{: .notice--info}

### Acute Disseminated Encephalomyelitis / ÊÄ•ÊÄßÊï£Âú®ÊÄßËÑ≥ËÑäÈ´ÑÁÇé

* **Overview**
  * Inflammatory demyelination of throughout CNS (spatial dissemination) with acute and monophasic course (compared to multiple sclerosis), preceded by viral infection or vaccination (hypersensitivity)
* **Presentation**
  * **Fever, headache, vomiting (acute onset and rapid remission)**: Inflammation of brain
* **Examination**
  * **[Blood] WBC increase, ESR increase, CRP increase**: Inflammation
  * **[MRI] Scattered high-signal lesions in brain**: Disseminated demyelination of CNS
* **Management**
  * **Steroid pulse therapy, plasmapheresis, high-dose immunoglobulin therapy**: Suppress acute inflammation
{: .notice--info}

### Adrenoleukodystrophy / ÂâØËÖéÁôΩË≥™„Ç∏„Çπ„Éà„É≠„Éï„Ç£„Éº

* **Overview**
  * X-linked recessive disorder, defects of peroxisome prevent breakdown of very long-chain fatty acids, which accumulate in white matter of brain (progressive demyelination) and adrenal gland (adrenal insufficiency)
* **Presentation**
  * **Personality and behavioral abnormalities (aggression), intellectual disability**: Impairment of commissural fibers of brain
  * **Gait disturbances (ataxic gait)**: Impairment of spinal cord
  * **Vision and hearing impairment**: Impairment of visual and auditory pathway
* **Examination**
  * **[Blood] Cortisol decrease, very long-chain fatty acids increase**: Adrenal insufficiency, fatty acid metabolism defect
  * **[MRI] High-signal lesion in brain**: Demyelination of CNS
  * **[Genetic test] ABCD1 mutation**
* **Management**
  * **Steroid hormone**: For adrenal insufficiency 
  * **No cure, dead in 1~5 years**
{: .notice--info}

## Peripheral Nerve Disorder / Êú´Ê¢¢Á•ûÁµåÈöúÂÆ≥

## Muscular Disorder / Á≠ãÁñæÊÇ£

## Infectious Disorder / ÊÑüÊüìÊÄßÁñæÊÇ£

## Functional Disease / Ê©üËÉΩÊÄßÁñæÊÇ£

## Neurocutaneous Syndrome / ÊØçÊñëÁóá

## Brain Tumor / ËÑ≥ËÖ´Áòç

## Head Injury / È†≠ÈÉ®Â§ñÂÇ∑

## Congenital Anomaly / ÂÖàÂ§©Â•áÂΩ¢

<!-- ## Cerebral Infarction / ËÑ≥Ê¢óÂ°û

### Atherothrombotic Infarction / „Ç¢„ÉÜ„É≠„Éº„É†Ë°ÄÊ†ìÊÄßËÑ≥Ê¢óÂ°û
### Cardioembolic Infarction / ÂøÉÂéüÊÄßËÑ≥Â°ûÊ†ìÁóá
### Lacunar Infarction / „É©„ÇØ„ÉäÊ¢óÂ°û
### Transient Ischemic Attack / ‰∏ÄÈÅéÊÄßËÑ≥ËôöË°ÄÁô∫‰Ωú
### Carotid Artery Stenosis / È†∏ÂãïËÑàÁã≠Á™ÑÁóá
### Cerebellar Infarction / Â∞èËÑ≥Ê¢óÂ°û
### Wallenberg Syndrome / WallenbergÁóáÂÄôÁæ§

## Cerebral Hemorrhage / ËÑ≥Âá∫Ë°Ä

### Putaminal Hemorrhage / Ë¢´ÊÆªÂá∫Ë°Ä
### Thalamic Hemorrhage / Ë¶ñÂ∫äÂá∫Ë°Ä
### Brainstem Hemorrhage / ËÑ≥ÂππÂá∫Ë°Ä
### Cerebellar Hemorrhage / Â∞èËÑ≥Âá∫Ë°Ä
### Subcortical Hemorrhage / ÁöÆË≥™‰∏ãÂá∫Ë°Ä
### Subarachnoid Hemorrhage / „Åè„ÇÇËÜú‰∏ãÂá∫Ë°Ä

## Other Cerebrovascular Disease / „Åù„ÅÆ‰ªñ„ÅÆËÑ≥Ë°ÄÁÆ°ÁñæÊÇ£

### Cerebral Aneurysm / ËÑ≥ÂãïËÑàÁò§
### Arteriovenous Malformation / ËÑ≥ÂãïÈùôËÑàÂ•áÂΩ¢
### Moyamoya Disease / „ÇÇ„ÇÑ„ÇÇ„ÇÑÁóÖ
### Carotid-Cavernous Fistula / ÂÜÖÈ†∏ÂãïËÑàÊµ∑Á∂øÈùôËÑàÊ¥ûÁòª
### Dural Arteriovenous Fistula / Á°¨ËÜúÂãïÈùôËÑàÁòª
### Sinus Thrombosis / ÈùôËÑàÊ¥ûË°ÄÊ†ìÁóá
### Hypertensive Encephalopathy / È´òË°ÄÂúßÊÄßËÑ≥Áóá
### Spinal Arteriovenous Malformation / ËÑäÈ´ÑÂãïÈùôËÑàÂ•áÂΩ¢
### Spinal Cord Infarction / ËÑäÈ´ÑÊ¢óÂ°û

## Dementia / Ë™çÁü•Áóá

### Alzheimer Type Dementia / AlzheimerÂûãË™çÁü•Áóá
### Vascular Dementia / Ë°ÄÁÆ°ÊÄßË™çÁü•Áóá
### Dementia with Lewy Bodies / LewyÂ∞è‰ΩìÂûãË™çÁü•Áóá
### Frontotemporal Lobar Degeneration / ÂâçÈ†≠ÂÅ¥È†≠ËëâÂ§âÊÄßÁóá

## Neurodegenerative Disease / Á•ûÁµåÂ§âÊÄßÁñæÊÇ£

### Parkinson's Disease / ParkinsonÁóÖ
### Progressive Supranuclear Palsy / ÈÄ≤Ë°åÊÄßÊ†∏‰∏äÊÄßÈ∫ªÁó∫
### Corticobasal Degeneration / Â§ßËÑ≥ÁöÆË≥™Âü∫Â∫ïÊ†∏Â§âÊÄßÁóá
### Huntington's Disease / HuntingtonÁóÖ
### MSA-C / MSA-C
### MSA-P / MSA-P
### Shy-Drager Syndrome / Shy-DragerÁóáÂÄôÁæ§
### Cortical Cerebellar Atrophy / ÁöÆË≥™ÊÄßÂ∞èËÑ≥ËêéÁ∏ÆÁóá
### SCA-3 / SCA-3
### SCA-6 / SCA-6
### Dentato-Rubro-Pallido-Luysian Atrophy / Ê≠ØÁä∂Ê†∏Ëµ§Ê†∏Ê∑°ËíºÁêÉ„É´„Ç§‰ΩìËêéÁ∏ÆÁóá
### Friedreich Ataxia / FriedreichÈÅãÂãïÂ§±Ë™øÁóá
### Syringomyelia / ËÑäÈ´ÑÁ©∫Ê¥ûÁóá
### Subacute Combined Degeneration of Spinal Cord / ‰∫úÊÄ•ÊÄßÈÄ£ÂêàÊÄßËÑäÈ´ÑÂ§âÊÄßÁóá
### Amyotrophic Lateral Sclerosis / Á≠ãËêéÁ∏ÆÊÄßÂÅ¥Á¥¢Á°¨ÂåñÁóá
### Spinal Muscular Atrophy / ËÑäÈ´ÑÊÄßÁ≠ãËêéÁ∏ÆÁóá
### Spinal and Bulbar Muscular Atrophy / ÁêÉËÑäÈ´ÑÊÄßÁ≠ãËêéÁ∏ÆÁóá

## Demyelinating Disease / ËÑ±È´ÑÊÄßÁñæÊÇ£

### Multiple Sclerosis / Â§öÁô∫ÊÄßÁ°¨ÂåñÁóá
### Neuromyelitis Optica / Ë¶ñÁ•ûÁµåËÑäÈ´ÑÁÇé
### Acute Disseminated Encephalomyelitis / ÊÄ•ÊÄßÊï£Âú®ÊÄßËÑ≥ËÑäÈ´ÑÁÇé
### Adrenoleukodystrophy / ÂâØËÖéÁôΩË≥™„Ç∏„Çπ„Éà„É≠„Éï„Ç£„Éº
### Metachromatic Leukodystrophy / Áï∞ÊüìÊÄßÁôΩË≥™„Ç∏„Çπ„Éà„É≠„Éï„Ç£„Éº

## Peripheral Neuropathy / Êú´Ê¢¢Á•ûÁµåÈöúÂÆ≥

### Guillain-Barr√© Syndrome / Guillain-Barr√©ÁóáÂÄôÁæ§
### Chronic Inflammatory Demyelinating Polyneuropathy / ÊÖ¢ÊÄßÁÇéÁóáÊÄßËÑ±È´ÑÊÄßÂ§öÁô∫Á•ûÁµåÁÇé
### Charcot-Marie-Tooth Disease / Charcot-Marie-ToothÁóÖ
### Familial Amyloid Polyneuropathy / ÂÆ∂ÊóèÊÄß„Ç¢„Éü„É≠„Ç§„Éâ„Éù„É™„Éã„É•„Éº„É≠„Éë„ÉÅ„Éº
### Diabetic Neuropathy / Á≥ñÂ∞øÁóÖÊÄßÁ•ûÁµåÈöúÂÆ≥
### Wernicke Encephalopathy / WernickeËÑ≥Áóá
### Carcinomatous Neuropathy / ÁôåÊÄß„Éã„É•„É≠„Éë„ÉÅ„Éº
### Crow-Fukase Syndrome / Crow-FukaseÁóáÂÄôÁæ§
### Trigeminal Neuralgia / ‰∏âÂèâÁ•ûÁµåÁóõ
### Bell's Palsy / BellÈ∫ªÁó∫
### Ramsay Hunt Syndrome / Ramsay HuntÁóáÂÄôÁæ§

## Muscular Disease / Á≠ãÁñæÊÇ£

### Duchenne Muscular Dystrophy / DuchenneÂûãÁ≠ã„Ç∏„Çπ„Éà„É≠„Éï„Ç£„Éº
### Becker Muscular Dystrophy / BeckerÂûãÁ≠ã„Ç∏„Çπ„Éà„É≠„Éï„Ç£„Éº
### Limb-Girdle Muscular Dystrophy / LGÂûãÁ≠ã„Ç∏„Çπ„Éà„É≠„Éï„Ç£„Éº
### Fascioscapulohumeral Muscular Dystrophy / FSHÂûãÁ≠ã„Ç∏„Çπ„Éà„É≠„Éï„Ç£„Éº
### Congenital Muscular Dystrophy / ÂÖàÂ§©ÊÄßÁ≠ã„Ç∏„Çπ„Éà„É≠„Éï„Ç£„Éº
### Myotonic Dystrophy / Á≠ãÂº∑Áõ¥ÊÄß„Ç∏„Çπ„Éà„É≠„Éï„Ç£„Éº
### Mitochondrial Encephalomyopathy / „Éü„Éà„Ç≥„É≥„Éâ„É™„Ç¢ËÑ≥Á≠ãÁóá
### Periodic Paralysis / Âë®ÊúüÊÄßÂõõËÇ¢È∫ªÁó∫
### Myasthenia Gravis / ÈáçÁóáÁ≠ãÁÑ°ÂäõÁóá
### Lambert-Eaton Myasthenic Syndrome / Lambert-EatonÁóáÂÄôÁæ§

## Phacomatosis / ÊØçÊñëÁóá

### Neurofibromatosis Type 1 / Á•ûÁµåÁ∑öÁ∂≠ËÖ´ÁóáÔºëÂûã
### Neurofibromatosis Type 2 / Á•ûÁµåÁ∑öÁ∂≠ËÖ´ÁóáÔºíÂûã
### Tuberous Sclerosis / ÁµêÁØÄÊÄßÁ°¨ÂåñÁóá
### Von Hippel-Lindau Disease / Von Hippel-LindauÁóÖ
### Sturge-Weber Syndrome / Sturge-WeberÁóáÂÄôÁæ§

## Infectious Disease / ÊÑüÊüìÊÄßÁñæÊÇ£

### Bacterial Meningitis / Á¥∞ËèåÊÄßÈ´ÑËÜúÁÇé
### Tuberculous Meningitis / ÁµêÊ†∏ÊÄßÈ´ÑËÜúÁÇé
### Fungal Meningitis / ÁúüËèåÊÄßÈ´ÑËÜúÁÇé
### Viral Meningitis / „Ç¶„Ç§„É´„ÇπÊÄßÈ´ÑËÜúÁÇé
### Herpes Simplex Encephalitis / ÂçòÁ¥î„Éò„É´„Éö„ÇπËÑ≥ÁÇéÁóá
### HIV-Associated Neurocognitive Disorder / HIV Èñ¢ÈÄ£Á•ûÁµåË™çÁü•ÈöúÂÆ≥
### HTLV-1 Associated Myelopathy / HTLV-1 Èñ¢ÈÄ£ËÑäÈ´ÑÁóá
### Subacute Sclerosing Panencephalitis / ‰∫úÊÄ•ÊÄßÁ°¨ÂåñÊÄßÂÖ®ËÑ≥ÁÇé
### Progressive Multifocal Leukoencephalopathy / ÈÄ≤Ë°åÊÄßÂ§öÂ∑£ÊÄßÁôΩË≥™ËÑ≥Áóá
### Creutzfeldt-Jakob Disease / Creutzfeldt-JakobÁóÖ
### Brain Abscess / ËÑ≥ËÜøÁòç
### Neurosyphilis / Á•ûÁµåÊ¢ÖÊØí
### Acute Encephalopathy / ÊÄ•ÊÄßËÑ≥Áóá
### Reye Syndrome / ReyeÁóáÂÄôÁæ§
### Acute Cerebellar Ataxia / ÊÄ•ÊÄßÂ∞èËÑ≥Â§±Ë™øÁóá

## Brain Tumor / ËÑ≥ËÖ´Áòç

### Diffuse Astrocytoma / „Å≥„Åæ„ÇìÊÄßÊòüÁ¥∞ËÉûËÖ´
### Glioblastoma / ËÜ†ËäΩËÖ´
### Oligodendroglioma / ‰πèÁ™ÅËµ∑ËÜ†ËÖ´
### Ependymoma / ‰∏äË°£ËÖ´
### Medulloblastoma / È´ÑËäΩËÖ´
### Meningioma / È´ÑËÜúËÖ´
### Schwannoma / Á•ûÁµåÈûòËÖ´
### Pituitary Adenoma / ‰∏ãÂûÇ‰ΩìËÖ∫ËÖ´
### Craniopharyngioma / È†≠ËìãÂíΩÈ†≠ËÖ´
### Germ Cell Tumor / ËÉöÁ¥∞ËÉûËÖ´Áòç
### Hemangioblastoma / Ë°ÄÁÆ°ËäΩËÖ´
### Malignant Lymphoma / ÊÇ™ÊÄß„É™„É≥„ÉëËÖ´
### Metastatic Brain Tumor / Ëª¢ÁßªÊÄßËÑ≥ËÖ´Áòç
### Spinal Cord Tumor / ËÑäÈ´ÑËÖ´Áòç

## Functional Disease / Ê©üËÉΩÊÄßÁñæÊÇ£

### Rolandic Epilepsy / Roland„Å¶„Çì„Åã„Çì
### Temporal Lobe Epilepsy / ÂÅ¥È†≠Ëëâ„Å¶„Çì„Åã„Çì
### Childhood Absence Epilepsy / Â∞èÂÖêÊ¨†Á•û„Å¶„Çì„Åã„Çì
### Juvenile Myoclonic Epilepsy / Ëã•Âπ¥„Éü„Ç™„ÇØ„É≠„Éã„Éº„Å¶„Çì„Åã„Çì
### West Syndrome / WestÁóáÂÄôÁæ§
### Lennox-Gastaut Syndrome / Lennox-GastautÁóáÂÄôÁæ§
### Dravet Syndrome / DravetÁóáÂÄôÁæ§
### Febrile Seizure / ÁÜ±ÊÄß„Åë„ÅÑ„Çå„Çì
### Cerebral Palsy / ËÑ≥ÊÄßÈ∫ªÁó∫
### Migraine / ÁâáÈ†≠Áóõ
### Tension-Type Headache / Á∑äÂºµÊÄßÈ†≠Áóõ
### Cluster Headache / Áæ§Áô∫È†≠Áóõ
### Restless Legs Syndrome / „ÇÄ„Åö„ÇÄ„ÅöËÑöÁóáÂÄôÁæ§

## Head Injury / È†≠ÈÉ®Â§ñÂÇ∑

### Skull Base Fracture / È†≠ËìãÂ∫ïÈ™®Êäò
### Cranial Vault Fracture / ÂÜÜËìãÈÉ®È™®Êäò
### Acute Epidural Hematoma / ÊÄ•ÊÄßÁ°¨ËÜúÂ§ñË°ÄËÖ´
### Acute Subdural Hematoma / ÊÄ•ÊÄßÁ°¨ËÜú‰∏ãË°ÄËÖ´
### Chronic Subdural Hematoma / ÊÖ¢ÊÄßÁ°¨ËÜú‰∏ãË°ÄËÖ´
### Cerebral Contusion / ËÑ≥Êå´ÂÇ∑
### Diffuse Axonal Injury / „Å≥„Åæ„ÇìÊÄßËª∏Á¥¢ÊêçÂÇ∑
### Spinal Cord Injury / ËÑäÈ´ÑÊêçÂÇ∑
### Normal Pressure Hydrocephalus / Ê≠£Â∏∏ÂúßÊ∞¥È†≠Áóá -->

# Psychiatry / Á≤æÁ•ûÁßë

## Introduction / Á∑èË´ñ

## Schizophrenia / Áµ±ÂêàÂ§±Ë™øÁóá

## Mood Disorder / Ê∞óÂàÜÈöúÂÆ≥

## Neurotic Disorder / Á•ûÁµåÁóáÊÄßÈöúÂÆ≥

## Physiologic Disorder / ÁîüÁêÜÁöÑÈöúÂÆ≥

## Personality Disorder / ‰∫∫Ê†ºÈöúÂÆ≥

## Developmental Disorder / Áô∫ÈÅîÈöúÂÆ≥

## Organic Mental Disorder / Âô®Ë≥™ÊÄßÁ≤æÁ•ûÈöúÂÆ≥

## Substance Related Disorder / Áâ©Ë≥™Èñ¢ÈÄ£ÈöúÂÆ≥

# Ophthalmology / ÁúºÁßë

## Introduction / Á∑èË´ñ

## Functional Disorder / Ê©üËÉΩÈöúÂÆ≥

## Conjunctiva Disorder / ÁµêËÜúÁñæÊÇ£

## Cornea Disorder / ËßíËÜúÁñæÊÇ£

## Uvea Disorder / „Å∂„Å©„ÅÜËÜúÁñæÊÇ£

## Retina Disorder / Á∂≤ËÜúÁñæÊÇ£

## Cataract / ÁôΩÂÜÖÈöú

## Glaucoma / Á∑ëÂÜÖÈöú

## Optic Nerve Disorder / Ë¶ñÁ•ûÁµåÁñæÊÇ£

## Eyelid and Lacrimal Apparatus Disorder / ÁúºÁûº„ÉªÊ∂ôÂô®ÁñæÊÇ£

## Miscellaneous Ophthalmic Disorder / „Åù„ÅÆ‰ªñ„ÅÆÁúºÁßëÁñæÊÇ£

# Otolaryngology / ËÄ≥ÈºªÂíΩÂñâÁßë

## Introduction / Á∑èË´ñ

## External and Middle Ear Disorder / Â§ñËÄ≥„Éª‰∏≠ËÄ≥ÁñæÊÇ£

## Inner Ear Disorder / ÂÜÖËÄ≥ÁñæÊÇ£

## Nose and Paranasal Sinus Disorder / Èºª„ÉªÂâØÈºªËÖîÁñæÊÇ£

## Oral Cavity and Tonsil Disorder / Âè£ËÖî„ÉªÊâÅÊ°ÉÁñæÊÇ£

## Pharynx and Larynx Disorder / ÂíΩÈ†≠„ÉªÂñâÈ†≠ÁñæÊÇ£

## Cervical and Facial Disorder / È†∏ÈÉ®„ÉªÈ°îÈù¢ÁñæÊÇ£

<!-- ### Upper Respiratory Tract / ‰∏äÊ∞óÈÅì -->

<!-- * **Nose**
  * **Structure**: Palatine, nasal septum (medial), ethmoid, 3 nasal choncha
  * **Histology**: Pseudostratified columnar epithelium, olfactory mucosa (olfactory cell, subtentacular cell, basal cell)
  * **Artery**: Anterior and posterior ethmoidal artery (ophthalmic artery), inferior labial artery (facial artery), sphenopalatine artery (maxillary artery)
  * **Nerve**: Olfactory nerve (CN I), anterior ethmoidal nerve (CN V2), nasopalatine nerve (CN V3)
  * **Nasal meatus**: Sphenoethmoidal recess (sphenoid sinus), superior meatus (posterior ethmoid sinus), middle meatus (other paranasal sinus), inferior meatus (nasolacrimal duct)
  * **Paranasal sinus**: Frontal sinus, sphenoid sinus, ethmoid sinus, sphenoid sinus
* **Pharynx**
  * **Structure**: Nasopharynx (nasal cavity), oropharynx (oral cavity), laryngopharynx (trachea, esophagus)
  * **Histology**: Pseudostratified columnar (nasopharynx), stratified squamous (oropharynx, laryngopharynx)
  * **Nerve**: CN V2 (nasopharynx), CN IX (oropharynx), CN X (laryngopharynx)
* **Larynx**
  * **Structure**: Thyroid cartilage, cricoid cartilage (C6), arytenoid cartilage, vestibular fold, vocal fold
  * **Muscle**: Cricothyroideus (tense), lateral cricoarytenoideus (close), posterior cricoarytenoideus (open), thyroarytenoideus (relax), transverse arytenoideus (close), oblique arytenoideus (constrict), vocalis (control)
  * **Nerve**: External laryngeal nerve (CN X, cricothyroideus), internal laryngeal nerve (CN X, sensation above vocal fold), recurrent laryngeal nerve (CN X, other muscle, left loop aoric arch, right loop subclavian artery)
{: .notice--info} -->

# Dermatology / ÁöÆËÜöÁßë

## Introduction / Á∑èË´ñ

## Eczema / ÊπøÁñπ

## Urticaria / ËïÅÈ∫ªÁñπ

## Erythema / Á¥ÖÊñëÁóá

## Bullous Dermatoses / Ê∞¥Áñ±Áóá

## Keratosis / ËßíÂåñÁóá

## Pigmentary Disorder / Ëâ≤Á¥†Áï∞Â∏∏Áóá

## Nevus / ÊØçÊñë

## Skin Tumor / ÁöÆËÜöËÖ´Áòç

## Skin Infection / ÁöÆËÜöÊÑüÊüìÁóá

## Epidermal Appendage Disorder / ÁöÆËÜöÈôÑÂ±ûÂô®ÁñæÊÇ£

## Dermis Disorder / ÁúüÁöÆÁñæÊÇ£

## Collagen Disease / ËÜ†ÂéüÁóÖ

## Metabolism Disorder / ‰ª£Ë¨ùÁï∞Â∏∏Áóá

## Physical Disorder / Áâ©ÁêÜÁöÑÈöúÂÆ≥


<!-- ## Eczema and Dermatitis / ÊπøÁñπ„ÉªÁöÆËÜöÁÇé

### Contact Dermatitis /  Êé•Ëß¶ÁöÆËÜöÁÇé
### Atopic Dermatitis / „Ç¢„Éà„Éî„ÉºÊÄßÁöÆËÜöÁÇé
### Asteatotic Eczema / ÁöÆËÑÇÊ¨†‰πèÊÄßÊπøÁñπ
### Seborrheic Dermatitis / ËÑÇÊºèÊÄßÁöÆËÜöÁÇé
### Nummular Eczema / Ë≤®Âπ£Áä∂ÊπøÁñπ
### Autosensitization Dermatitis / Ëá™ÂÆ∂ÊÑü‰ΩúÊÄßÁöÆËÜöÁÇé
### Stasis Dermatitis / „ÅÜ„Å£ÊªûÊÄßÁöÆËÜöÁÇé
### Lichen Vidal / VidalËãîÁô¨
### Pompholyx / Ê±óÁñ±

## Urticaria and Pruritis / ËïÅÈ∫ªÁñπ„ÉªÊéªÁóí

### Urticaria / ËïÅÈ∫ªÁñπ
### Angioedema / Ë°ÄÁÆ°ÊÄßÊµÆËÖ´
### Prurigo / ÁóíÁñπ
### Pruritus Cutaneous / ÁöÆËÜöÁòôÁóíÁóá

## Erythema and Drug Eruption / Á¥ÖÊñëÁóá„ÉªËñ¨Áñπ

### Erythema Exsudativum Multiforme / Â§öÂΩ¢Êª≤Âá∫ÊÄßÁ¥ÖÊñë
### Erythema Nodosum / ÁµêÁØÄÊÄßÁ¥ÖÊñë
### Erythema Induratum / Á°¨ÁµêÊÄßÁ¥ÖÊñë
### Sweet's Disease / SweetÁóÖ
### Drug Eruption / Ëñ¨Áñπ
### Fixed Drug Eruption / Âõ∫ÂÆöËñ¨Áñπ
### Stevens-Johnson Syndrome / Stevens-JohnsonÁóáÂÄôÁæ§
### Toxic Epidermal Necrolysis / ‰∏≠ÊØíÊÄßË°®ÁöÆÂ£äÊ≠ªÁóá
### Drug-Induced Hypersensitivity Syndrome / Ëñ¨Ââ§ÊÄßÈÅéÊïèÁóáÁóáÂÄôÁæ§
### Skin Disorders Caused by Anticancer Drugs / Êäó„Åå„ÇìËñ¨„Å´„Çà„ÇãÁöÆËÜöÈöúÂÆ≥
### Erythroderma / Á¥ÖÁöÆÁóá
### Graft-Versus-Host Disease / ÁßªÊ§çÁâáÂØæÂÆø‰∏ªÁóÖ

## Bullous Dermatoses and Pustulosis / Ê∞¥Áñ±Áóá„ÉªËÜøÁñ±Áóá

### Pemphigus Vulgaris / Â∞ãÂ∏∏ÊÄßÂ§©Áñ±Áò°
### Pemphigus Foliaceus / ËêΩËëâÁä∂Â§©Áñ±Áò°
### Bullous Pemphigoid / Ê∞¥Áñ±ÊÄßÈ°ûÂ§©Áñ±Áò°
### Dermatitis Herpetiformis Duhring / DuhringÁñ±ÁñπÁä∂ÁöÆËÜöÁÇé
### Epidermolysis Bullosa Acquisita / ÂæåÂ§©ÊÄßË°®ÁöÆÊ∞¥Áñ±Áóá
### Epidermolysis Bullosa Hereditaria / ÂÖàÂ§©ÊÄßË°®ÁöÆÊ∞¥Áñ±Áóá
### Palmoplantar Pustulosis / ÊéåËπ†ËÜøÁñ±Áóá

## Keratosis / ËßíÂåñÁóá

### Psoriasis Vulgaris / Â∞ãÂ∏∏ÊÄß‰πæÁô¨
### Guttate Psoriasis / Êª¥Áä∂‰πæÁô¨
### Pustular Psoriasis / ËÜøÁñ±ÊÄß‰πæÁô¨
### Psoriatic Erythroderma / ‰πæÁô¨ÊÄßÁ¥ÖÁöÆÁóá
### Parapsoriasis En Plaques / Â±ÄÈù¢Áä∂È°û‰πæÁô¨
### Pityriasis Lichenoides / ËãîÁô¨Áä∂Á≤ÉÁ≥†Áñπ
### Lichen Planus / ÊâÅÂπ≥ËãîÁô¨
### Pityriasis Rosea Gibert / Gibert„Å∞„ÇâËâ≤Á≤ÉÁ≥†Áñπ
### Pityriasis Rubra Pilaris / ÊØõÂ≠îÊÄßÁ¥ÖËâ≤Á≤ÉÁ≥†Áñπ
### Keratosis Pilaris / ÊØõÂ≠îÊÄßËßíÂåñÁóá
### Clavus and Callus / È∂èÁúº„ÉªËÉºËÉù
### Acanthosis Nigricans / ÈªíËâ≤Ë°®ÁöÆËÖ´
### Ichthyosis Vulgaris / Â∞ãÂ∏∏ÊÄßÈ≠öÈ±óÁô¨
### X-Linked Ichthyosis / XÈÄ£ÈéñÊÄßÈ≠öÈ±óÁô¨
### Congenital Ichthyosiform Erythroderma / ÂÖàÂ§©ÊÄßÈ≠öÈ±óÁô¨ÊßòÁ¥ÖÁöÆÁóá
### Epidermolytic Ichthyosis / Ë°®ÁöÆËûçËß£ÊÄßÈ≠öÈ±óÁô¨
### Palmoplantar Keratoderma / ÊéåËπ†ËßíÂåñÁóá
### Darier's Disease / DarierÁóÖ

## Pigmentary Disorder / Ëâ≤Á¥†Áï∞Â∏∏Áóá

### Oculocutaneous Albinism / ÁúºÁöÆËÜöÁôΩÁöÆÁóá
### Vitiligo Vulgaris / Â∞ãÂ∏∏ÊÄßÁôΩÊñë
### Nevus Depigmentosus / ËÑ±Ëâ≤Á¥†ÊÄßÊØçÊñë
### Vogt-Koyanagi-Harada Disease / Vogt-Â∞èÊü≥-ÂéüÁî∞ÁóÖ
### Leucoderma Sutton / SuttonÁôΩÊñë
### Ephelides / ÈõÄÂçµÊñë
### Melasma / ËÇùÊñë
### Senile Lentigo / ËÄÅ‰∫∫ÊÄßËâ≤Á¥†Êñë

## Nevus / ÊØçÊñë

### Epidermal Nevus / Ë°®ÁöÆÊØçÊñë
### Sebaceous Nevus / ËÑÇËÖ∫ÊØçÊñë
### Melanocytic Nevus / Ëâ≤Á¥†ÊÄßÊØçÊñë
### Spitz Nevus / SpitzÊØçÊñë
### Nevus Spilus / ÊâÅÂπ≥ÊØçÊñë
### Nevus of Ota / Â§™Áî∞ÊØçÊñë
### Mongolian Spot / ËíôÂè§Êñë
### Blue Nevus / ÈùíËâ≤ÊØçÊñë

## Skin Tumor / ÁöÆËÜöËÖ´Áòç

### Seborrheic Keratosis / ËÑÇÊºèÊÄßËßíÂåñÁóá
### Porokeratosis / Ê±óÂ≠îËßíÂåñÁóá
### Epidermal Cyst / Ë°®ÁöÆÂö¢ËÖ´
### Hypertrophic Scar and Keloid / ËÇ•ÂéöÊÄßÁò¢Áóï„Éª„Ç±„É≠„Ç§„Éâ
### Mastocytoma / ËÇ•Ê∫ÄÁ¥∞ËÉûÁóá
### Infantile Hamangioma / ‰π≥ÂÖêË°ÄÁÆ°ËÖ´
### Glomus Tumor / „Ç∞„É≠„É†„ÇπËÖ´Áòç
### Kasabach-Merritt Syndrome / Kasabach-MerrittÁóáÂÄôÁæ§
### Capillary Malformation / ÊØõÁ¥∞Ë°ÄÁÆ°Â•áÂΩ¢
### Basal Cell Carcinoma / Âü∫Â∫ïÁ¥∞ËÉûÁôå
### Squamous Cell Carcinoma / ÊúâÊ£òÁ¥∞ËÉûÁôå
### Keratoacanthoma / „Ç±„É©„Éà„Ç¢„Ç´„É≥„Éà„Éº„Éû
### Solar Keratosis / Êó•ÂÖâËßíÂåñÁóá
### Bowen's Disease / BowenÁóÖ
### Extramammary Paget's Disease / ‰π≥ÊàøÂ§ñPagetÁóÖ
### Merkel Cell Carcinoma / MerkelÁ¥∞ËÉûÁôå
### Malignant Melanoma / ÊÇ™ÊÄßÈªíËâ≤ËÖ´
### Angiosarcoma / Ë°ÄÁÆ°ËÇâËÖ´
### Kaposi's Sarcoma / KaposiËÇâËÖ´
### Mycosis Fungoides / ËèåÁä∂ÊÅØËÇâÁóá
### S√©zary Syndrome / S√©zaryÁóáÂÄôÁæ§

## Skin Infection / ÁöÆËÜöÊÑüÊüìÁóá

### Folliculitis / ÊØõÂåÖÁÇé
### Furuncle and Carbuncle / Áô§„ÉªÁô∞
### Paronychia / Áà™Âõ≤ÁÇé
### Erysipelas / ‰∏πÊØí
### Cellulitis / ËúÇÂ∑£ÁÇé
### Necrotizing Fasciitis / Â£äÊ≠ªÊÄßÁ≠ãËÜúÁÇé
### Gas Gangrene / „Ç¨„ÇπÂ£äÁñΩ
### Impetigo Contagiosa / ‰ºùÊüìÊÄßËÜøÁóÇÁñπ
### Staphylococcal Scalded Skin Syndrome / „Éñ„Éâ„Ç¶ÁêÉËèåÊÄßÁÜ±ÂÇ∑ÊßòÁöÆËÜöÁóáÂÄôÁæ§
### Toxic Shock Syndrome / „Éà„Ç≠„Ç∑„ÉÉ„ÇØ„Ç∑„Éß„ÉÉ„ÇØÁóáÂÄôÁæ§
### Scarlet Fever / Áå©Á¥ÖÁÜ±
### Tuberculosis Cutis / ÁöÆËÜöÁµêÊ†∏
### Nontuberculous Mycobacteriosis / ÈùûÁµêÊ†∏ÊÄßÊäóÈÖ∏ËèåÁóá
### Leprosy / HansenÁóÖ
### Herpes Simplex / ÂçòÁ¥îÁñ±Áñπ
### Varicella / Ê∞¥Áóò
### Herpes Zoster / Â∏ØÁä∂Áñ±Áñπ
### Hand Foot and Mouth Disease / ÊâãË∂≥Âè£ÁóÖ
### Measles / È∫ªÁñπ
### Rubella / È¢®Áñπ
### Exanthema Subitum / Á™ÅÁô∫ÊÄßÁô∫Áñπ
### Erythema Infectiosum / ‰ºùÊüìÊÄßÁ¥ÖÊñë
### Gianotti Disease / GianottiÁóÖ
### Verruca Vulgaris / Â∞ãÂ∏∏ÊÄßÁñ£Ë¥Ö
### Verruca Plana / ÊâÅÂπ≥Áñ£Ë¥Ö
### Molluscum Contagiosum / ‰ºùÊüìÊÄßËªüÂ±ûËÖ´
### Dermatophytosis / ÁôΩÁô¨
### Cutaneous Candidiasis / ÁöÆËÜö„Ç´„É≥„Ç∏„ÉÄÁóá
### Malassezia Infection / „Éû„É©„Çª„ÉÅ„Ç¢ÊÑüÊüìÁóá
### Sporotrichosis / „Çπ„Éù„É≠„Éà„É™„Ç≥„Éº„Ç∑„Çπ
### Dematiaceous Fungal Infection / ÈªíËâ≤ÁúüËèåÁóá
### Scabies / Áñ•Áô¨
### Pediculosis / „Ç∑„É©„ÉüÁóá
### Lyme Disease / „É©„Ç§„É†ÁóÖ
### Scrub Typhus / „ÉÑ„ÉÑ„Ç¨„É†„Ç∑ÁóÖ 

## Epidermal Appendage Disease / ÁöÆËÜöÈôÑÂ±ûÂô®„ÅÆÁñæÊÇ£

### Miliaria / Ê±óÁñπ
### Hyperhidrosis / Â§öÊ±óÁóá
### Anhidrosis / ÁÑ°Ê±óÁóá
### Bromidrosis / Ëá≠Ê±óÁóá
### Acne Valgaris / Â∞ãÂ∏∏ÊÄßÁó§Áò°
### Acneiform Eruption / Áó§Áò°ÊßòÁô∫Áñπ
### Rosacea / ÈÖíÁö∂
### Rosacea-Like Dermatitis / ÈÖíÁö∂ÊßòÁöÆËÜöÁÇé
### Androgenetic Alopecia / Áî∑ÊÄßÂûãËÑ±ÊØõÁóá
### Alopecia Areata / ÂÜÜÂΩ¢ËÑ±ÊØõÁóá
### Trichotillomania / ÊäúÊØõÁóá
### Ingrown Nail / Èô•ÂÖ•Áà™
-->

# Orthopedic Surgery / Êï¥ÂΩ¢Â§ñÁßë

## Introduction / Á∑èË´ñ

## Upper Limb Disorder / ‰∏äËÇ¢ÁñæÊÇ£

## Lower Limb Disorder / ‰∏ãËÇ¢ÁñæÊÇ£

## Trunk Disorder / ‰ΩìÂππÁñæÊÇ£

## Joint Disorder / Èñ¢ÁØÄÁñæÊÇ£

## Peripheral Nerve Disorder / Êú´Ê¢¢Á•ûÁµåÁñæÊÇ£

## Trauma / Â§ñÂÇ∑

## Metabolic Disorder / ‰ª£Ë¨ùÊÄßÁñæÊÇ£

## Infectious Disorder / ÊÑüÊüìÊÄßÁñæÊÇ£

## Bone Tumor / È™®ËÖ´Áòç

# Urology / Ê≥åÂ∞øÂô®Áßë

## Introduction / Á∑èË´ñ

## Urinary Tract Infection and Stone / Â∞øË∑ØÊÑüÊüìÁóá„ÉªÁµêÁü≥

## Urinary Tract Tumor / Â∞øË∑ØËÖ´Áòç

## Urinary Tract Dysfunction / Â∞øË∑ØÊ©üËÉΩÈöúÂÆ≥

## Urinary Tract Congenital Anomaly / Â∞øË∑ØÂÖàÂ§©Áï∞Â∏∏

## Penis Disorder / Èô∞ËåéÁñæÊÇ£

## Testicle Disorder / Áùæ‰∏∏ÁñæÊÇ£

## Prostate Disorder / ÂâçÁ´ãËÖ∫ÁñæÊÇ£


<!-- ### Male Genital Organ / Áî∑ÊÄßÂô®

* **Scrotum**
  * **Structure**: Skin, smooth muscle (dartos)
  * **Artery**: Anterior scrotal artery (external pudendal artery), posterior scrotal artery (perineal artery)
  * **Nerve**: Scrotal nerve (perineal nerve)
  * **Spermatic cord**: Ductus deferens, tesicular artery, pampiniform plexus, genitofemoral nerve
* **Testis**
  * **Structure**: External fascia (external oblique), middle fascia (internal oblique), internal fascia (fascia transversalis), tunica vaginalis (peritoneum), tunica albuginea, lobule, seminoferous tube
  * **Artery**: Testicular artery (abdominal aorta)
  * **Vein**: Right testicular vein (inferior vena cava), left testicular vein (left renal vein)
  * **Spermatogenesis**: Spermatogonia, 1st spermatocyte, 2nd spermatocyte, spermatid, sperm
  * **Cell**: Sertoli cell (blood-testis barrier, activin, inhibin, MIF), Leydig cell (testosterone)
  * **Genital tracty**: Seminoferous tubule (spermatogenic cell, Sertoli cell), tubuli recti (Sertoli cell), rete testis (simple cuboidal), ductuli efferentes (simple columnar), epididymis (pseudostratified columnar, steriocelia), vas deferens (pseudostratified columnar, steriocelia)
* **Gland**
  * **Siminal vesicle**: Into prostate seminal coliculus
  * **Prostate**: Into prostatic sinus, central zone, peripheral zone (adenocarcinoma), transitional zone (BPH)
  * **Bulbourethral gland**: Into uretra
* **Penis**
  * **Structure**: 2 corpus cavernosa (crura, with tunica albuginea), 1 corpus spongisum (blub, glans)
  * **Artery**: Deep artery of penis (corpus cavernosa, perineal artery), artery of bulb (corpus spongiosum, perineal artery), dorsal artery of penis (glans, perineal artery)
  * **Nerve**: Dorsal nerve of penis (perineal nerve)
  * **Function**: Erection (parasympathetic, inferior hypogastric ganglion), ejaculation (sympathetic, superior hypogastric ganglion)
{: .notice--info} -->

<!-- ## Urinary Tract Dysfunction / Â∞øË∑ØÊ©üËÉΩÈöúÂÆ≥

### Hydronephrosis / Ê∞¥ËÖéÁóá
### Neurogenic Bladder / Á•ûÁµåÂõ†ÊÄßËÜÄËÉ±
### Overactive Bladder / ÈÅéÊ¥ªÂãïËÜÄËÉ±
### Stress Incontinence / ËÖπÂúßÊÄßÂ∞øÂ§±Á¶Å

## Urinary Tract and Genital Infection / Â∞øË∑Ø„ÉªÊÄßÂô®ÊÑüÊüìÁóá

### Pyelonephritis / ËÖéÁõÇËÖéÁÇé
### Renal Abscess / ËÖéËÜøÁòç
### Cystitis / ËÜÄËÉ±ÁÇé
### Urinary Tuberculosis / Â∞øË∑ØÁµêÊ†∏
### Urethritis / Â∞øÈÅìÁÇé
### Prostatitis / ÂâçÁ´ãËÖ∫ÁÇé
### Epididymitis / Á≤æÂ∑£‰∏ä‰ΩìÁÇé
### Orchitis / Á≤æÂ∑£ÁÇé

## Urinary Tract and Genital Tumor / Â∞øË∑Ø„ÉªÊÄßÂô®ËÖ´Áòç

### Urinary Stone / Â∞øË∑ØÁµêÁü≥
### Renal Cell Carcinoma / ËÖéÁ¥∞ËÉûÁôå
### Renal Pelvic and Ureteral Cancer / ËÖéÁõÇ„ÉªÂ∞øÁÆ°Áôå
### Bladder Cancer / ËÜÄËÉ±Áôå
### Penile Cancer / Èô∞ËåéÁôå
### Benign Prostatic Hyperplasia / ÂâçÁ´ãËÖ∫ËÇ•Â§ßÁóá
### Prostatic Cancer / ÂâçÁ´ãËÖ∫Áôå
### Testicular Tumor / Á≤æÂ∑£ËÖ´Áòç

## Genital Dysfunction / ÊÄßÂô®Ê©üËÉΩÁï∞Â∏∏
### Varicocele / Á≤æÁ¥¢ÈùôËÑàÁò§
### Testicular Torsion / Á≤æÂ∑£ÊçªËª¢Áóá
### Phimosis / ÂåÖËåé
### Erectile Dysfunction / ÂãÉËµ∑ÈöúÂÆ≥
### Priapism / ÊåÅÁ∂öÂãÉËµ∑Áóá
### Male Infertility / Áî∑ÊÄß‰∏çÂ¶äÁóá -->

# Gynecology / Â©¶‰∫∫Áßë

## Introduction / Á∑èË´ñ

## Sexuel Development Disorder / ÊÄßÂàÜÂåñÁñæÊÇ£

## Endocrine Disorder / ÂÜÖÂàÜÊ≥å„ÅÆÁï∞Â∏∏

## Aging-Related Disorder / Âä†ÈΩ¢„Å´„Çà„ÇãÁñæÊÇ£

## Genital Infection / ÊÄßÂô®ÊÑüÊüìÁóá

## Valvar and Vaginal Disorder / Â§ñÈô∞„ÉªËÖüÁñæÊÇ£

## Uterine Disorder / Â≠êÂÆÆÁñæÊÇ£

## Ovarian Disorder / ÂçµÂ∑£ÁñæÊÇ£

## Breast Disorder / ‰π≥ËÖ∫ÁñæÊÇ£

## Infertility / ‰∏çÂ¶äÁóá

<!-- ## Endocrine Disorder / ÂÜÖÂàÜÊ≥å„ÅÆÁï∞Â∏∏

### Anovulatory Cycle / ÁÑ°ÊéíÂçµÂë®ÊúüÁóá

### Luteal Insufficiency / ÈªÑ‰ΩìÊ©üËÉΩ‰∏çÂÖ®

### Premenstrual Syndrome / ÊúàÁµåÂâçÁóáÂÄôÁæ§

### Dysmenorrhea / ÊúàÁµåÂõ∞Èõ£Áóá

### Hyperprolactinemia / È´ò„Éó„É≠„É©„ÇØ„ÉÅ„É≥Ë°ÄÁóá

### Anorexia Nervosa / Á•ûÁµåÊÄß„ÇÑ„ÅõÁóá

### Amenorrhea Due to Weight Loss / ÂçòÁ¥îÊÄß‰ΩìÈáçÊ∏õÂ∞ëÊÄßÁÑ°ÊúàÁµå

### Sheehan Syndrome / SheehanÁóáÂÄôÁæ§

### Polycystic Ovary Syndrome / Â§öÂö¢ËÉûÊÄßÂçµÂ∑£ÁóáÂÄôÁæ§

## Sex Development Disorder / ÊÄßÂàÜÂåñÁñæÊÇ£

### Congenital Adrenocortical Hyperplasia / ÂÖàÂ§©ÊÄßÂâØËÖéÁöÆË≥™ÈÅéÂΩ¢ÊàêÁóá

### Androgen Insensitivity Syndrome / „Ç¢„É≥„Éâ„É≠„Ç≤„É≥‰∏çÂøúÁóá

### Turner Syndrome / TurnerÁóáÂÄôÁæ§

### Klinefelter Syndrome / KlinefelterÁóáÂÄôÁæ§ -->

# Obstetrics / Áî£Áßë

## Introduction / Á∑èË´ñ

## Early Pregnancy Disorder / Â¶äÂ®†ÂàùÊúü„ÅÆÁï∞Â∏∏

## Later Pregnancy Disorder / Â¶äÂ®†‰∏≠„ÉªÂæåÊúü„ÅÆÁï∞Â∏∏

## Complicated Pregnancy / Âêà‰ΩµÁóáÂ¶äÂ®†

## Mother to Children Infection / ÊØçÂ≠êÊÑüÊüìÁóá

## Delivery Disorder / ÂàÜÂ®©„ÅÆÁï∞Â∏∏

## Puerperium Disorder / Áî£Ë§•„ÅÆÁï∞Â∏∏

# Pediatrics / Â∞èÂÖêÁßë

## Introduction / Á∑èË´ñ

## Neonate Disorder / Êñ∞ÁîüÂÖêÁñæÊÇ£

## Congenital Disorder / ÂÖàÂ§©Áï∞Â∏∏

## Cardiovascular Disorder / Âæ™Áí∞Âô®ÁñæÊÇ£

## Respiratory Disorder / ÂëºÂê∏Âô®ÁñæÊÇ£

## Gastrointestinal Disorder / Ê∂àÂåñÂô®ÁñæÊÇ£

## Endocrine and Metabolism Disorder / ÂÜÖÂàÜÊ≥å„Éª‰ª£Ë¨ùÁñæÊÇ£

## Renal and Urologic Disorder / ËÖé„ÉªÊ≥åÂ∞øÂô®ÁñæÊÇ£

## Hematologic Disorder / Ë°ÄÊ∂≤ÁñæÊÇ£

## Immunologic Disorder / ÂÖçÁñ´ÁñæÊÇ£

## Infectious Disorder / ÊÑüÊüìÊÄßÁñæÊÇ£

## Neurologic Disorder / Á•ûÁµåÁñæÊÇ£

## Mental Disorder / Á≤æÁ•ûÁñæÊÇ£

## Neoplasm / Êñ∞ÁîüÁâ©

<!-- ## Cardiovascular Disease / Âæ™Áí∞Âô®ÁñæÊÇ£

### Atrial Septal Defect / ÂøÉÊàø‰∏≠ÈöîÊ¨†ÊêçÁóá
### Ventricular Septal Defect / ÂøÉÂÆ§‰∏≠ÈöîÊ¨†ÊêçÁóá
### Atrioventricular Septal Defect / ÊàøÂÆ§‰∏≠ÈöîÊ¨†ÊêçÁóá
### Patent Ductus Arteriosus / ÂãïËÑàÁÆ°ÈñãÂ≠òÁóá
### Coarctation of the Aorta / Â§ßÂãïËÑàÁ∏ÆÁ™ÑÁóá
### Eisenmenger Syndrome / EisenmengerÁóáÂÄôÁæ§
### Tetralogy of Fallot / FallotÂõõÂæ¥Áóá
### Complete Transposition of Great Arteries / ÂÆåÂÖ®Â§ßË°ÄÁÆ°Ëª¢‰ΩçÁóá
### Total Anomalous Pulmonary Venous Return / Á∑èËÇ∫ÈùôËÑàÈÇÑÊµÅÁï∞Â∏∏Áóá
### Double Outlet Right Ventricle / ‰∏°Â§ßË°ÄÁÆ°Âè≥ÂÆ§Ëµ∑ÂßãÁóá
### Hypoplastic Left Heart Syndrome / Â∑¶ÂøÉ‰ΩéÂΩ¢ÊàêÁóáÂÄôÁæ§
### Pulmonary Stenosis / ËÇ∫ÂãïËÑàÁã≠Á™ÑÁóá
### Pure Pulmonary Atresia / Á¥îÂûãËÇ∫ÂãïËÑàÈñâÈéñ
### Truncus Arteriosus Communis / Á∑èÂãïËÑàÂππÁóá
### Ruptured Aneurysm of the sinus of Valsalva / ValsalvaÊ¥ûÂãïËÑàÁò§Á†¥Ë£Ç
### Tricuspid Atresia / ‰∏âÂ∞ñÂºÅÈñâÈéñÁóá
### Ebstein's Disease / EbsteinÁóÖ
### Single Ventricle / ÂçòÂøÉÂÆ§Áóá

## Gastrointestinal Disease / Ê∂àÂåñÂô®ÁñæÊÇ£

### Congenital Esophageal Atresia / ÂÖàÂ§©ÊÄßÈ£üÈÅìÈñâÈéñ
### Hypertrophic Pyloric Stenosis / ËÇ•ÂéöÊÄßÂπΩÈñÄÁã≠Á™ÑÁóá
### Congenital Duodenal Atresia or Stenosis / ÂÖàÂ§©ÊÄßÂçÅ‰∫åÊåáËÖ∏ÈñâÈéñ„ÉªÁã≠Á™ÑÁóá
### Congenital Intestinal Atresia or Stenosis / ÂÖàÂ§©ÊÄßÂ∞èËÖ∏ÈñâÈéñ„ÉªÁã≠Á™ÑÁóá
### Intestinal Malrotation / ËÖ∏ÂõûËª¢Áï∞Â∏∏Áóá
### Meckel Diverticulum / MeckelÊÜ©ÂÆ§
### Intussusception / ËÖ∏ÈáçÁ©çÁóá
### Hirschsprung Disease / HirschsprungÁóÖ
### Necrotizing Enterocolitis / Â£äÊ≠ªÊÄßËÖ∏ÁÇé
### Anal Atresia / ÈéñËÇõ 
### Bochdalek Hernia / BochdalekÂ≠î„Éò„É´„Éã„Ç¢
### Omphalocele / ËáçÂ∏Ø„Éò„É´„Éã„Ç¢
### Gastroschisis / ËÖπÂ£ÅÁ†¥Ë£Ç
### Gilbert Syndrome / GilbertÁóáÂÄôÁæ§
### Crigler-Najjar Syndrome / Cirgler-NajjarÁóáÂÄôÁæ§
### Dubin-Johnson Syndrome / Dubin-JohnsonÁóáÂÄôÁæ§
### Rotor Syndrome / RotorÁóáÂÄôÁæ§
### Biliary Atresia / ËÉÜÈÅìÈñâÈéñÁóá
### Congenital Biliary Dilatation / ÂÖàÂ§©ÊÄßËÉÜÈÅìÊã°ÂºµÁóá

## Metabolism Disease / ‰ª£Ë¨ùÁñæÊÇ£

### Phenylketonuria / „Éï„Çß„Éã„É´„Ç±„Éà„É≥Â∞øÁóá
### Maple Syrup Urine Disease / „É°„Éº„Éó„É´„Ç∑„É≠„ÉÉ„ÉóÂ∞øÁóá
### Homocystinurea / „Éõ„É¢„Ç∑„Çπ„ÉÅ„É≥Â∞øÁóá
### Urea Cycle Defect / Â∞øÁ¥†„Çµ„Ç§„ÇØ„É´Áï∞Â∏∏Áóá
### Von Gierke Disease / Von GierkeÁóÖ
### Pompe Disease / PompeÁóÖ
### Galactosemia / „Ç¨„É©„ÇØ„Éà„Éº„ÇπË°ÄÁóá
### Lactose Intolerance / ‰π≥Á≥ñ‰∏çËÄêÁóá
### Mucopolysaccharidoses / „É†„Ç≥Â§öÁ≥ñÁóá
### Tay-Sachs Disease / Tay-SachsÁóÖ
### Fabry Disease / FabryÁóÖ
### Gaucher Disease / GaucherÁóÖ
### Nieman-Pick Disease / Nieman-PickÁóÖ
### Lesch-Nyhan Syndrome / Lesch-NyhanÁóáÂÄôÁæ§
### Wilson's Disease / WilsonÁóÖ
### Menkes Disease / MenkesÁóÖ
### Marfan Syndrome / MarfanÁóáÂÄôÁæ§
### Ehlers-Danlos Syndrome / Ehlers-DanlosÁóáÂÄôÁæ§
### Ketotic Hypoglycemia / „Ç±„Éà„É≥ÊÄß‰ΩéË°ÄÁ≥ñÁóá
### Acetonic Vomiting / „Ç¢„Çª„Éà„É≥Ë°ÄÊÄßÂòîÂêêÁóá
### Osteomalacia / È™®ËªüÂåñÁóá
### Osteogenesis Imperfecta / È™®ÂΩ¢Êàê‰∏çÂÖ®Áóá
### Chondrodysplasia / ËªüÈ™®Áï∞ÂΩ¢ÊàêÁóá

## Endocrine Disease / ÂÜÖÂàÜÊ≥åÁñæÊÇ£

### Growth Hormone Deficiency / ÊàêÈï∑„Éõ„É´„É¢„É≥Ê¨†‰πèÁóá
### Congenital Hypothyroidism / ÂÖàÂ§©ÊÄßÁî≤Áä∂ËÖ∫Ê©üËÉΩ‰Ωé‰∏ãÁóá
### Precocious Puberty / Êó©Áô∫ÊÄßÊÄùÊò•Êúü
### McCune-Albright Syndrome / McCune-AlbrightÁóáÂÄôÁæ§
### Turner Syndrome / TurnerÁóáÂÄôÁæ§
### Klinefelter Syndrome / KlinefelterÁóáÂÄôÁæ§
### Kallman Syndrome / KallmanÁóáÂÄôÁæ§
### Prader-Willi Syndrome / Prader-WilliÁóáÂÄôÁæ§
### Congenital Adrenocortical Hyperplasia / ÂÖàÂ§©ÊÄßÂâØËÖéÁöÆË≥™ÈÅéÂΩ¢Êàê
### Androgen Insensitivity Syndrome / „Ç¢„É≥„Éâ„É≠„Ç≤„É≥‰∏çÂøúÁóá

## Renal and Urologic Disease / ËÖé„ÉªÊ≥åÂ∞øÂô®ÁñæÊÇ£

### Polycystic Kidney Disease / Â§öÁô∫ÊÄßÂö¢ËÉûËÖé
### Sponge Kidney / Êµ∑Á∂øËÖé
### Horseshoe Kidney / È¶¨ËπÑËÖé
### Congenital Hydronephrosis / ÂÖàÂ§©ÊÄßÊ∞¥ËÖéÁóá
### Duplicated Renal Pelvis and Ureter / ÈáçË§áËÖéÂ≠üÂ∞øÁÆ°
### Ectopic Ureter / Â∞øÁÆ°Áï∞ÊâÄÈñãÂè£
### Ureterocele / Â∞øÁÆ°Áò§
### Vesicourethral Reflux / ËÜÄËÉ±Â∞øÁÆ°ÈÄÜÊµÅ
### Hypospadias / Â∞øÈÅì‰∏ãË£Ç
### Cryptorchidism / ÂÅúÁïôÁ≤æÂ∑£
### Hydrocele Testis / Èô∞Âö¢Ê∞¥ËÖ´

## Hematologic Disease / Ë°ÄÊ∂≤ÁñæÊÇ£

### Hemophilia / Ë°ÄÂèãÁóÖ
### Von Willebrand Disease / Von WillebrandÁóÖ
### Bernard-Soulier Syndrome / Bernard-SoulierÁóáÂÄôÁæ§
### Glanzmann Thrombasthenia / Ë°ÄÂ∞èÊùøÁÑ°ÂäõÁóá

## Immune Disease / ÂÖçÁñ´ÁñæÊÇ£

### Severe Combined Immunodeficiency / ÈáçÁóáË§áÂêàÂÖçÁñ´‰∏çÂÖ®Áóá
### X-linked Agammaglobulinemia / XÈÄ£ÈéñÁÑ°Œ≥-„Ç∞„É≠„Éñ„É™„É≥Ë°ÄÁóá
### Hyper-IgM Syndrome / È´òIgMÁóáÂÄôÁæ§
### Wiskott-Aldrich Syndrome / Wiskott-AldrichÁóáÂÄôÁæ§
### Ataxia Telangiectasia / ÊØõÁ¥∞Ë°ÄÁÆ°Êã°ÂºµÊÄßÈÅãÂãïÂ§±Ë™øÁóá
### DiGeorge Syndrome / DiGeorgeÁóáÂÄôÁæ§
### Ch√©diak-Higashi Syndrome / Ch√©diak-HigashiÁóáÂÄôÁæ§
### Chronic Granulomatous Disease / ÊÖ¢ÊÄßËÇâËäΩËÖ´Áóá

## Neurological Disease / Á•ûÁµåÁñæÊÇ£

### Craniosynostosis / È†≠ËìãÁ∏´ÂêàÊó©ÊúüÁôíÂêàÁóá
### Spina Bifida / ‰∫åÂàÜËÑäÊ§é
### Cranium Bifidum / ‰∫åÂàÜÈ†≠Ëìã
### Congenital Hydrocephalus / ÂÖàÂ§©ÊÄßÊ∞¥È†≠Áóá
### Chiari Malformation / ChiariÂ•áÂΩ¢
### Dandy-Walker Syndrome / Dandy-WalkerÁóáÂÄôÁæ§
### Arachnoid Cyst / „Åè„ÇÇËÜúÂö¢ËÉû

## Neoplasm / Êñ∞ÁîüÁâ©

### Hepatoblastoma / ËÇùËäΩËÖ´
### Wilms' Tumor / WilmsËÖ´Áòç -->

<!-- # Emergency Medicine / ÊïëÊÄ•Áßë

## Shock / „Ç∑„Éß„ÉÉ„ÇØ

### Cardiopulmonary Arrest / ÂøÉËÇ∫ÂÅúÊ≠¢
### Hypovolemic Shock / Âæ™Áí∞Ë°ÄÊ∂≤ÈáèÊ∏õÂ∞ëÊÄß„Ç∑„Éß„ÉÉ„ÇØ
### Anaphylactic Shock / „Ç¢„Éä„Éï„Ç£„É©„Ç≠„Ç∑„Éº„Ç∑„Éß„ÉÉ„ÇØ
### Neurogenic Shock / Á•ûÁµåÂéüÊÄß„Ç∑„Éß„ÉÉ„ÇØ
### Septic Shock / ÊïóË°ÄÁóáÊÄß„Ç∑„Éß„ÉÉ„ÇØ
### Cardiogenic Shock / ÂøÉÂéüÊÄß„Ç∑„Éß„ÉÉ„ÇØ
### Extracardiac Obstructive Shock / ÂøÉÂ§ñÈñâÂ°ûÊÄß„Ç∑„Éß„ÉÉ„ÇØ

## Emergency Disease / ÊïëÊÄ•ÁñæÊÇ£

### Airway Foreign Body / Ê∞óÈÅìÁï∞Áâ©
### Gastrointestinal Foreign Body / Ê∂àÂåñÁÆ°Áï∞Áâ©
### Status Epilepticus / „Å¶„Çì„Åã„ÇìÈáçÁ©çÁä∂ÊÖã
### Acute Abdomen / ÊÄ•ÊÄßËÖπÁóá
### Multiple Organ Dysfunction Syndrome / Â§öËáìÂô®‰∏çÂÖ®

## Thoracic Injury / ËÉ∏ÈÉ®Â§ñÂÇ∑

### Tracheobronchial Injury / Ê∞óÁÆ°„ÉªÊ∞óÁÆ°ÊîØÊêçÂÇ∑
### Pulmonary Contusion / ËÇ∫Êå´ÂÇ∑
### Flail Chest / ËÉ∏ÈÉ≠ÂãïÊè∫
### Open Pneumothorax / ÈñãÊîæÊÄßÊ∞óËÉ∏
### Tension Pneumothorax / Á∑äÂºµÊÄßÊ∞óËÉ∏
### Aortic Injury / Â§ßÂãïËÑàÊêçÂÇ∑
### Massive Hemothorax / Â§ßÈáèË°ÄËÉ∏

## Abdominal Injury / ËÖπÈÉ®Â§ñÂÇ∑

### Liver Injury / ËÇùÊêçÂÇ∑
### Splenic Rupture / ËÑæÁ†¥Ë£Ç
### Kidney Injury / ËÖéÂ§ñÂÇ∑
### Urethral Injury / Â∞øÈÅìÂ§ñÂÇ∑
### Bladder Injury / ËÜÄËÉ±Â§ñÂÇ∑
### Testicular Injury / Á≤æÂ∑£Â§ñÂÇ∑

## Other Injury / „Åù„ÅÆ‰ªñ„ÅÆÂ§ñÂÇ∑

### High Energy Trauma / È´ò„Ç®„Éç„É´„ÇÆ„ÉºÂ§ñÂÇ∑
### Crush Syndrome / ÂúßÊå´ÁóáÂÄôÁæ§
### Compartment Syndrome / „Ç≥„É≥„Éë„Éº„Éà„É°„É≥„ÉàÁóáÂÄôÁæ§
### Fat Embolism Syndrome / ËÑÇËÇ™Â°ûÊ†ìÁóáÂÄôÁæ§
### Burns / ÁÜ±ÂÇ∑
### Smoke Inhalation Injury / Ê∞óÈÅìÁÜ±ÂÇ∑

## Diseases due to Physical Factors / Áâ©ÁêÜÁöÑË¶ÅÂõ†„Å´„Çà„ÇãÁñæÊÇ£

### Heat Illness / ÁÜ±‰∏≠Áóá
### Accidental Hypothermia / ÂÅ∂Áô∫ÊÄß‰Ωé‰ΩìÊ∏©Áóá
### Altitude Sickness / È´òÂ±±ÁóÖ
### Decompression Sickness / Ê∏õÂúßÁóá

## Poisoning / ‰∏≠ÊØí

### Food Poisoning / È£ü‰∏≠ÊØí
### Drug Poisoning / Ëñ¨Áâ©‰∏≠ÊØí
### Organic Solvent Poisoning / ÊúâÊ©üÊ∫∂Ââ§‰∏≠ÊØí
### Toxic Gas Poisoning / ÊúâÊØí„Ç¨„Çπ‰∏≠ÊØí
### Metal Poisoning / ÈáëÂ±û‰∏≠ÊØí
### Pesticide Poisoning / Ëæ≤Ëñ¨‰∏≠ÊØí -->
